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The critical role of a disrupted gut-liver axis in the pathogenesis of many diseases has 
only recently been accepted. The role of diets in the related bidirectional relationship 
between the gut, along with its microbiota, and the liver are however poorly defined. 
Designing an experimental animal model to study the gut-liver axis requires the use 
of commercial control diets such as chow or purified low-fat (LF) diets. While chow 
is a whole foods grain-based diet, LF contains high amount of easily accessible 
refined carbohydrates together with reduced dietary fibre and resembles a low-fat 
Western style diet. In this thesis, we compared chow and LF diets to characterise 
their differential effects on the gut-liver axis with focus on the ileum in C57BL/6J 
mice. For the first time, we showed that the LF diet significantly increased hepatic 
triglycerides, ileal bile acid levels and altered the ileal microbiota compared to chow. 
Long-term consumption of the LF diet led to further increased hepatic triglycerides, 
reduced ileal expression of antimicrobial peptides and cell cycle related genes. Next, 
we investigated strategies to prevent the LF induced phenotype by; 1) reducing the 
consumption of the LF diet with calorie restriction (CR) and, 2) addition of dietary 
fibres to the LF diet. We found that CR was successfully able to prevent the 
pathophysiological effects of the LF diet on the gut-liver axis and led to a distinct 
ileal microbiota profile. The second prevention strategy of enriching the LF diet with 
dietary fibres reduced the LF induced accumulation of hepatic triglycerides in mice. 
Moreover, our results showed differential effects of the structurally distinct dietary 
fibres on the ileal immune related gene expression. Lastly, we characterised the diet 
induced changes in genetically identical mice obtained from different vendors, to 
show differential ileal microbiota and bile acid profiles. Our studies highlight that 
dietary composition and animal source can affect the ileal microbiota composition 
and function, and lead to significant phenotype variability. The novel results from 
this thesis indicate that dietary fibres are essential food components with mode of 
actions not just in the colon but also in the ileum. Our studies further confirm that 
even low-fat Western style diets may have a pathophysiological impact on human 
health if the diet is depleted in essential food components such as dietary fibres.   
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Our ancestor’s diet comprised of whole foods and most of the consumed sugar 
derived from fruits. At present times, changes in lifestyle, dietary trends like 
veganism and increased production of ultra-processed foods has meant 
overconsumption of refined carbohydrates, deficiency of dietary fibres (DF) and 
essential micronutrients in individuals. These types of foods predispose people to a 
wide range of chronic illnesses including cardiovascular disease (CVD), non-
alcoholic fatty liver disease (NAFLD), diabetes, and cancers of the gastrointestinal 
tract (O'Keefe et al., 2018). The pathophysiology of these diseases is highly complex 
and involves several pathways in the gut-liver axis. In this thesis, we compare 
different dietary interventions to counteract the effects of a highly refined diet on the 
gut and liver of mice. The aim of our research is to 1) characterise molecular and 
microbial signatures associated with highly refined diet, 2) explore dietary 
interventions that may counteract these pathophysiological phenotypes.  
1.1 The gut- liver axis 
The gut and liver communicate bidirectionally through the biliary tract and portal 
vein (Fig.1.1). The liver communicates with the intestine by releasing bile acids into 
the biliary tract. In the gut, host and microbes metabolise endogenous (e.g. bile acids, 
amino acids) as well as exogenous substrates (from diet and environmental 
exposure), to produce microbial metabolites, microbe-associated molecular patterns 
(MAMPs; e.g., lipopolysaccharides (LPS) and secondary bile acids which translocate 
to the liver through the portal vein and influence liver functions.  
 
 





1.1.1 Communication via bile acids 
Bile acids are synthesised from cholesterol in the liver and act as detergents to 
facilitate the digestion and absorption of dietary fats, and fat-soluble vitamins. Bile 
acids are conjugated to glycine or taurine in the liver, stored in the gallbladder and 
from there secreted postprandially into the duodenum part of the small intestine via 
the biliary tract. After dietary fat is absorbed, about 95% of the bile acids are actively 
reabsorbed in the ileum and transported back to the liver via the portal vein. The 
remaining 5% of the total secreted bile acids may be lost in the faeces. The liver 
recycles the reabsorbed bile acids and releases them back to the small intestine and 
therefore, a continuous circulation of bile acids exists between the liver and the 
intestine, also known as the enterohepatic circulation (Ticho et al., 2019). 
The bile acids that are synthesised in the hepatocytes are known as primary bile 
acids. These include cholic acid (CA; 3α-,7α-, and 12α-hydroxylated) and 
chenodeoxycholic acid (CDCA; 3α- and 7α-hydroxylated) in most mammals. In 
mice, next to CA and CDCA, a group of bile acids termed muricholic acids (MCAs) 
are the most abundant in the bile acid pool. The two major MCAs in mice are α-
muricholic acid (αMCA;3α-, 6β-, and 7α- hydroxylated) and β-muricholic acid 
(βMCA; 3α-, 6β-, and 7β- hydroxylated). The first reaction in the bile acids synthesis 
pathway is catalysed by cytochrome P450 7A1 (cholesterol 7α-hydroxylase; 
CYP7A1) (Fig. 1.2). CYP7A1 is a rate limiting enzyme, and critical for efficient 
synthesis of bile acids. Indeed, deletion of CYP7A1 function by homozygous 
knockout of the Cyp7a1 gene in mice reduced bile acid synthesis by approximately 
60% and bile acid pool size by approximately 75%, and resulted in increased faecal 
fat content, hypercholesterolemia, and poor survival. The classical pathway can 
generate CDCA and CA, whilst the alternative pathway that involved CYP27A1 
primarily produces CDCA. The ratio between CA and CDCA is determined by 
another enzyme in the classical bile acids synthesis pathway; cytochrome P450 8B1 
(sterol 12α-hydroxylase; CYP8B1). CYP8B1 is responsible for hydroxylating the 
12α carbon of the steroid ring. Therefore, CYP8B1 is involved in the synthetic routes 
of CA, which is 12α-hydroxylated, and not CDCA (Ticho et al., 2019). Transgenic 
Cyp8b1 knockout mice were shown to have a profoundly different bile acid profile 
compared to wild-type animals (Li-Hawkins et al., 2002). Secondary bile acids found 
in mammals are deoxycholic acid (DCA; 3α- and 12α- hydroxylated) and lithocholic 
acid (LCA; 3α- hydroxylated), that are generated in the intestine by microbiota via 
7α-dehydroxylation of CA and CDCA, respectively (Fig. 1.2). In mice specifically, 
ursodeoxycholic acid (UDCA; 3α- and 7β- hydroxylated) is produced from CDCA by 
intestinal bacteria via 7- hydroxyl epimerization.  
Under physiological conditions, most of bile acids are produced via the classical 
pathway. However, in the event of liver injury the alternate acidic pathway may 
become predominant. The alternative bile acids pathway is initiated by sterol 27-






Figure 1.2 Bile acids synthesis. CYP7A1: cholesterol 7α-hydroxylase, CYP27A1: sterol-27-
hydroxylase, CYP8B1: 12α-hydroxylase, CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, 
deoxycholic acid; LCA, lithocholic acid. T and G are taurine and glycine conjugates. *CYP27A1: 
alternative bile acids synthesis pathway. Sourced from Molinaro et al., (2018): Trends in 
Endocrinology & Metabolism. 
 
The de novo bile acids are released from the liver across the canalicular membrane 
by the bile salt export pump (BSEP/ABCB11). Biliary bile acids are stored in the 
gallbladder and secreted into the duodenum postprandially, where they act as 
detergents for lipids as well as signalling biomolecules. In the lumen bile acids travel 
along the length of the small intestine and are actively reabsorbed in the terminal 
ileum by the apical sodium-dependent bile acid transporter (ASBT/SLC10A2). 
Reabsorbed bile acids are shuttled from the apical to the basolateral membrane of the 
enterocyte and are transported into the portal circulation by the organic solute 
transporter alpha/beta heterodimer (OSTα/β, SLC51A/B). These bile acids are 




membrane via sodium-taurocholate co-transporting polypeptide (NTCP/SLC10A1) 
(Fig.1.3).  In addition to their active uptake by ASBT in the ileal enterocytes, bile 
acids with a high enough pKa can passively diffuse through membranes in the 
intestine. Higher pKa means weaker bile acid, reduced water solubility and increased 
lipophilicity (Suga et al., 2017). 
Unconjugated bile acids have a high pKa (∼6) and are able to passively diffuse 
through membranes. Conjugation of primary bile acids with taurine and glycine in 
the liver decreases the pKa of bile acids, and therefore require transporter mediated 
uptake. In addition to producing secondary bile acids, gut microbiota can deconjugate 
bile acids and thus increase their pKa. However, ASBT and OSTα/β remain the 
critical transporters for the intestinal absorption and enterohepatic circulation of bile 
acids (Krag and Phillips, 1974; Ticho et al., 2019). 
In the recent years, bile acids have received great attention due to their role as 
hormone-like signalling molecules. Bile acids interact with extra- and intracellular 
cellular receptors, including the nuclear receptor farnesoid X receptor 
(FXR/NR1H4). Several studies have reported FXR as a major regulator of bile acid 
homeostasis that functions to protect against bile acids induced cytotoxicity. 
Depending on the structure, bile acids have the ability to act as FXR agonists or 
antagonists. In the liver, FXR controls the expression of bile acid transporters to 
reduce cellular bile acids. Hepatic FXR inhibits the expression of NTCP through a 
Small heterodimer partner (SHP)-dependent process resulting in reduced uptake of 
bile acids from the portal circulation (Denson et al., 2001). Intestinal FXR plays an 
important role in supressing bile acid synthesis. Activation of FXR in the intestine 
increases the transcription of fibroblast growth factor 15 (Fgf15 in rodents, FGF19 in 
humans). FGF15/19 is transported to the hepatocytes in the portal blood, where it 
binds to the FGF receptor 4 (FGFR4)/β-klotho (KLB) complex. This complex blocks 
CYP7A1 transcription in a SHP dependent manner, thereby reducing bile acids 
synthesis (Kir et al., 2012). Studies using transgenic mouse models have helped 
unravel the complex mechanisms underlying FGF15/19 biological activity. Mice 
lacking FGF15, FGFR4 and KLB show impaired bile acids metabolism (with 
increased bile acids synthesis and serum bile acids levels), and exogenous FGF15 
administration is unable to repress CYP7A1 in both FGFR4 and KLB knockout mice 
(Yu et al., 2000; Ito et al., 2005). In addition to the involvement of FGF15/19 in bile 
acid homeostasis, FGF15/19 is an important regulator of glucose and energy 
homeostasis. Kir et al. (2011) demonstrated FGF15 involvement in glucose 
regulation by using Fgf15- knockout mice. These mice were unable to maintain 
physiological concentrations of glucose, additionally, they displayed impaired 
hepatic glycogen storage and glucose intolerance. The authors suggest FGF15/19-
FGFR4-KLB complex triggers an increase in hepatic glycogen synthase activity and 
glycogen synthesis, via activation of small guanosine triphosphatase RAS, and 
extracellular signal regulated protein kinase (ERK) signalling pathway (Kir et al., 
2011). FGF15 is known to inhibit hepatic gluconeogenesis in an insulin independent 
manner via downregulation of genes involved in gluconeogenesis. The inhibition of 
gluconeogenesis occurs by inactivation of cAMP regulatory element–binding protein 




coactivator-1α (PGC-1α) (Fig. 1.3). This FGF15/19-dependent pathway regulates 
hepatic glucose metabolism following the fall in insulin levels, thereby regulating 
hepatic metabolism from the fed to fasted state (Potthoff et al., 2011). Dysregulation 
of FGF15 has also been associated with the development of hepatocellular carcinoma 
(HCC) in mice, in which the Fgf15 gene expression is increased in the ileum as well 
as hepatocytes (Cui et al., 2018; Gadaleta1 and Moschetta, 2019).  
 
 
Figure 1.3 FGF15/19 effects on glucose regulation in the liver. FGF15/19: fibroblast growth factor, 
BA: bile acids, FXR: farnesoid X receptor, FGFR4: FGF receptor, KLB:  β-klotho, CREB: cAMP regulatory 
element–binding protein, PGC1α: transcriptional co-regulator peroxisome proliferator-activated 
receptor 1α. Adapted from Kir et al., (2011).  
 
Multiple lines of evidence indicate that bile acids and the gut microbiota closely 
interact and modulate each other. Bile acids exert direct control on the intestinal 
microbiota by activation of FXR dependent gene regulation. Inagaki et al. (2006) 
demonstrated that bile duct ligation (BDL) and obstructing bile flow to the intestine 
in mice caused bacterial overgrowth, mucosal damage, and consequent systemic 
inflammation. The authors also showed that the adverse effects of BDL were 
reversed by administration of the synthetic FXR agonist (GW4064) that induced 
genes related to enteroprotection, inhibited bacterial overgrowth and systemic 
translocation. It is becoming increasingly evident that bile acids profoundly impact 
the composition of the gut microbiota, and that bacterial disturbance may alter the 
fine balance between primary and secondary bile acids and their subsequent 
enterohepatic cycling. Dysregulation of enterohepatic circulation can lead to the 
accumulation of bile acids in the hepatocytes and enterocytes, thereby inducing bile 








Figure 1.4 Enterohepatic circulation of bile acids. BA: bile acids, CYP7A1: cholesterol 7α-hydroxylase, 
BSEP: bile salt export pump, ASBT: apical sodium-dependent bile acid transporter, OSTα/β: organic 
solute transporter α/β heterodimer, NTCP: Na+-taurocholate cotransporting polypeptide, FXR: 
farnesoid X receptor, FGF15/19: fibroblast growth factor. Sourced from Ticho et al., (2019): 
Comprehensive Physiology.  
 
1.1.2 Intestinal barrier function 
The gut barrier consists of a physical barrier, a biochemical barrier and an immune 
system barrier (Chu et al., 2019). The physical barrier is supported mainly by the gut 
microbiota, mucus layer and a single layer of intestinal epithelial cells that are linked 
by tight junction proteins. Molecules with antimicrobial and anti-inflammatory 
properties, such as bile acids and antimicrobial proteins (including α-defensins and β-
defensins, C-type lectins, cathelicidin, lysozyme and intestinal alkaline phosphatase) 
support and mediate the highly structured biochemical barrier (Dupont et al., 2014). 
Secretory immunoglobulin A (IgA) and lymph node resident immune cells form the 
components of immune system barrier (Melo-Gonzalez et al., 2019).  
The gut microbiota is comprised of thousands of microbial species including, 
archaea, bacteria, fungi and viruses. The gut microbiota plays a crucial role in host’s 
physiology and is involved in various processes such as immune response, nutrition 
absorption and intestinal permeability. Mammalian gut bacteria mainly comprises of 
Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria phylum, however, 
their abundance may be modulated by genetic (Tran et al., 2019) and physiological 
factors such as age and environmental factors such as diet, medication (antibiotics) 




maintain tissue homeostasis and mutualism to prevent colonization by pathogenic 
bacteria. The gradient of microbial density in the gastrointestinal tract increases from 
duodenum (104/ml) to the distal ileum (108/ml), and the colon (1011/ml) (Donaldson 
et al., 2016). 
Mucus and tight junction proteins form the structure of the physical barrier between 
luminal bacteria and the underlying epithelial layer. Mucus is comprised of mucin 
proteins, mainly mucin 2 (MUC2) which is secreted by goblet cells (Van der Sluis et 
al., 2006). The thickness of the mucus layer is dependent on the location in the gut. 
The large intestine has a dense mucus layer, compared to the less dense and porous 
mucus layer found in the small intestine. MUC2 not only provides physical 
protection but has also been reported to restrict the immune response towards 
intestinal antigens by imprinting enteric dendritic cells (DCs) towards an anti-
inflammatory state (Shan et al., 2013). The mucus is also associated with 
antimicrobial properties through the action of antimicrobial peptides (AMPs) such as 
α-defensins, β-defensins, C-type lectins, and lysozyme which are released into the 
mucus gel to reinforce the barrier. Hence, the mucus layer is the very first line of 
defence against gut bacteria and exogenous molecules in the gut lumen 
(Vancamelbeke and Vermeire, 2017).  
Underneath the mucus layer, the intestinal epithelial cells (IECs) comprise of several 
distinct cell types; absorptive enterocytes, goblet cells, enteroendocrine cells, Paneth 
cells, microfold (M) and Tuft cells. These cells together form a continuous and 
polarised monolayer that separates the lumen from the lamina propria. Tight junction 
proteins are apical adhesives that seal the intercellular space. These junctional 
proteins include large families of claudins, occludins, junctional adhesion molecules 
(JAMs) as well as scaffolding molecules (Vancamelbeke and Vermeire, 2017). 
Altogether, this physical barrier functions to maintain gut epithelial integrity, 
epithelium polarity to allow transport of nutrients, and create a barrier against 
pathogens and dietary antigens by separating the lamina propria from the lumen 
(Odenwald and Turner, 2017). Moreover, crosstalk between the gut bacteria and 
immunity is represented by AMPs which are mostly produced by Paneth cells. 
Pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-
Like receptors (NLRs) also recognise bacterial components and release interleukins 
(such as IL-22) to shape the gut microbiota and maintain gut homeostasis. Innate 
lymphoid cells (ILCs) have recently been discovered to play a role in innate immune 
cell population. The population and function of the intestinal ILCs are reported to be 
influenced by the signals from the microbiota (Gury-Benari et al., 2016). The small 
intestine is the largest producer of immunoglobulins in the body. Secretory IgA plays 
an important role in protecting the host against pathogens and shaping the gut 
microbiota (Lycke et al., 2017). Palm et al. (2014) identified colitogenic (colitis 
promoting) intestinal bacteria to be coated with secretory IgA in a mouse model of 
microbiota-driven colitis. The study suggests IgA coating of these inflammatory 
commensal bacteria prevents bacterial dysbiosis during colitis and helps to maintain 
homeostatic gut microbiota. Altogether, the intestinal barrier is highly dynamic and 
adaptable to both internal and exogenous signals (such as cytokines, bacteria, dietary 




derived products (for instance, bacteria cell wall components and microbial 
metabolites) can circulate to the liver via the portal vein and induced hepatic and 
systemic inflammation (Aron-Wisnewsky et al., 2020). Western style diets have been 
known to profoundly affect gut microbiota composition and adversely impact the gut 
barrier function (Aron-Wisnewsky et al., 2020) (More on Western diets in Paragraph 
1.2.1). 
1.1.3 Carbohydrate metabolism  
Human population has thrived on diets with varying carbohydrate amounts. The basic 
carbohydrates that are consumed by most humans include simple sugars (glucose and 
fructose; fruits, honey, beverages), disaccharides (lactose; milk and dairy products 
and sucrose; table sugar), and complex carbohydrates (starch; potato, rice and wheat 
and dietary fibres (DF); grains, non-starchy vegetables, pulses). The current 
carbohydrate intake in humans typically comprises of 45-60% of total energy 
(Ludwig et al., 2018). It is becoming increasingly clear that the quality as well as the 
amount of carbohydrate plays an important role in population health. Increased 
consumption of high glycaemic load grains such as white rice, potato products, and 
added sugars (e.g. in beverages) are causally related to obesity, diabetes, and 
cardiovascular disease, whereas non-starchy vegetables, whole fruits, legumes, and 
whole kernel grains are associated with lower risk of metabolic diseases (Feinman et 
al., 2015, Ludwig et al., 2018). 
In theory, dietary carbohydrates are compounds that can be metabolised directly into 
glucose, or that undergo oxidation into pyruvate. Glucose homeostasis involves three 
physiological stages: 1) intestinal glucose absorption in the fed state, 2) hepatic 
glucose production, and 3) extrahepatic glucose usage by the brain, skeletal muscle, 
and adipose tissue (Merino et al., 2019). Inside the small intestine, carbohydrates 
(e.g. starch, sucrose) are broken down into monosaccharides by the brush border 
ectoenzymes known as α-glucosidases expressed on the enterocytes. One of the brush 
border enzymes is maltase glucoamylase (MGAM) which hydrolyses α-1,4 
glycosidic linkages between glucose molecules in maltose (from starch). Another 
brush border enzyme is sucrase-isomaltase (SIS), which hydrolyses α-1,2 glycosidic 
linkages between glucose and fructose molecules, thereby breaking down sucrose. 
Other brush border enzymes include lactase involved in breaking down lactose from 
milk into glucose and galactose (Goodman, 2010).  
Although glucose and fructose share the same molecular formula (C6H12O6) and 
caloric value (4 kcal/g), they have distinct metabolism in the intestine (Merino et al., 
2019) (Fig. 1.5 and Fig. 1.6).  
Glucose is absorbed into the intestinal epithelial cells by the sodium-glucose linked 
transporter (SGLT1/SLC5A1) that is expressed at the apical membrane, and glucose 
transporter 2 (GLUT2/ SLC2A2) at the basolateral membrane. SGLT1 and GLUT2 
expression is regulated by luminal concentration of glucose, insulin, and caloric 
demand (Merino et al., 2020). Further, in response to high luminal glucose 
concentration, GLUT2 may be translocated to the apical membrane of the enterocyte, 




Blood glucose enters hepatocytes via GLUT2 and is phosphorylated by glucokinase 
to form glucose-6-phosphate (G-6-P), which leads to decreased glucose 
concentration in the cell and stimulates further glucose uptake. G-6-P acts a substrate 
for glycogenesis in the fed state. It can also be metabolised into pyruvate, which can 
be used to generate ATP through the tricarboxylic acid (TCA) cycle or enter 
lipogenesis pathway. G-6-P can be dephosphorylated by glucose 6 phosphatase (G-6-
Pase) to generate glucose for metabolic adaptation during fasting (Rui, 2014).  
 
Figure 1.5 Glucose uptake in the intestine. G: glucose, SGLT1: sodium-glucose co-transporter 1, 
GLUT2: glucose transporter 2. Figure sourced from Merino et al., (2020): Nutrients. 
 
The transport of fructose relies on GLUT5 (SLC2A5) as the primary transporter 
responsible for fructose uptake into the enterocyte at the apical side of the membrane, 
whereas GLUT2 transports most of fructose from the cytosol into blood circulation at 
the basolateral side of the enterocyte (Ferraris et al., 2018). Once fructose is 
transported to the cytosol, it is rapidly phosphorylated by the ketohexokinase (KHK) 
to fructose-1-phosphate (F1P) using ATP as a phosphate donor. The resultant F1P is 
further broken down into glyceraldehyde (GA) and dihydroxyacetone phosphate 
(DHAP) by the aldolase B (ALDOB). Finally, the triokinase (TKFC) catalyses the 
phosphorylation of GA by ATP to form the glycolytic intermediate glyceraldehyde-
3-phosphate (GA-3-P) (Hannou et al., 2018). Traditionally, the liver has been 
considered as the main site of metabolism of dietary fructose, however, this concept 
has been challenged by Jang et al. (2018), the authors used isotopic tracing 
techniques and portal blood sampling to demonstrate that 90% of dietary fructose is 




saturate the absorption capacity of the small intestine, leading to fructose spill over 
into the liver and stimulate de novo lipogenesis. 
 
 
Figure 1.6 Fructose uptake in the intestine. G: glucose, F: fructose, GLUT2/5: Glucose transporter 2 
or 5. Figure sourced from Merino et al., (2020): Nutrients 
 
1.2 Influence of diet on the gut-liver axis 
Several researchers have shown that dietary factors may influence the gut microbiota, 
enterohepatic circulation and intestinal barrier function (Zmora et al., 2018). The 
changes in the gut microbiota may influence the host metabolism by affecting energy 
balance and by producing microbial metabolites that may induce various phenotypes 
depending on the health of the host (Zhao et al., 2020; Koh et al., 2016). 
1.2.1 Western style diet 
The UK government guidelines for macronutrient composition for adults comprises 
of 50% of total energy as carbohydrate (no more than 5% of total energy should be 
derived from free sugars), 15% as protein, and 35% as fat. However, the adherence 
of the UK population to these guidelines is suboptimal. A UK study based on 
National Diet and Nutrition Survey (NDNS) 2014–2016 reported that free sugars 
accounted for almost 13% total energy intake (Amoutzopoulos et al., 2020). The 
recommended fibre intake for UK adults is generally 30g per day, whereas the 
average intake does not reach recommendations and stays between 16-20g per day 
(Stephen et al., 2017). Western style diet is generally described by increased 




high in saturated fat and refined carbohydrate (starch, sucrose and fructose) content. 
Western style diets have been associated with various metabolic diseases such as 
obesity, diabetes, NAFLD and gut microbial dysbiosis (Santos-Marcos, 2019). The 
adverse health effects of increased fat consumption have led the public to embrace a 
low-fat diet for heart disease prevention and weight loss. This phenomenon has 
encouraged the food industry to manufacture highly palatable and convenient ultra-
processed food products that are low in fat and dietary fibres (DF), and enriched with 
highly refined carbohydrates such as high fructose corn syrup, starch and sucrose 
(Hall et al., 2019). During the past two decades, the consumption of calories from 
ultra-processed foods has almost tripled (from 11% to 32%). The ultra-processed 
foods are formulations of ingredients that are obtained from fractioning of whole 
foods by various industrial processes including, grinding, pureeing, hydrolysis, or 
hydrogenation. These modified foods are then assembled by using industrial 
techniques such as extrusion, moulding and pre-frying. Colour and additives are 
frequently added to make the end-product hyper-palatable and to enhance duration 
(Monteiro et al., 2019). The nature of the processes and ingredients used in the 
preparation of these foods and their displacement of whole foods containing meals 
make ultra-processed foods intrinsically unhealthy. In a recent French study using 
data from NutriNet-Santé study, Schnabel et al (2018) showed statistically significant 
associations between consumption of ultra-processed foods and increased risk of 
cancer and gastrointestinal diseases. Long-term consumption of the ultra-processed 
diet could lead to permanent loss of several species of the gut bacteria and possibly 
induce inheritable metabolic changes via the epigenome (Sonnenburg et al., 2016). 
Zinöcker and Lindseth (2018) reviewed the effects of high consumption of ultra-
processed foods in animals to show dysbiosis in the gut, systemic inflammation and 
onset of metabolic disease, due to high starch, sucrose and low fibre in the ultra-
processed foods.  
In line with these findings, research in the recent years has focused on the promising 
potential of gut microbiota targeted therapies, for example, probiotics and prebiotics 
to tackle the health effects caused by overconsumption of processed foods (Martinez 
et al., 2017; Aron-Wisnewsky et al., 2020). 
1.2.2 Western style diet and NAFLD 
NAFLD is an epidemic liver disease, that affects approximately one third of the 
entire population in the world. This disease represents as a wide range of clinical 
phenotypes from early hepatic steatosis to non-alcoholic steatohepatitis (NASH), 
fibrotic NASH, advanced fibrosis, liver cirrhosis and eventually hepatocellular 
carcinoma (HCC) (Tilg et al., 2020).  
The underlying pathophysiology of NAFLD involves various pathways including the 
role of dietary factors and gut microbiota as a crucial player in disease progression. 
In the past decade, it has been increasingly recognized that various common food 
components (trans-fats, fructose, choline in red meat) have proinflammatory potential 
and may contribute to the pathogenesis of NAFLD (Neuschwander-Tetri et al., 2012; 
Jang et al., 2018; Chen et al., 2016). The role of gut microbiota was confirmed by 




severities of NAFLD in humans. The authors showed increased abundance of species 
from Proteobacteria (Escherichia coli) in fibrotic NASH patients. Endotoxins from 
Proteobacteria include proinflammatory LPS, that are found in high concentrations 
in the blood and hepatocytes of NASH patients (Carpino et al., 2020). LPS can 
induce inflammation in hepatocytes via Toll like receptor 4 (TLR4) and NF-κB 
signalling pathway leading to proinflammatory cytokines and chemokines; Tumour 
necrosis factor α, (TNFα), interleukin 1β (Il-1β) (Alexander and Rietschel, 2001). As 
well as the proinflammatory role of LPS, it has also been associated with promoting 
lipogenesis in the liver. Recently, Todoric et al. (2020) reported that microbial 
endotoxin (LPS) engages TLR4 to trigger TNF production by liver macrophages, 
which induced lipogenic enzymes, thereby driving de novo lipogenesis in 
hepatocytes.  
In contrast, various prebiotics, probiotics and dietary restriction interventions have 
been proposed to counteract the above effects (Hu et al., 2020; Chen and Vitetta, 
2020). 
1.2.3 Addition of dietary fibres to Western style diet 
DF are described by wide array of polysaccharides that are indigestible by the host 
enzyme systems. DF not only provide direct benefits to the host by increasing the 
faecal bulking and providing laxative effects, but they also act as a substrate for the 
gut microbiota. The gut microbiota contains thousands of carbohydrate active 
enzyme (CAZyme) families that enable them to degrade these non-digestible 
carbohydrates into short chain fatty acids (SCFAs). DF can be generally categorised 
as insoluble (e.g. cellulose) or soluble fibres (e.g. inulin, pectin and psyllium).  
Most DF comprise of sugars monomers (e.g. glucose, fructose, xylose, arabinose) 
with α- or β- linkages, and different ring structure (pyranose or furanose) to form 
polysaccharides and oligosaccharides. Therefore, the structural heterogeneity 
between the DF may have an impact on their fermentability, microbial diversity, and 
differential host response (Rao et al., 2013; Singh et al., 2019). Soluble and insoluble 
DF originate from different food sources, such as legumes, vegetables, nuts, seeds, 
fruits, and cereals (Table 1.1). For example, pectins are found in fruits, such as apples 
and citrus fruits, whereas β-glucans and arabinoxylans are present in cereals. Due to 
the decreased consumption of whole foods in Western countries, fortification of 
processed foods or prebiotic supplements with enzymatically extracted non-
digestible carbohydrates such as psyllium and inulin are popular means to increase 
fibre intake (Makki et al., 2018).  
Pectin is a soluble fibre and its structure is a linear chain of D-
galactopyranosyluronic acids linked via α-(1→4) bonds, with carboxyl groups of 
some residues esterified with methyl ether. One of the main properties of pectin is its 
ability to form gels that are stable in acidic conditions (Khotimchenko., 2020). Due 
to the gelling ability of pectin, it is often used in milkshake, ice cream and sauces 
(Cameron et al., 2018). Pectin is known to lower circulating cholesterol and glucose 




DF in cereals such as wheat and barley, largely comprises of cell wall polymers and 
include cellulose, hemicellulose, lignin and soluble fibres such as β-glucans and 
arabinoxylans. The β-glucans in cereals mainly exist as glucose monomers linked via  
β-(1→4) and β-(1→3) glycosidic bonds and its fermentation in the gut is associated 
with high level of propionate and butyrate. Arabinoxylans are comprised of a mixed 
linkage between arabinose and xylose. Diets supplemented with wheat arabinoxylans 
have been shown to be associated with increased viscosity of small intestine content, 
changes in gut microbiota composition that led to high levels of short chain fatty 
acids, and reduced serum triglyceride levels (Gong et al., 2018). 
Psyllium is another gel forming fibre sourced from a valuable Chinese herbal plant, 
Plantago ovata. This DF is a popular ingredient for over the counter laxatives and 
has been reported to have a variety of biological effects, including gut 
immunomodulatory and blood glucose regulation (Jane et al., 2019). The structural 
backbone of psyllium consists of xylose units and β-(1→4)-linked D-xylopyranosyl 
residues (Zhang et al., 2019). Studies on the addition of psyllium to food products 
presents attractive strategies to allow consumers to increase their fibre intake. 
Psyllium has been added to biscuits, cakes and gluten-free products (Franco et al., 
2020). 
Inulin is a polysaccharide that mainly originates from chicory root. It belongs to a 
class of DF knows as fructans and their structure is a linear chain of fructose with 
β(2→1) linkage (Davani-Davari et al.m 2019). Salazar et al. (2015) reported 
consumption of inulin in obese women led to increased abundance of 
Bifidobacterium species, reduced serum LPS and improved metabolic parameters. 
The wide range of uses of inulin by the food industry include, sugar and fat 
replacement, and as a prebiotic ingredient in juice and dairy beverages (Castellino et 
al., 2020). 
The major SCFAs produced by the gut microbiota include acetate, propionate and 
butyrate. SCFAs act as important energy and signalling molecules that bridge the gap 
between the gut microbiota and the host (Koh et al., 2016). Butyrate is the preferred 
energy source for colonocytes and is locally consumed, whereas other SCFAs can be 
absorbed by the enterocytes and enter liver via the portal vein. One of the 
mechanisms as to how butyrate may protect against colorectal cancer and gut 
inflammation is by acting as a histone deacetylation (HDAC) inhibitor (Donohoe et 
al., 2012). SCFAs also act as ligands for free fatty acid receptors (FFARs) which can 
be found in various cell types and organs including immune cells, adipose tissue, and 
the liver, to induce various anti-inflammatory and metabolic effects (improved 
glucose and lipid metabolism) (Kimura et al., 2013). However, the role of FFARs in 
SCFAs signalling and how SCFAs contribute to improved metabolic health needs 
further clarification. 
Overall, DF provide as an attractive strategy to improve Western style diet induced 
gut microbiome. However, a better understanding of diet-microbiota interactions is 
required to further understand the underlying mechanisms for their beneficial effect 




Table 1.1 Properties and source of dietary fibres (DF). 
Dietary Fibre (DF) Properties Source 
Arabinoxylans Soluble Most cereals 
β-glucans Viscous and soluble Barley and Oats 
Cellulose Poor solubility Plant foods 
Inulin Non viscous, soluble Several plants 
Pectin Viscous and soluble Fruits such as apples 
Psyllium Viscous and soluble Plantago ovata 
 
1.2.4 Calorie restriction (CR) to counteract the adverse effects of Western style diets 
The increased consumption of Western style diets is one of the drivers for age related 
increased incidence of metabolic diseases such as type II diabetes and NAFLD 
(Fontana, 2009; Afshin et al., 2019). These diseases present a major burden not only 
on the individual, but also at a societal level, owing to the increased medical cost on 
the health sector (Bloom et al., 2016). Consequently, there is an urgent need for the 
development of innovative lifestyle interventions and therapeutics that can improve 
age-associated chronic diseases.  
Calorie restriction (CR) is a dietary intervention that reduces calorie intake while 
preventing malnutrition or reduction in essential nutrients. Initially, CR induces 
weight loss and over time energy expenditure (EE) declines until it eventually 
matches energy intake and leads to a new stable body weight (Most and Redman, 
2020). CR has been shown to induce beneficial metabolic changes and oppose age-
related physiological and pathological changes, thereby extending longevity (Fontana 
and Klein, 2007; Colman et al., 2009). The underlying mechanisms for beneficial 
effects of CR have been explored in several studies to show enhanced cellular 
protection, reduction of inflammation and oxidative DNA damage (Qu et al., 2000; 
Kim et al., 2016). In the recent years, research on the effects of CR on the gut 
microbiome has also markedly increased. The impact of CR on gut microbiota has 
been studied in various models including yeast, rodents, primates and humans (Mair 
and Dillin, 2008; Meydani et al., 2016). CR studies in model organisms found 
improved multiple aspects of health and increased survival with CR dose of 30–40%. 
However, translation of animal CR studies to humans is not as straightforward. This 
was confirmed in the controlled clinical study of healthy non-obese adults with a 
target of 25% CR for two years (CALERIE study, Kraus et al., 2019). While, the 
achieved level of energy reduction over the two years was only 12% (from normal 
average calorie intake of 2467kcal/day to 2170kcal/day), confirming that most 
humans are not capable of sustained major reduction in calorie intake.  
Research on ageing gut microbiota has found disturbed balance between beneficial 
and harmful bacteria that may drive inflammaging (Claesson et al., 2012). Some of 
the benefits of CR have been associated with an overall increased relative abundance 
of probiotic species from the Bifidobacterium and Lactobacillus genus (Zhang et al., 
2013; Russo et al., 2016). The increased abundance of Lactobacillus and 
Bifidobacterium has been negatively correlated with total cholesterol, low-density 




2015; Fraumene et al., 2018). Moreover, studies have also reported increased 
abundance of health associated mucin degrading bacteria, Akkermansia in response 
to CR (Fabbiano et al., 2018).  Dao et al. (2016) showed individuals with a high 
baseline abundance of Akkermansia before CR had improved insulin sensitivity and 
overall healthier metabolic status than individual with a low Akkermansia baseline 
abundance. Increased levels of Akkermansia have been inversely associated with 
body fat mass and glucose intolerance in mice (Everard, et al., 2013).  
In addition to the microbiota’s response, CR has been reported to increase bile acids 
pool size in mice (Green et al., 2019; Fu and Klaassen, 2013). Increase in CR-
induced bile acids is associated with increased expression of bile acids synthesis 
enzyme CYP7A1 (Fu and Klaassen et al., 2013), which indicated that under CR 
conditions the liver becomes increasingly efficient at metabolising lipids. Moreover, 
CR switches metabolism towards energy conservation by enhanced breakdown of 
lipids via β-oxidation, and by increased glycogenolysis and gluconeogenesis (Zheng 
et al., 2018), thereby, improving metabolic parameters.  
CR has been shown to reduce the onset of age-related cancers by reducing oxidative 
stress and enhancing DNA repair (Heydari et al., 2007). Another mechanism by 
which CR provides protection against age related pathologies is by boosting the 
regenerative capacity of stem cells in the host (Mihaylova et al., 2014). Many 
mammalian tissues (skin, liver, neurogenic) are maintained by stem cells. For 
example, the intestinal crypt contains Lgr5+ cells that are markers for the intestinal 
stem cells (ISCs), and regulate cell turnover (Barker et al., 2012). CR has been 
reported to increase the number of stem cells in the intestinal crypts (Yilmaz et al., 
2012; Igarashi and Guarente, 2016), which has been suggested to contribute towards 
the cancer protecting effects of CR (Bruens et al., 2020).  
The effects of CR on gut microbiota, bile acid metabolism and intestinal regeneration 
indicates an important role of the gut-liver axis in CR induced health and lifespan. 
Although, preclinical research on health-promoting potential of CR has proved to be 
promising, the increased availability of energy-dense foods and social behaviour 
towards food makes this intervention difficult and demanding to maintain in humans. 
Considering this, CR related changes in the gut-liver signalling may provide a unique 
doorway to discover novel molecules and innovative methods to optimize healthy 
ageing without the need for drastic food restriction.  
1.3 Mouse models for studying the gut-liver axis 
Studying the direct interactions between human gut microbiota and the host tissue is 
often challenging due to the difficulties involved with obtaining samples. Even 
though faecal samples can be easily obtained from humans, scientists may not be 
able to control several experimental variables, such as diet, and environmental factors 
(Seksik and Landman, 2015).  
Mice models offer advantages due to their similar gastrointestinal anatomy, 
straightforward sample collection, and better control over diet and genetics. 
Therefore, mice have been extensively used to translate the knowledge on 




Most research on the gut microbiota has been performed in C57BL/6J mice, 
however, there is no specific mouse strain that has been recommended for studying 
the effect of diet on microbiota. The mice that scientists often use are sourced from 
inhouse facilities, or those that are easily commercially available. This may not be an 
ideal method, as recent research has shown environmental factors and genetic 
background of mice to have a significant impact on their gut microbiota (Rasmussen 
et al., 2019).  
In order to design animal experiment to study the effect of diets on the gut-liver axis, 
selecting the proper control diet is a crucial factor. However, the choice of control 
diet for mice studies is often not optimal, mostly due to lack of a robust and healthy 
control diet (Pellizzon and Ricci, 2018). The most commonly used control diets 
within the research community are the chow, and purified diets based on the 
American Institute of Nutrition 93 maintenance diet (AIN-93M) also known as low-
fat (LF) diet. The exact formula of the chow diet is often not defined, and the amount 
of each ingredient used can vary widely depending on the batch, source, and season. 
In contrast, purified diets are composed of refined ingredients therefore, the formula 
of the diet is well defined, and the amount of each ingredient is openly available to 
researchers. The purified diet is a processed diet with highly refined ingredients, 
increased simple carbohydrates and reduced fibre content which may be detrimental 
to the health of the mice (González-Blázquez et al., 2020).  
The protein in chow diet is mainly plant based (potato protein, hydrolysed wheat 
gluten, soya, maize gluten), whereas the purified diet contains only casein extracted 
from cow’s milk. Several studies have comprehensively investigated the impact of 
dietary protein on gut microbiota composition (Kar et al., 2017; Zhao et al., 2020). 
Moreover, chow diet contains increased level of isoflavones from soy (daidzein and 
genistein) that are absent in the LF diet. Isoflavones are polyphenolic compounds that 
are among the most common categories of phytoestrogens. These compounds are 
structurally similar to 17-β-oestradiol and their metabolism involves the help of the 
gut microbiota (Křížová et al., 2019). Guevara-Cruz et al. (2020) showed 
consumption of genistein altered the gut microbiota of obese patients, followed by 
reduced insulin resistance and metabolic endotoxemia.  
Therefore, the differences in the composition of control diets may lead to differential 
outcomes in studies investigating the effect of diets on mouse physiology. The choice 
of proper control diet in metabolic studies is extremely important for successful 
reproduction of the research data and calls for the development of a healthy universal 
control diet. 
In view of these differences, the use of mouse models for translational research may 
be criticised, however, there is no suitable alternative present to reproduce the 
communication pathways involved in microbiota-gut-liver crosstalk. Although, in 
vitro models represent a strategy to overcome the mentioned limitations and 
recapitulate basic disease mechanisms in a controlled environment, their reduced 
complexity compared to in vivo models restricts their effectiveness to study the gut-
liver axis (Pearce et al., 2018). The advent of bioengineering advances has made 




microbiome interactions. Jalili-Firoozinezhad et al. (2019) described an in vitro 
system that mimics the host and microbiota interactions in the human intestine. The 
authors successfully cultured primary human intestinal cells with a diverse species of 
aerobic and anaerobic microbiota on the microfluid chip, by establishing an elegant 
oxygen gradient across the mammalian cells and the lumen. Although, this 
technology is in its early stages, the gut microbiome on a chip can provide ample 
opportunities to successfully study the microbiota-host interactions in detail in the 
future.  
1.4 Aims and outline of the thesis 
The aim of the research presented in this thesis is to study the effects of different 
dietary interventions on the health of the gut-liver axis in mice, by focusing on the 
ileum. Most of the studies that investigate the response of gastrointestinal (GI) tract 
to dietary interventions have mainly focused on the colon. The ileum contains the 
second largest microbiota population in the GI tract and has closer proximity to the 
gut bacteria due to the less dense mucus layer found here. Furthermore, transport of 
bile acids is mediated by the ileal enterocytes thus connecting the gut to the liver via 
the portal vein. We hypothesised that due to the aforementioned reasons, the ileum 
plays an important role in the dietary impact on the gut-liver axis. The limited 
information on the ileal response to diet prompted us to study the molecular 
microbiota changes in the ileum, in response to dietary interventions.  
In our first experimental chapter (Chapter 3), we compare the response of the gut-
liver axis to two diets, the plant-based high fibre chow (RM3-P, SDS Diets, UK) and 
low fibre purified diet (LF) (D17060802, a version of AIN93M from Research Diets, 
USA) that also resembles the low-fat ultra-processed foods in Western style diet. The 
study provides an opportunity to compare diets that are similar in calories but differ 
in their composition on the health of the gut-liver axis.  
Chapter 3 aims and hypotheses: We hypothesised that the increased refined 
carbohydrates and low fibre in the LF diet may lead to an ‘unhealthy’ gut-liver 
phenotype in mice. We aimed to describe the changes in the liver phenotype, ileal gut 
microbiota and bile acid composition in response to the 4 weeks feeding of the LF 
compared to chow diet. The duration of these experiments was based on previous 
unpublished results from feeding mice the LF diet for 2-8 weeks. In our hands, the 
period of 4 weeks was shown to be the earliest timepoint where LF induced a 
significant gut-liver phenotype. 
Furthermore, due to the lack of fibre and high content of easily metabolisable 
carbohydrates, we propose that the gut-liver axis of LF fed mice is more susceptible 
to an inflammatory challenge. To test this hypothesis, we created a model of systemic 
low-grade inflammation by injecting mice with low dose of lipopolysaccharide (LPS; 
0.5mg/Kg body weight) once a week for 4 weeks (Raduolovic et al., 2018; López-
Collazo and del Fresno, 2013).  
In collaboration with Dr Steegenga at Wageningen University, ileal samples from 




background: IDEAL study) were used to study the long-term effects of the LF diet in 
Chapter 4.  
Chapter 4 aims and hypotheses: We used this opportunity to investigate whether 
lifelong CR protected the mice against the LF induced phenotype. We hypothesised 
that decreased consumption of the LF diet may prevent LF induced 
pathophysiological effects on the gut-liver axis. We also used the study to 
characterise the ileal response to lifelong CR in mice. To the best of our knowledge, 
this is the first study to present gene expression profiling of the ileal mucosa and 
microbiota composition in response to lifelong CR in adult (6 months) and aged (24 
months) old mice. The age of 6 months in mice represents mature adults, whereas 24 
months old mice represent old age, and this is when age-related changes (e.g., 
diminished lung function, kidney degeneration and impaired wound healing) can be 
detected (Flurkey et al., 2007). 
Research on the impact of CR on mouse physiology is often performed on different 
background diets. In continuation of this concept and due to the differences observed 
between chow and LF fed mice in the previous chapters, we aimed to characterise the 
changes in the ileum and the liver of mice after 8 weeks of CR intervention with 
chow or LF diet background. We hypothesised that not only the dose of CR but also 
the composition of the background diet may lead to differential response of gut-liver 
axis. The IDEAL study showed that mice needed approximately 8-10 weeks to adapt 
to CR feeding schedule and reach a relatively stable weight. Therefore, we chose 
dietary intervention period of 8 weeks as the earliest timepoint to test the effects of 
‘short term’ CR on the gut-liver axis. 
In Chapter 5, we designed new rodent diets in collaboration with Research Diets 
Inc. (USA). Aims and hypothesis: The aim of this study was to describe the effects 
of different fibres on the ileal, liver gene expression and ileal microbiota. The mice 
were fed with LF and LF+fibre diets for 10 weeks. We hypothesised that the 
detrimental effects of the LF diet on the gut-liver axis of mice may be due to the 
reduced fibre content in this diet. Indeed, the addition of fibres improved the liver 
phenotype of mice and led to a differential ileal microbiota composition. The 
duration of 10 weeks was chosen to ensure experimental manipulation of gut-liver 
phenotype with the feeding of fibre enriched diet. We performed preliminary fibre 
feeding experiment of 2 weeks which did not result in a prominent improvement of 
the gut-liver phenotype. 
Interestingly, we observed that despite the same amount of fibres used in our new 
diets, the composition of the fibres led to differential ileal gene expression between 
the fibre groups. Increased consumption of DF has been shown to have various 
benefits for human health (Makki et al., 2018), however, the role of structural 
heterogeneity of the different fibres in the gut-liver axis is largely unexplored. 
The reproducibility of preclinical biomedical research using mice models is currently 
being scrutinised by National Institutes of Health (NIH). Chapter 6 aims and 
hypotheses: In addition to the differences observed between control diets, we also 




vendors. We investigate the variation in the gut microbiota and consequently the gut-
liver axis of mice from an external vendor and inhouse animal facility. We 
hypothesised that mice would present different microbiota profiles based on their 
distinct environmental exposures. Such differences may explain in part the poor 
experimental reproducibility in animal research, despite using similar mouse models 
and strains. Finally, the general discussion, future perspective and human relevance 





























































2.1 List of chemicals and reagents used for the experimental studies mentioned 
in this thesis.  
 
Table 2.1 List of chemicals and reagents. 
Reagents Product number Supplier 
Ac-DEVD-AFC  






propanesulfonate) hydrate BioXtra 98%) 
C5070 Sigma-Aldrich 
Chloroform (99%) 372978 Sigma-Aldrich 
DNase I, Amplification Grade 18068015 Invitrogen 
DPX new mounting medium 100579 Merck 
Eosin Y solution, alcoholic HT110116 Sigma-Aldrich 
Ethanol (BioUltra, for molecular biology, ≥99.8%) 51976 Sigma-Aldrich 
FITC-dextran 4 kDa (FD4) FD4 TdB Labs 
Formalin solution, neutral buffered, 10% HT501128 Sigma-Aldrich 




Histo-Clear II Histology Clearing Agent NAT1334 Scientific Labs UK 
IsoFlo (isoflurane, USP, 100%) 50019100 Zoetis Inc 
Isopropanol (2-Propanol) 99.5% I9516 Sigma-Aldrich 
Lipopolysaccharides from Escherichia coli O111:B4 L2630 Sigma-Aldrich 
Lysozyme from chicken egg white 90% SAE0152 Sigma-Aldrich 
Methanol for HPLC, ≥99.9% 34860 Sigma-Aldrich 
Paraplast Plus for tissue embedding P3683 Sigma-Aldrich 
Phosphate Buffered Saline, 10X, Sterile 6506-OP Sigma-Aldrich 
PIPES (Piperazine-1,4-bis(2-ethanesulfonic acid) ≥99%  P6757 Sigma-Aldrich 
QIAamp DNA Mini Kit 51306 Qiagen 
QIAzol Lysis Reagent 79306 Qiagen 
SuperScript III Reverse Transcriptase 18080093 Invitrogen 
SYBR Green PCR Master Mix 4309155 Applied 
Biosystems 
Triglycerides liquicolormono colorimetric test 10724 HUMAN 
Diagnostics 
Triton™ X-100 X100 Sigma-Aldrich 











All experimental procedures and protocols performed were reviewed and approved 
by the Animal Welfare and Ethical Review Body and were conducted in accordance 
to the specification of the United Kingdom Animal Scientific Procedures Act, 1986 
(Amendment Regulations 2012).  
2.3 Animal model 
For all experiments male C57BL/6J mice were used. We chose this strain as our 
animal model because of its popularity in studying consequences of diet on metabolic 
health (Wong et al., 2016).  
Mice were either obtained from the Disease Modelling Unit (DMU) of the University 
of East Anglia (UEA) and/or Charles River UK (CRUK, Margate, UK). At the DMU, 
mice were maintained in Individually Ventilated Cages (IVC), controlled 
environment (21±2°C; 12-h light/dark cycle; light from 7:00 AM) and fed ad libitum 
on a standard chow diet (RM3-P; Special Diet Services (SDS), United Kingdom, 
Table 2.2). According to the experimental requirements, mice were either switched to 
other diets or kept under the same chow diet for the duration of the experiments. 
Power calculations have been undertaken to determine group sizes for all mouse 
experimental procedures, aiming to detect differences of 15% or more with a power 
of 0.85 and alpha set at 5%; calculations being informed by our previous experiments 
(Blokker et al, unpublished results), resulting in a minimum group size of n=6. In all 
cases, mice were randomized between groups and mice were divided into two cages 
per experimental group.  All mice were aged 10-13 weeks old at the start of the 
experiment, to ensure stabilization of the microbiota (Laukens et al., 2016). The mice 
were weighed twice a week and food consumption was recorded at the same time by 
weighing the remaining diet. Mice were transferred to a clean cage on Monday each 
week. At the end of each experiment, mice were sedated with isoflurane and blood 
was collected by cardiac puncture under terminal anaesthesia. Sera was then isolated 
via centrifugation at 2000 xg for 10 minutes. Organs were collected and processed as 
described below. 
2.4 Organ collection and processing 
The small intestine of each mouse was collected, cleaned of any mesenteric fat, 
pancreatic tissue and Peyer’s patches and then transferred to a petri dish containing 
ice cold phosphate buffer saline (PBS). The tissue was then divided into 3 equal 
parts, referring approximately to the duodenum (Part 1), jejunum (Part 2) and ileum 
(Part 3). The luminal content of each section was gently pushed out using a spatula 
and collected into separate Eppendorf tubes and snap frozen in liquid nitrogen for 
microbiota analysis. After pushing out the content, the ileum was further divided into 
6 sections as depicted in Figure (2.1). The section 2 was collected for histology and 
stored immediately in 10% neutral buffer formalin (NBF) solution for 24 hours, 
before being transferred into 50% ethanol until embedding (See Histology, paragraph 
2.7). The sections 1, 3 and 5 were collected together in an Eppendorf tube and snap 
frozen in liquid nitrogen. These sections were then used for gene expression analysis. 
The remaining two large sections (4 and 6) were collected in a cryotube and snap 




The liver was collected, and weight was recorded before dividing the liver into 
further sections as illustrated in Figure 2.2. The sections labelled H were collected for 
histology, the sections labelled R were collected for RNA isolation and the remaining 
liver pieces including pieces labelled Pr (protein), BA (bile acids) were collected into 





















Figure 2.1 Method of sample collection from ileum at the time of sacrifice. 
Figure 2.2 Method of sample collection from livers at the time of sacrifice. 




2.5 Experimental designs  
2.5.1 Study 1: Investigating the impact of chow versus LF diet on gut-liver axis 
Twelve male C57BL/6J mice were obtained from the DMU at UEA. The mice were 
randomly divided into two groups, 1) Chow, n=6 and 2) LF diet group, n=6. The 
mice were fed a standard chow diet (RM3, SDS, UK, Table 2.2) and/or a purified 
low-fat (LF) diet (D17060802, Research Diets, USA, Table 2.2) for a period of 4 
weeks. The LF D17060802 is a variant of commonly used control diet D1245OH, 
which slightly differs on the fat source. The fat source in D1245OH comes from 
soybean oil and lard, while the fat source of D17060802 (our LF diet) is a mixture of 
soybean oil and palm oil in order to balance saturated and unsaturated fat 
composition. Brief description of the diets is shown in Table 2.2. A more detailed 
description of the diet is included in Supplement data 1. The impact of the two diets 
on the gut-liver axis is investigated in Chapter 3. 
 
Table 2.2 Summary of dietary composition of chow and semi purified low-fat (LF) diet used. 
 chow diet 
SDS diets RM3 
LF diet 
D17060802 
KJ/g 15.21 16.21 
Protein (%) 26.9 20  
Carbohydrate (%) 61.2 70  
Fat (%) 11.5 10  
 
Starch (g/Kg) 338.8 452.2 Corn Starch 
Maltodextrin 10 (g/Kg) 0 75 
Sucrose (g/Kg) 43.7 173 
Fibre (g/Kg) 161.5 




2.5.2 Study 2: The impact of chow versus LF diet feeding on mice exposed to a low 
dose lipopolysaccharide (LPS) challenge 
Twenty-four mice were randomly divided into four groups, 1) Chow, 2) LF, 3) Chow 
LPS, and 4) LF LPS, n=6 per group. In the LPS group, mice were injected with low 
dose 0.5mg per kg of body weight of LPS intraperitoneally (i.p.) once a week for the 
duration of four weeks in addition to the diet treatment. The dose was chosen to 
induce a model of low-grade inflammation as described by Ramírez et al., (2018). 
The control groups received a sham i.p. injection (sterile PBS) in addition to the diets 
per week for four weeks. The effect of LPS on the gut-liver axis of chow and LF fed 
mice is investigated in Chapter 3. 
The method of i.p. injections for administering substances is widely used in rodent 
experiments. This technique allows for LPS to be administered and rapidly absorbed 
systemically (Baek et al., 2015). 
Mice were restrained and head of the mouse was tilted downwards, and the needle 




wall. A new 26-27 gauge, 3/4-inch needle was used for each mouse and the injected 
volume was standardized to 150µl for the sham group. 
After the four weeks intervention, 44mg per 100 g body weight fluorescein 
isothiocyanate-conjugated dextran (FITC-dextran 4) was administered via oral 
gavage to measure gut permeability. Oral gavage was performed by restraining the 
mouse by firmly grasping the skin over the dorsal neck and with the tail held between 
the palm and ring finger. By using a plastic, flexible catheter (FTP-20-30 20ga x 
30mm Instech Solomon) 100 -150µl of FITC-dextran dissolved in sterile PBS was 
dispensed into the stomach. After two hours, mice were sacrificed via exsanguination 
by cardiac puncture under terminal anaesthesia and whole blood was collected in an 
Eppendorf tube and kept on ice in the dark for 30 minutes. Sera was then isolated via 
centrifugation at 2000 xg for 10 minutes. The time required for FITC-dextran 4 to 
reach its optimum level in systemic circulation has been reported to be approximately 
2 hours (Woting and Blaut, 2018).   
An aliquot of 50µl of serum was diluted with 50µl of sterile PBS and added onto a 96 
well microplate. Additionally, a standard serial dilution of FITC-dextran ranging 
from 0 to 8000 ng/ml was added to the plate. FITC fluorescence was determined by 
spectrophotometry on a SpectraMax M2/M2e microplate reader with an excitation of 
485 nm and an emission wavelength of 528 nm. Background emission signals in 
serum samples of the mice receiving PBS were subtracted from those of mice treated 
with FITC-dextran. 
2.5.3 Study 3: IDEAL ageing study performed in Wageningen University, 
Netherlands 
The long-term calorie restriction (CR) study has been performed in Wageningen 
University (WUR) in accordance with the Dutch national guidelines. Male C57BL/6J 
mice were housed individually at the age of 9 weeks and were randomly divided into 
a LF and LFCR group. The control LF group were given ad libitum access to the 
purified American Institute of Nutrition 93 W (AIN-93W) diet (version of AIN-93M 
and similar composition to the LF (D17060802) diet) used in our previous studies. 
The CR mice received the same diet, however, in portions containing 70% calories of 
the average intake of the LF group and provided daily at 15:30. The CR diet was 
supplemented with added vitamins and minerals to avoid malnutrition. Body weight 
was recorded every week. Mice were sacrificed at 6 and 24 months of age to 
differentiate between the effects of CR at young and old age. The age of 6 months in 
mice represents mature adults, whereas in 24 months old mice the biomarkers of old 
age are prominently detected. Liver and colon transcriptomics data from this study 
has been published by Rusli et al., (2017) and Kok et al., (2018) respectively. As part 
of a collaboration with Dr. Wilma Steegenga at WUR, we received the ileal and ileal 
content samples from 6 and 24 months old mice fed with LF and LFCR diet. 







We performed the following measurements in the ileum samples (n=5-6 per group); 
• Gene expression analysis in the ileum tissue via microarray  
• Bile acids were measured in the ileum tissue samples   
• 16S rRNA sequencing of the microbiota in the ileal luminal content  
•           Histology analysis by H&E staining on the paraffin embedded ileal tissue  
Furthermore, microarray data from the liver samples was reanalysed to extract 
energy metabolism related genes. The effect of lifelong LF and calorie restricted LF 
diet on the gut-liver axis is investigated in Chapter 4.  
2.5.4 Study 4: Effect of a caloric restriction intervention on chow and LF diet on the 
gut-liver axis 
Twenty-four mice were randomly distributed into two control groups, chow (n=6) 
and LF (n=6) (original LF: D17060802) diet and two caloric restriction (CR) groups, 
chowCR (n=6) and LF CR (n=6) for 8 weeks. This duration was chosen as it’s the 
earliest timepoint to allow the mice to adjust to the CR diet and reach stable weight. 
The control groups always had free access to food, whereas the CR mice received 
both the chow and LF diet in portions containing 70 energy percent (En%) of the 
mean intake of the respective control group. The CR diets were based on the same 
background diets, however supplemented with vitamins and minerals to avoid 
malnutrition at 70E% energy intake and was provided daily at 15:30 for eight weeks. 
The grade of 30E% CR was chosen to match previous study performed in 
Wageningen University (Kok et al., 2018) and studies performed by Green et al., 
(2019) and Fu and Klaassen (2013) that showed significant changes in global 
metabolomics and bile acid metabolism under 30%CR. CR mice finished their daily 
portions within two hours after feeding. In order to avoid drastic weight loss, a 
gradual decrease in food intake was provided to the mice one week before the start of 
CR feeding. All mice were provided with ad libitum access to water. The comparison 
of the effects of CR on the gut-liver axis of chow and LF diet fed mice is 
characterised in Chapter 4. 
2.5.5 Study 5: Investigating the impact of dietary fibres (DF) addition to the LF diet 
on the gut-liver axis 
In collaboration with Research Diet Inc (New Brunswick, USA), new purified diets 
were designed. Firstly, the LS (Low sucrose variation of the LF diet) (D12450J) was 
added to the experimental design, the LS diet is based on the previously used LF 
(D17060802), but with reduced sucrose (68.8g instead of 172.8g), in order to 
improve the detrimental health effects of high sucrose content. Of note, the reduced 
sucrose content in the LS diet was replaced with increased starch content to regulate 
for calorie intake (LS: 506g corn starch, LF: 452g). Additionally, 2 more diets were 
designed containing soluble fibres; (1) LS enriched with 75g of inulin (LS+In), (2) a 
combination diet comprised of; 25g inulin, 25g pectin and 25g psyllium (LS+Comb). 
For brief description of the diet refer to Table 2.3. Full composition of diet is 




Fifty mice were randomly divided into 4 groups with n=10 per group and fed with 1) 
chow, 2) LF, 3) LS, 4) LS+In and 5) LS+Comb diet for a duration of 10 weeks. At 
the end of 10 weeks, mice were sacrificed, and organs collected as described in 
Paragraph 2.4. The role of dietary fibres on the gut-liver axis of mice is investigated 
in Chapter 5.  
 
Table 2.3 Summary of composition of fibre enriched diets. LF: Low-fat diet, LS: Low-fat diet with 
reduced sucrose content, LS+In: LS diet enriched with inulin, LS+Comb: LS diet enriched with inulin, 
pectin and psyllium. 








KJ/g 16.1 16.1 15.4 15.4 
Protein (%) 20 20 20 20 
Carbohydrate (%) 70 70 70 68 
Fat (%) 10 10 10 10 
Corn Starch (g) 452.2 506 478 481.3 
Maltodextrin 10 (g) 75 125 125 125 
Sucrose (g) 173 68.8 68.8 68.8 





0 0 75 
Inulin 
25 + 25 + 25 
In+Pec+ Psy 
Total (g)  1055 1055 1101 1105 
 
Table 2.4 Summary of amount of fibre in the fibre enriched diets. 
 Chow LF LS+In LS+Comb 
Total Fibre gm% 16.2 4.7 11.3 11.3 
Soluble Fibre 
gm% 
Not defined 0.0 6.8 5.2 
Insoluble fibre 
gm% 
Not defined 4.7 4.5 6.1 
 
2.5.6 Study 6: A comparative study on the effect of the source of C57BL/6J mice on 
their ileal microbiota  
Twenty-four male C57BL/6J mice were obtained from the inhouse facility DMU and 
commercial vendor, Charles River Laboratories, UK (CRUK). The CRUK mice were 
purchased at the age of ten weeks and held for two weeks under a chow diet at the 
DMU in order to acclimatise to their new environment. At the age of twelve weeks, 
mice from CRUK and DMU were further divided into four groups; 1) CRUK chow 
(n=6), 2) CRUK LF (n=6), 3) DMU chow (n=6) and 4) DMU LF (n=6). The mice 
were fed the chow diet (RM3-P) and/or a purified LF diet (original high sucrose LF 
diet: D17060802, Research Diets, USA) for a period of four weeks. The effect of the 






2.6 Gene expression analysis 
Liver and ileum samples were homogenised in 1 ml Qiazol (Qiagen, UK) per 100mg 
of tissue for 30 seconds at 6000 rpm in a Precellys®24 (Bertin Technologies, 
France). After homogenization, the samples were transferred into new Eppendorf 
tubes and 200µl chloroform was added. Samples were then centrifuged for 15 
minutes at 12,000 RPM at 4˚C and the aqueous layer was transferred to a new 2ml 
collection tube. Isopropanol (500µl per ml) was added and mixed by inverting the 
tubes, rested for 5-10 minutes on ice and then centrifuged for 10 minutes at 12,000 
RPM at 4˚C. The RNA pellet that was left, was washed twice with 80% ethanol and 
dissolved in 100µl RNase free water. RNA concentration was measured with a 
Nanodrop (Thermo Scientific, Wilmington, USA). A 260/280nm ratio of ~1.8 was 
considered an acceptable indicator of good RNA quality. The ratio of absorbance at 
260/230nm is used as a secondary measure of RNA purity. A ratio within the range 
2.0 - 2.2 was considered pure. A ratio of lower than 2, may indicate contaminants in 
the sample.  
Complementary DNA (cDNA) was synthesized from 2µg of RNA which was first 
treated with DNase and subsequently reverse transcription was performed using 
SuperScript III Reverse Transcriptase. A quantitative polymerase chain reaction 
(qPCR) was performed using SYBR green master mix according to the 
manufacturer’s instructions. Reactions were performed on Applied Biosystems ViiA 
7 and 384 wells plate (Applied Biosystems, Thermo Fisher Scientific, UK) using 5µL 
of SYBR green and primer mix (full list of the primers used, please see table 2.5) and 
1.5µL of cDNA (diluted 1:20). The reaction was initialized at 50°C for 5 minutes and 
95°C for 2 minutes, after which 40 cycles of denaturation (95°C; 15 seconds) and 
annealing/extension (59°C; 1 min) were performed. Afterwards, a melting curve was 
created and checked for a single product per gene. Delta CT values were calculated 
by subtracting the CT value of the housekeeping gene TATA-box binding protein 
(Tbp) from the target gene CT value. The delta delta CT was calculated as the 
difference in delta CT as described above between the target and reference samples 
(Equation 1). The final result of this method is then presented as the fold change of 
target gene expression in a target sample relative to a reference sample, normalized 
to a reference gene. The housekeeping gene Tbp was used for all gene expression 
analysis using qPCR because of its optimal expression stability. Housekeeping gene 
Tbp has been reported to be a constantly expressed reference gene in mouse intestine 
and liver tissue (Wang et al., 2010; Tatsumi et al., 2008). 
                 
Equation 2. 1 Formula used to calculate delta delta CT value 
ΔCT = CT (target gene) – CT (housekeeping gene) 






Table 2.5 Primer sequence used for gene expression analysis. 
Gene Refseq Forward Reverse 
Acaca  NM_133360 GAGGAAGTTGGCTATCCAG GCAGGAAGATTGACATCAGC 
Asbt NM_011388 TGGAATGCAGAACACTCAGC GCAAAGACGAGCTGGAAAAC 
Chrebp  NM_021455.5 ACAAAAAGCGGCTCCGTAAGTCC GGGGGCGGTAATTGGTGAAGAA 
Cldn3 NM_009902.4 ACCAACTGCGTACAAGACGAG CAGAGCCGCCAACAGGAAA 
Cyp7a1 NM_007824.3 GAGCGCTGTCTGGGTCACGG GCCAGCCTTTCCCGGGCTTT 
Cyp8b1 NM_010012.3 TTGCAAATGCTGCCTCAACC TAACAGTCGCACACATGGCT 
Fabp NM_008375 CACCATTGGCAAAGAATGTG AACTTGTCACCCACGACCTC 
Fasn  NM_007988.3 AGTGCGTGGGGCGCAATCTC CGCTCGGCTCGATGGCTCAG 
Fbp1 NM_019395.3 TAGACATCGTTCCCACCGAGAT CTTCACTTGGCTTTGTGCTTCC 
Fgf15 NM_008003 CAGTCTTCCTCCGAGTAGCG TGAAGACGATTGCCATCAAG 
Fgf21  NM_020013.4 ACACAATTCCAGCTGCCTTG TAGAGGCTTTGACACCCAGG 
Fgfr4 NM_008011 CTGCCAGAGGAAGACCTCAC GTAGTGGCCACGGATGACTT 
Fxr NM_009108 GGCCTCTGGGTACCACTACA AAGAAACATGGCCTCCACTG 
Glut2  NM_031197.2 GTCGCCTCATTCTTTGGTG CTGATACACTTCGTCCAGC 
Glut5 NM_019741.3 TCATGACCATCCTCACGATCTTT GCGGCCGTCAGCACTAAG 
Il1b NM_008361.4 GCCTCGTGCTGTCGGACC TGTCGTTGCTTGGTTCTCCTTG 
Khk NM_001310524.1 CCCACCGCCCCGAGTAGTAGACA CACACCTGCCGGGGAATGG 
Ocln NM_008756.2 AGCTCATAGTTCAACACAGCCTC TTCTTCCACAGCTGAAGGACTCA 
Ostα NM_145932 TTGTGATCAACCGCATTTGT CTCCTCAAGCCTCCAGTGTC 
Ostβ NM_178933 ATCCTGGCAAACAGAAATCG GGCCAAGTCTGGTTTCTCTG 
Sglt1  NM_019810.4 TGGTGTACGGATCAGGTCATTG TTCAGATAGCCACACAGGGTACA 
Shp NM_011850 TCTGCAGGTCGTCCGACTATT AGGCAGTGGCTGTGAGATGC 
Tbp  NM_013684.3 GAAGCTGCGGTACAATTCCAG CCCCTTGTACCCTTCACCAAT 
Tlr4 NM_021297.3 GCTTTCACCTCTGCCTTCAC GAAACTGCCATGTTTGAGCA 
Tnfα  NM_001278601.1 CAGGGGCCACCACGCTCTTC CTTGGGGCAGGGGCTCTTGAC 
Zo-1  NM_009386.2 GGACCCTGACCACTATGAAACAG ATAGGTGGATATTCCCTGACCCA 
 
RNA Sequencing 
After RNA isolation as described before, selected samples from Study 3 were sent to 
Novogene genome sequencing company (Cambridge, UK) for Illuminia based 
RNASeq analysis.  
Microarray analysis 
Selected samples from the IDEAL Study 5 were sent for microarray analysis at 
WUR. RNA quality was assessed with a Bioanalyzer (Aligent 2100 Bioanalyzer, 
Santa Clara, USA), and microarrays were performed using the Mouse geneChip 1.1 
ST arrays from Affymetrix (Thermo Fisher Scientific, Santa Clara, USA). Arrays 
were normalised using Robust Multiarray Average and ~22 k genes were included in 
the data set.  
Network Analyst 3.0 (Zhou et al., 2019) a web-based software application was used 
to analyse and interpret the data. Log2FC of 1.5 and a P value of 0.05 were used as 




0.1 were selected for further analysis. Ingenuity Pathways Analysis (IPA) web-based 
software application was used to explore canonical pathways affected by the filtered 
genes in the IDEAL study 5.  
2.7 Histology  
After fixation in 10% NBF, tissues were stored in 50% ethanol until embedding. The 
samples were processed on the Leica ASP 300, program overnight no formalin and 
the samples were embedded in Paraplast the next morning. Tissue sections were cut 
at 5μm thickness using a HistoCore BIOCUT - Manual Rotary Microtome and 
secured on SuperFrost Plus™ Adhesion slides (Thermo Scientific, UK) and mounted 
with DPX mounting medium. The next morning the slides were stained with 
haematoxylin and eosin (H&E) following the protocol from Feldman and Wolfe, 
(2014) and photographs were taken with an Olympus BX60 microscope at 4X and 
10X magnification. Procedure for staining with H&E is detailed below. 
Deparaffinize the slides as follows. 
2 x 5 minutes Histoclear 
2 minutes 100% ethanol 
2 minutes 80% ethanol 
2 minutes 70% ethanol 
5 minutes Wash slides in distilled water  
4 minutes Harris Haematoxylin 
5 minutes wash under running distilled water 
15 seconds 1% HCl/70% ethanol  
15 seconds brief rinse with distilled water 
1 minute 0.1% sodium bicarbonate 
5 minutes distilled water 
2 minutes Eosin 
Rehydrate the slides as follows: 
2 minutes 70% ethanol    
2 minutes 80% ethanol    
2 minutes 100% ethanol             
5 minutes Histoclear I      
5 minutes Histoclear II    




2.8 Caspase 3 activity  
This assay works with a Caspase-3 specific tetrapeptide substrate DEVD and a 
fluorochrome 7-Amino-4-trifluoromethylcoumarin (AFC). Active caspase 
specifically hydrolyses the substrate DEVD-AFC resulting in the release of 
fluorogenic AFC which can be quantified by a spectrophotometer at 400 nm 
excitation, 505 nm emission wavelength.  
Proteins from 30mg of liver samples were extracted using the AFC lysis buffer 
(Table 2.6) and prepared for the Caspase 3 assay following the manufacturer’s 
instructions.   
 








2.9 Hepatic triglycerides measurement 
The triglycerides were extracted following an adjusted version of the Bligh and Dyer 
method (Bligh and Dyer, 1959). Approximately 50mg of liver tissue was 
homogenized in 200µl of chloroform and 400µl of 100% methanol. To this solution, 
160µl distilled water was added, and the sample was homogenized again after which 
the sample was centrifuged for 10 minutes at 12,000 RPM at 4°C. The organic lower 
layer was subsequently transferred to clean Eppendorf tubes and the chloroform was 
evaporated overnight in the fume hood. The dried pellet was dissolved in 250µl of 
2% Triton X-100 (Laboratory grade, Sigma-Aldrich) and this solution was used to 
perform the colorimetric assay by using the triglycerides liquicolor kit following the 
manufacturer’s protocol.  
2.10 Bile acids analysis 
Bile acids were measured in the liver and ileal tissue samples. Ileal tissue was used 
instead of ileal content because of limited content sample. Approximately 25mg of 
tissue was homogenised in 1ml of ice cold 70% methanol for 30 seconds and 6000 
RPM in a Precellys®24 (Bertin Technologies, France). After centrifugation (5 min, 
12,000 RPM, 4˚C) the supernatant was transferred to a new collection tube and 
methanol content was removed by using Speed-Vac vacuum concentrator (70 min, 
50˚C). Volume was restored to 1ml by adding 5% methanol. The samples were 
loaded onto OASIS PRIME HLB-1 30mg SPE cartridges (Waters, UK), washed 
twice with 5% methanol and eluted in 500µl 100% methanol. 
AFC-Lysis buffer Volume Final concentration 
Hepes 1M pH 7.4 100µL 10mM 
Chaps 10% 100µL 0.1% 
EDTA 0.5mM pH 8 40µL 2mM 
DTT 1M 50µL 5mM 




Internal standards (d4) were added at the following time points: before 
homogenisation, before rotary evaporation, before loading onto cartridges, after 
elusion (for information on standards please refer to Supplementary data 2). Cleaned-
up extracts were analysed using High-performance liquid chromatography (HPLC) – 
mass spectrometry operated in multiple reaction monitoring (MRM) mode.  
The mass spectrometer was operated in electrospray negative mode with capillary 
voltage of -4500V at 550˚C. Instrument specific gas flow rates were 25ml/min 
curtain gas, GS1: 40ml/min and GS2: 50ml/min. Please see supplementary data 2 for 
Liquid chromatography–mass spectrometry (LC-MS) conditions and mass 
fragmentation monitoring values. Quantification was applied using Analyst 1.6.2 
online tool (SCIEX, 2020 DH Tech. Dev. Pte. Ltd) to integrate detected peak areas 
relative to the deuterated internal standards. 
2.11 Microbiota analysis  
Microbial DNA was isolated from approximately 50mg ileal luminal content with the 
Qiagen DNA mini kit. Additional steps were added to the DNA mini kit protocol to 
ensure breakage of all bacterial samples. Briefly, the samples were homogenised 
using silica glass beads for 4x 30 seconds at 6000 rpm in a Precellys®24 (Bertin 
Technologies, France) and heated to 95°C for 5 minutes. Additionally, samples were 
incubated with a lysis buffer containing 20mg/ml lysozyme (Lysozyme from chicken 
egg white, Sigma-Aldrich) after which the homogenising was repeated. The 
lysozyme was used to help effectively capture usually difficult to lyse taxa, such as 
gram-positive bacteria. Consequently, DNA was isolated using the Qiagen DNA 
mini kit following instructions from the manufacturer. DNA quantity was assessed 
using a Nanodrop 2000 Spectrophotometer (Fisher Scientific, UK). 
A minimum of 50ng of DNA was sent to Novogene (Cambridge, UK). Quality 
assessment was performed by agarose gel electrophoresis to detect DNA integrity, 
purity, fragment size and concentration. The 16S rRNA amplicon sequencing of the 
V4 region was performed with an Illumina MiSeq (paired-end 250 bp; San Diego, 
CA). Alpha and beta diversity were calculated by QIIME and displayed with R 
software (Novogene, Cambridge). Comprehensive statistical and meta-analysis 
including differential analysis of taxa abundance was completed with the online tool 
Microbiome Analyst 5.0 (Chong et al., 2020). More information on sequencing data 
processing in supplementary data 2.  
2.12 Statistics 
Statistician analysis has been performed using Graphpad Prism (Version 8). The 
statistical tests used are indicated in each figure legend. When diet groups were 
compared over time or LPS as a variable, a 2-way ANOVA with Bonferroni post-hoc 
test was used, when three or more groups were compared at a single time point a 1-
way ANOVA was used with Tukey’s multiple comparison. Lastly, when two groups 
were compared at one time point, an unpaired t-test was used to test for significance. 
p<0.05 was considered overall as statistically significant and indicated as ***= 
p<0.001 **= p<0.01 *= p<0.05. Data not following a normal distribution detected by 











Animal models are invaluable for biomedical research. Factors such as genetic 
background and environmental conditions are given importance when designing 
experiments to ensure reproducibility. However, the choice of diet is often 
overlooked, especially if the diet is not the focus of the study. Several research 
studies have drawn conclusions about dietary effects on metabolism, 
pathophysiology or immunology from comparing the standard chow diet with 
purified diets (Warden and Fisler, 2008).   
The choice of experimental diet is typically selected based on the quantity of 
carbohydrates or fats to best induce the condition being investigated. However, the 
qualitative composition of the diet is also of great importance. For example, standard 
chow diet is based on a variety of grains and cereals such as wheat, wheatfeed, soya, 
barley (SDS diet, UK). The exact formula of the chow diet is often not defined, 
furthermore, the amount of each ingredient used can vary widely depending on the 
batch, source and season. In contrast, purified diets are composed of refined 
ingredients and the formula of the diet is well defined and shared with researchers. 
The main source of carbohydrates in purified diet comes from corn starch, casein for 
protein, soybean oil for fat and cellulose for fibre (e.g. low-fat diet (LF), American 
Institute of Nutrition 93 maintenance, AIN-93M, Research Diets, USA). The use of 
refined ingredients allows the researchers to report the exact formula of the diet used 
in their study, replicate the composition of the diet or modify the individual 
components to meet the experimental needs of the study.  
It is widely accepted that choice of diet can impact the overall health of the host 
(Santos-Marcos et al., 2019). The relationship between diet and the gut microbiota 
can have an influence on the absorption of nutrients, metabolism, immune system 
and behavioural outcomes (Gentile and Weir, 2018; Almeida-Suhett et al., 2019). 
The dietary fibres (DF) from wheat and barley in the chow diet can be degraded by 
the host’s gut microbiota thereby, influencing the bacterial population. Whereas, the 
purified diet contains refined carbohydrates (sucrose and starch) that are readily 
digested by the host. The LF diet contains reduced DF content compared to chow, 
and DF in the LF diet solely comes from cellulose, which is an insoluble fibre, and 
does not interact with the gut microbiota (Soliman, 2019).  
In this chapter we aimed to characterise the effects of the two diets, the grain based 
chow (RM3-P, SDS Diets, UK) and a highly refined low-fat diet (LF) (D17060802, 
based on the AIN-93M, Research Diets, USA) on the gut-liver axis of mice. The 
study provides an opportunity to compare diets that are similar in calories but differ 
in macronutrient composition. It is widely reported that long-term consumption of 
high refined carbohydrate diet can lead to sustained hyperglycaemia that can 
contribute to non-alcoholic fatty liver disease (NAFLD) (Jegatheesan and De Bandt., 
2017). We hypothesised that the difference in the carbohydrate composition of the 
chow and LF diet may lead to an ‘unhealthy’ gut-liver phenotype in mice. Further, 
due to the lack of fibre and high content of easily metabolizable carbohydrates, we 
hypothesised that the gut-liver axis of LF fed mice is more susceptible to an 




episodic systemic inflammation by injecting the mice with low dose of 
lipopolysaccharide (LPS) once a week for 4 weeks (Raduolovic et al., 2018; López-
Collazo and del Fresno, 2013). This model was chosen to mimic recurrent systemic 
inflammation that is observed during ageing and may give us an insight into the long-
































3.2.1 Body composition of mice fed with chow and LF diet 
Standard chow diet and a purified LF diet were compared over a period of four 
weeks. Figure 3.1 shows compositional profile of chow and LF diet. Full 








Chow diet LF diet
 
Figure 3.1 Summary of the composition of chow and LF diet per kilogram. The LF diet contains 
decreased fibre and increased sucrose and starch compared to the chow diet. 
 
As shown in Figure 3.2, body weight and average calorie intake was similar between 
chow and LF fed mice after 4 weeks intervention (Fig. 3.2A and B). We analysed the 
length of small intestine and weight of liver to show no difference between the diet 
groups (Fig. 3.2C and D). To get a further insight into the metabolic phenotype 
induced by the LF diet, we quantified the triglycerides content in the liver to show 
increased levels in the LF fed group (60±0.1%, P=0.004) (Fig. 3.2E). Furthermore, 
histological analysis showed hepatocyte ballooning and lipid droplet accumulation in 


























































































































































Figure 3.2 Mice were fed a standard chow diet or a purified low-fat (LF) diet for 4 weeks. During this 
time, no differences in either body weight (A) or calorie intake (B) were observed. Small intestinal 
length (C), and liver weight (g) to body weight (g) ratio (D) were recorded after sacrifice and did not 
show difference between the two diet groups. Triglyceride content in the liver (E) and histological 
analysis with haematoxylin and eosin (H&E) staining of the liver sections from the chow (F) and LF 
group (G) showed accumulation of lipid droplets in the LF fed mice. Significance was tested using 2-
way ANOVA with Bonferroni post-hoc test (A) and unpaired t-test for B, C, D, and E (***=p<0.001, 
**= p<0.01, *= p<0.05). Values are the means ± SEM of n=6 mice in each group. Mice per group were 
divided into two cages (as 3 mice per cage), calorie intake was measured per cage and divided by 3 




3.2.2 Increased expression of lipogenic genes in the livers of the LF group  
The increase in fat accumulation observed through histological and triglyceride 
analyses was also reflected on gene expression level in the liver. We examined the 
gene expression of sterol regulatory-element binding protein 1 (Srebp1) transcription 
factor involved in de novo lipogenesis to show increasing trend in response to the LF 
diet (55±0.2% P=0.05). While SREBP1 target genes; acetyl-CoA carboxylase alpha 
(Acaca) and fatty acid synthase (Fasn) were shown to be significantly increased in 
response to the LF diet (110±0.3%, 160±0.6%, P<0.05 respectively). Gene 
expression analysis of fibroblast growth factor 21 (Fgf21) suggested an increasing 
trend in the LF group (P=0.08). FGF21 is a peroxisome proliferator-activated 
receptor α (PPARα) target and PPARα is a regulator in de novo lipogenesis pathway 
(Rusli et al., 2016) (Fig. 3.3 A, B, C, and D).  
The gene expression levels of hepatic fructokinase Khk was found to have an 
increasing trend in the LF compared to chow diet group (55±0.2%, P=0.08), whereas 
the glucose transporter 5 (Glut5 also known as Slc2a5) mainly involved in the 
transport of fructose was not changed between the two groups (Fig. 3.3 E and F). 
The gene expression of toll like receptor 4 (Tlr4) a pattern recognition receptor that 
recognizes pathogens to induce innate immune system, and pro-inflammatory 
cytokines interleukin 1 beta (Il1β) were found to have increasing trends in the liver of 
mice fed with the LF diet (Tlr4 56±0.2% P=0.06 and Il1β 70±0.3%, P=0.07) (Fig. 3.3 
G and H). Altogether, assessment of liver lipid content, histological and gene 
expression analysis showed that LF diet fed mice presented increased fat deposition 
in parallel with increased triglycerides levels without liver weight differences when 


















































































































































































































































Figure 3.3 Liver expression profiles of lipid, carbohydrate metabolism genes. Srebp1 (A), Acaca (B), 
Fasn (C), Fgf21 (D), Khk (E) were found to be increased in response to the low-fat (LF) diet. Fructose 
transporter Glut5 (F) was not changed between the two diet groups. The expression levels of 
inflammation related genes Tlr4 (G) and Il1β (H) showed an increasing trend in the LF diet group. 
Significance was tested using unpaired t-test method (***=p<0.001, **= p<0.01, *= p<0.05). Values 
are the means ± SEM of n=5-6 mice in each group. 
 
3.2.3 Sequencing of 16S rRNA from the ileum microbiota in response to the chow 
and LF diet 
Shannon diversity relates both operational taxonomic unit (OUT) richness and 
evenness while, observed species is the total number of species in the community 
(only richness) (Kim et al., 2017). Figure (3.4 A and B) shows a trend towards 
decreasing Shannon index (26±0.3%, P =0.05) and significantly increased observed 
species (17±10%, P=0.04) in the LF diet group. Beta diversity compares microbial 
communities between samples based on their composition. To compare the microbial 
communities between samples, the distance or dissimilarity between each sample is 
calculated and then an ordination-based method such as principal coordinates of 
analysis (PCoA) is used for visual representation at low-dimensional space 
(Microbiome Analyst; Chong et al., 2020). To measure the dissimilarity between 
microbial communities in chow and LF fed mice, PCoA was performed with Bray-
Curtis dissimilarity (Fig. 3.4 C). The percentage on each axis indicates the 
contribution value to discrepancy among samples. PCoA plot showed that after four 
weeks feeding of the diets, there was a clear clustering of ileal microbiota from chow 
samples compared to LF diet. Samples from chow fed mice (blue dots) are clustered 
to the left, which indicates compositional differences, and is confirmed by a 
significant result in the ANOSIM (analysis of group similarities, P value ANOSIM = 




abundance of Bacteroidetes by 82±0.1% (P<0.0001) in ileum of LF fed mice, 
whereas relative abundance of Firmicutes was significantly increased by 52±0.1% 
(P<0.0001) in the LF group (Fig. 3.4 D). Figure 3.4 E shows altered microbial 
profiles at the genus level in the individual mice in each group. Relative abundance 
of Bacteroidetes S247 group is consistently increased in the chow fed mice, while, 
Romboutsia and Lactococcus from Firmicutes phylum is prevalent in the LF fed 
mice. Moreover, Table 3.1 shows genera that were significantly different between 
chow and LF diet group. Our results show differential ileal microbiota composition 
in response to chow and LF feeding in mice.  
 










































































































































































Figure 3.4 Ileal microbial composition in chow and low-fat (LF) fed mice. Alpha diversity for chow 
and LF diet groups (A). Beta diversity profiling of chow and LF ileal microbiota. Principal coordinates 
of analysis (PCoA) was carried out at the genus level. Chow samples are plotted as blue dots, and LF 
are represented as red dots. The groups show significant differences in similarity tested by ANOSIM 
(P value = 0.003) (B).  At the phylum level the Firmicutes: Bacteroidetes ratio was increased in LF fed 
mice (C). Genera profiles of individual mice in the chow and LF group (E). Significance was tested by 
performing Kruskal-Wallis test for alpha diversity measures (*= p<0.05). Values are the means ± SEM 




Table 3.1 Genera that were different in the ileum of chow and low-fat (LF) fed mice. Values are 
based on absolute abundance. Significance was calculated using unpaired t-test, (**= p<0.01, *= 
p<0.05). Values are the means of n=6 mice in each group. 







Faecalibaculum Firmicutes 1336 15476 6728 0.062 
Lactococcus Firmicutes 1236 5138 1014 0.003** 
Romboutsia Firmicutes 1925 15410 4243 0.010* 
Unknown genus S24-7 group Bacteroidetes 21365 4776 3496 0.001** 
Cronobacter Proteobacteria 30.2 154.6 57.2 0.04* 
Stenotrophomonas Proteobacteria 9.7 232.3 76.4 0.015* 
 
3.2.4 The effect of diets on ileal bile acids profile and gene expression 
The interaction between the microbiota and the liver is linked through the portal vein, 
which carries gut-derived products to the liver, and the feedback of bile acids from 
the liver to the small intestine. Alterations in the gut microbiota are also associated 
with changes in the bile acid homeostasis (Molinaro et al., 2018). Therefore, to 
further investigate the effects of the altered microbiota between the two diets, bile 
acids present in the ileal tissue at the time of sacrifice were analysed via liquid 
chromatography–mass spectrometry (LC-MS) as described in Chapter 2 of this 
thesis. Cholesterol in the serum was quantified to show no difference between the 
two diet groups (Fig. 3.5A). The total bile acids were shown to be significantly 
increased by 72±0.2% (P=0.03) in response to the LF diet (Fig. 3.5B). Further 
analysis of the individual bile acids revealed primary bile acids to be significantly 
enhanced by 67±0.2%, P=0.03 in the LF group (Fig. 3.5B). Taurine conjugated 
primary bile acid TβMCA and taurine conjugated secondary bile acids TUDCA were 
significantly increased by 196±338% and 975±48% (P=0.003, 0.03 respectively) in 
the ileum of LF compared to chow fed mice (Table 3.2). The gene expression levels 
of bile acid uptake transporter Asbt and the gut enterokine, fibroblast growth factor 
15 (Fgf15) showed a trend towards increased expression in the LF fed mice (P>0.05). 
However, the expression levels of farnesoid X receptor, Fxr and bile acid organic 
solute transporter alpha, (Ostα) were not altered in the ileum (Fig. 3.5C). Moreover, 
in the liver, the gene expression levels of bile acid synthesis enzyme, cholesterol 7α-
hydroxylase (Cyp7a1), Fxr, and its targets; fibroblast growth factor receptor 4 
(Fgfr4) and small heterodimer partner (Shp) also remained unchanged in chow and 
















































































































































































































































































































Figure 3.5 Bile acids profile and gene expression in the ileum and liver in response to the low-fat (LF) 
diet. Serum cholesterol levels were not significantly different between the diet groups (A). In the 
ileum total and primary bile acid levels were significantly increased in response to LF diet (B). Bile 
acid related genes were tested to show a trend towards an increase in the expression levels of Asbt 
and Fgf15, in the ileum of LF mice (C). Bile acid related genes in the liver were not altered between 
the diet groups (D). Significance was calculated using unpaired t-test (*= p<0.05). Values are the 












Table 3.2 Ileal bile acids profile show increased levels in mice fed the low-fat (LF) diet compared to 
chow. Bile acid were quantified in ileal tissue by liquid chromatography–mass spectrometry (LC-
MS) and are given in µmol/g tissue. Significance was calculated using unpaired t-test (**= p<0.01, 
*= p<0.05). Values are the means of n=5-6 mice in each group. 
 
Mean chow Mean LF SE of difference P value 
αMCA 103.2 169.5 49.8 0.2 
βMCA 554.1 692.2 152.7 0.4 
CA 405.5 494.4 74.3 0.3 
CDCA 10.1 12.2 3.8 0.6 
MCA 6.6 11.7 3.0 0.1 
TαMCA 366.1 680.6 212.8 0.2 
TβMCA 666.8 1979 338.2 0.003** 
TCA 665.2 603.9 202.4 0.8 
TCDCA 13.8 35.7 11.3 0.1 
DCA 29.2 22.0 12.0 0.6 
HDCA 6.1 7.2 3.8 0.8 
LCA 3.0 2.4 0.5 0.2 
TDCA 26.7 72.1 32.3 0.2 
TUDCA 12.2 131.2 48.7 0.034* 
UDCA 11.2 13.9 5.1 0.6 
 
3.2.5 Impact of diets on the ileum villus and crypt morphometry and barrier function 
genes 
Due to the nutrient compositional changes in the chow and LF diet, we hypothesized 
alterations of the small intestinal physiology. H&E analysis of the ileal samples of 
mice fed the experimental diets showed no changes in villus height or crypt depth 
(Fig. 3.6A, B and C). Next, we tested the gene expression related to ileal barrier 
function in response to the two diets. Figure 3.6D shows LF diet led to decreasing 
trend in levels of mucin 2 (Muc2) (by 32±0.1% P= 0.08), and significantly decreased 
expression levels of claudin 3 (Cldn3) (by 35±0.1%, P= 0.04) and zonula occluden 
protein (Zo-1) (also known as tight junction protein 1, Tjp1) (40±0.1% ,P=0.01). 
Altogether, the barrier function genes were found to be downregulated in the ileum 






































































































































Figure 3.6 Changes in ileal physiology in response to the low-fat (LF) diet. Ileal physiology was 
analysed by haematoxylin and eosin (H&E) staining and barrier function genes were measured in 
response to the LF diet. Villus height (A) and crypt depth (B), Photomicrograph showing villi and 
crypts in section of ileum (Images were taken at 4x magnification) (C) Gene expression of Muc2, 
Cldn3 and tight junction protein Zo-1 in the ileum were tested with qPCR (D). Significance was tested 
by using unpaired t-test (*= p<0.05). Values are the means of n=5-6 mice in each group. qPCR: 
Quantitative polymerase chain reaction.  
 
3.2.6 Increased expression of carbohydrate metabolism related genes in the ileum of 
LF diet fed mice 
We analysed the gene expression of two α-glucosidases, maltase-glucoamylase 
(Mgam) for starch and sucrase-isomaltase (Sis) for sucrose hydrolysis. The gene 
expression levels of Mgam and Sis were shown to be significantly increased in the 
LF diet compared to the chow group (Mgam: 99±0.2%; Sis:68±0.1%, P<0.001) (Fig. 
3.7A and B). After hydrolysis, the released monosaccharides (glucose and fructose) 
are transported by the epithelial cells into the bloodstream via sodium-dependent 
glucose cotransporter (SGLT1) and glucose transporters found in the membrane of 
enterocytes, GLUT2 for glucose and GLUT5 for fructose (Goodman, 2010). Gene 
expression levels for Sglt1 and Glut2 were found to show a significant increase in the 
ileum of mice fed the LF diet (Sglt1: 58±0.1%; Glut2: 350±0.7%, P<0.001) (Fig. 
3.7C and D). The expression levels of fructose metabolism genes, Glut5 and Khk 
showed a trend towards an increase in the LF fed mice, however it did not reach 




gluconeogenic gene was tested to show significant increase in the LF group 
(182±0.4%, P=0.003) (Fig. 3.7G). Whereas, triokinase (Tkfc) that converts 
glyceraldehyde to glycolytic/gluconeogenic intermediate glyceraldehyde 3-phosphate 















































































































































































































































Figure 3.7 Genes related to carbohydrate metabolism are increased in the ileum of mice fed the low-
fat (LF) diet compared to chow. Significance was tested using unpaired t-test (***= p<0.001, **= 
p<0.01). Significance was calculated using unpaired t-test (*= p<0.05). Values are the means ± SEM 
of n=6 mice in each group. 
 
3.2.7 LPS administration in mice enhances the LF diet induced detrimental effects on 
the liver 
The low dose LPS challenge provided an experimental model of periodic systemic 
low-grade inflammation that is a typical feature of ageing (Howcroft et al., 2013; 
d’Avila et al., 2018). This experiment aimed to investigate the response of the gut-
liver axis to the high fibre chow and low-fibre, high refined carbohydrate purified 
(LF) diet in a state of mild systemic inflammation induced by an intraperitoneal dose 
of 0.5mg LPS per kg body weight per week for 4 weeks (Raduolovic et al., 2018). 
The control group received equal amount of sterile phosphate buffered saline (PBS) 






Figure 3.8 Summary of the LPS challenge experiment. Mice were divided into four groups: chow + 
PBS, LF + PBS, chow + LPS and LF + LPS. During the feeding experiment, mice were administered with 
LPS or sterile PBS per week for four weeks. At the time of sacrifice, blood, liver and ileum samples 
were collected. Low-fat diet: LF, PBS: Phosphate buffered saline, LPS: Lipopolysaccharide 
 
We did not observe a significant difference between the weight gain of chow and 
chow LPS group, whereas LF LPS mice showed decreasing weight gain compared to 
the LF control group (36±0.4%, P=0.04) (Fig. 3.9A and B). There was no difference 
observed in calorie intake between the groups (Fig. 3.9C). The liver weight of mice 
did not change in response to diets or the LPS challenge (Fig. 3.9D). Increased liver 
stress was quantified by measuring caspase 3 activity as an indication of apoptotic 
cells and showed a significant increase in the LF LPS group compared to LF control 
(90±0.1%, P<0.0001). Moreover, the caspase 3 activity was also increased in LF LPS 
compared to chow LPS group (50±0.1%, P=0.001) (Fig. 3.9E). Similar to the first 
study, liver histology showed hepatocyte ballooning and accumulation of lipid 
droplets in the livers of mice fed with LF diet (Fig.3.10B). Livers from the LF LPS 
group showed hepatocyte ballooning as well as increased inflammation illustrated by 









































































































































































































Figure 3.9 Body weight, calorie intake and liver phenotype were analysed in response to the LPS 
challenge. Body weight changes during the experiment (A), Body weight gain at the end of 4 weeks 
(B), and average calorie intake of mice in the different groups (C). Liver weight (g) relative to body 
weight (g) ratio showed no difference between the groups (D). Apoptosis was measured in the liver 
by caspase 3 activity (C3) assay and the LF LPS group C3 activity was significantly increased compared 
to LF control and chow LPS group. Significance was tested using 2-way ANOVA with Tukey’s multiple 
comparison test between the groups (***= p<0.001, *= p<0.05). Values are the means ± SEM of n=5-
6 mice in each group. Mice per group were divided into two cages (as 3 mice per cage), calorie intake 






(A) Chow (B) LF
(C) Chow LPS (D) LF LPS
 
Figure 3.10 Histological analysis of livers. Liver sections were stained with haematoxylin and eosin 
(H&E) and micrographs taken at 20x magnification, chow (A), Low-fat (LF) (B), chow LPS (C), and LF 
LPS (D). Arrow on the LF LPS micrograph denotes accumulation of monocytes. LPS: 
Lipopolysaccharide. 
 
Expression of lipogenic gene Fasn was observed to be increased in the liver in 
response to the LF compared to chow fed mice (169±0.4%, P=0.01). The gene 
expression of Fgf21 showed an increasing trend by 548±3%, P=0.1 in the livers of 
LF mice. This LF induced effect was observed regardless of LPS treatment (chow 
LPS vs LF LPS 124±0.4%, P=0.03; 753±3%, P=0.1, Fasn and Fgf21 respectively) 
(Fig. 3.11A and B).  
Treatment with LPS led to increased expression of inflammation related genes, 
serum amyloid 1 (Saa1) (Fig. 3.11C), tumour necrosis factor alpha (Tnfα) (Fig. 
3.11D), macrophage marker; mouse epidermal growth factor-like module-containing 
mucin-like hormone receptor-like 1 (F4/80) (Fig. 3.11E), and nucleotide-binding 
domain-like receptor (Nlrp3) (Fig. 3.11F), in chow LPS compared to chow control 
(Saa1: 412±0.9%, P=0.001; Tnfα: 350±1%,P=0.0007; F4/80: 140±0.5%, P= 0.001; 
Nlrp3: 112±0.3%, P=0.0008), and in LF LPS compared to LF control (Saa1: 
315±0.9%, P=0.001; Tnfα 178±1% P=0.01; F4/80: 132±0.5%, P=0.002; Nlrp3: 
48.5±0.3%, P=0.04).  The increased expression of the inflammation related genes 
confirms that the LPS injections successfully induced an inflammation response in 




Nlrp3 in LF LPS compared to chow LPS group, however the difference did not reach 






























































































































































































































































Figure 3.11 Gene expression analysis of liver. Increased expression of lipid metabolism related 
genes; Fasn (A) in the liver of low-fat (LF) (control and LPS) group compared to chow counterparts. 
The gene expression levels of Fgf21 showed an increasing trend with LF diet independent of LPS 
treatment (B). Expression of inflammation related genes, Saa1, Tnfα, F4/80 and Nlrp3 was increased 
in mice injected with LPS regardless of diet (C, D, E, and F). Significance was tested using 2-way 
ANOVA with Tukey’s multiple comparison test (***= p<0.001, **= p<0.01, *= p<0.05). Values are the 












3.2.8 The response of ileum to the LPS challenge in mice fed with chow and LF diet 
Due to the previously observed differences in the expression of barrier function 
genes, intestinal permeability was tested using fluorescein isothiocyanate, FITC-
dextran. FITC-dextran was administered via oral gavage two hours before sacrifice 
and the appearance of fluorescence was measured in the serum. A higher 
fluorescence indicates an increase in gut permeability, as FITC-dextran crosses the 
intestinal epithelium. Increased concentrations of FITC-dextran were observed in 
mice fed the LF diet and increasing trend was observed for the LF LPS treatment 
group (chow vs LF: 265±1%, P=0.04; chow LPS vs LF LPS: 352±1%, P=0.08) (Fig. 
3.12A). In line with FITC-dextran concentrations, barrier function genes were tested 
to suggest decreased Cldn3 and occludin, (Ocln) expression in groups fed the LF diet 
(Fig. 3.12B). The barrier function gene expression showed decreasing trend in the LF 
fed mice independent of the LPS challenge (chow vs LF: Cldn3: 30±0.04%, P<0.01; 
Ocln: 18±0.1%, P=0.08 and, chow LPS vs LF LPS: Cldn3: 33±0.1%, P=0.02; Ocln: 
42±0.2%, P=0.05). Inflammation related genes were tested to show a significant 
increase in expression of interleukin 1 β (Il1β) and Tnfα in the LF LPS compared to 
LF control group (Fig. 3.12C). The expression of myeloid differentiation primary 
response gene 88, (Myd88) showed an increasing trend in LF LPS mice (P>0.1). The 
gene expressions of Il1β and Tnfα were also shown to be increased in LF LPS 
compared to chow LPS mice. While no difference in inflammation related gene 
expression was observed between chow and chow LPS group. Our previous findings 
showed the expression of carbohydrate related genes, Mgam, Sis and Glut2 to be 
increased in the ileum of LF mice. The current study reproduced this effect in the 
control as well as LPS treated LF fed mice. However, the carbohydrate metabolism 
genes were not affected by LPS treatment (Fig. 3.12D). Summary of statistics in 















































































































































































































































































































































































































Figure 3.12 Intestinal permeability and gene expression changes in response to diet and LPS 
challenge. Low-fat (LF) fed mice had increased intestinal permeability measured by FITC-dextran 
independent of LPS treatment (A), Barrier function gene expression levels were decreased in the 
ileum of LF fed mice (B), Inflammation related genes had increased expression in response to LF LPS 
compared to  chow LPS (C), Carbohydrate metabolism related gene expression increased in LF fed 
mice independent of LPS treatment (D). Significance was tested using 2-way ANOVA with Tukey’s 
multiple comparison test (***= p<0.001, **= p<0.01, *= p<0.05). Values are the means ± SEM of n=5-




Table 3.3 Summary of statistics for ileal gene expression analysis. Significance was tested using 2-
way ANOVA with Tukey’s multiple comparison test (***= p<0.001, **= p<0.01, *= p<0.05). Values 




SE of diff. P value 
Myd88 
chow vs. LF 7.0 0.7 1.0 
chow vs. chow LPS 7.0 0.7 1.0 
LF vs. LF LPS 51 0.7 0.9 
chow LPS vs. LF LPS 52 0.7 0.9 
Il1β 
chow vs. LF 83 0.7 0.6 
chow vs. chow LPS 71 0.7 0.7 
LF vs. LF LPS 130 0.7 0.007** 
chow LPS vs. LF LPS 146 0.7 0.004** 
Tnfα 
chow vs. LF 59 0.7 0.9 
chow vs. chow LPS 62 0.7 0.8 
LF vs. LF LPS 179 0.7 0.001** 
chow LPS vs. LF LPS 173 0.7 0.001** 
Mgam  
chow vs. LF 154 0.6 0.00001**** 
chow LPS vs. LF LPS 209 0.6 0.0001*** 
Sis 
chow vs. LF 182 0.6 0.0005*** 
chow LPS vs. LF LPS 189 0.6 0.00003**** 
Glut2 
chow vs. LF 455 0.7 0.002** 
















The studies performed in this chapter demonstrated that the purified LF diet 
compared to the chow has differential effects on the gut-liver axis independent of 
weight gain. The LF diet leads to significant changes in 1) liver phenotype of mice, 
2) ileal gene expression related to carbohydrate metabolism and barrier function, 3) 
ileal microbiota and 4) ileal bile acid composition. Moreover, our data showed LF 
fed mice had increased sensitivity to the LPS challenge compared to chow.  
No changes in body weight or calorie intake of mice were observed during the four 
weeks feeding of the two diets, which indicates that the significant changes observed 
in the gut and liver of mice in response to the diet are independent of weight gain. 
We show that the LF diet feeding of 4 weeks, led to increased hepatic triglycerides in 
mice compared to the chow fed group, which was confirmed by upregulation of 
genes related to de novo lipogenesis, Acaca and Fasn. We observed increased 
expression of PPARα target gene Fgf21 in the livers of LF fed mice. Maekawa et al. 
(2017) has reported increased hepatic Fgf21 mRNA expression in mice fed a high 
refined carbohydrate diet that led to increased energy expenditure, thus attenuating 
weight gain. Moreover, Rusli et al. (2016) found upregulation of PPARα targets 
including Fgf21 gene expression in the livers of mice with NAFLD and suggest a 
protective role of FGF21 against fatty acid induced lipotoxicity and oxidative stress 
in NAFLD.  
Diet is an important external factor that affects the gut microbiota (Gentile and Weir, 
2018), therefore, we next examined the influence of chow and LF diet on the ileal 
microbiota of mice. We observed changes in α diversity between the diet groups and 
the shifting of the ileal microbiota induced by the different diets as indicated by the β 
diversity. Although, the count of observed species was higher in the LF compared to 
chow diet, the evenness (Shannon index) was decreased in the LF group, which 
suggests uniformity of the population size of each of the species (Wagner et al., 
2018). Microbial analysis at the phylum level indicated that the LF diet group 
exhibited an increased proportion of Firmicutes and reduced proportion of 
Bacteroidetes. Dalby et al (2017) reported increased Firmicutes: Bacteroidetes ratio 
to in mice fed the purified LF and high fat diets relative to standard chow, which may 
suggest that differences in fat content between the diets was not the main driver of 
the change in Bacteroidetes and Firmicute quantity, but the lack of fibre in the 
purified diets compared to chow diet. Further examination at the genus level showed 
an increased population of the genus from Bacteroidales S24-7 family in the chow 
compared to the LF diet fed mice. Ormerod et al. (2016) proposed the name Ca. 
Homeothermaceae for this genus which contains increased abundance of enzymes 
involved in the degradation of complex plant cell wall glycans (hemicellulose and 
pectin) as are present in the chow diet. Although, Bacteroidales S24-7 family of 
bacteria has been well described in the murine gut, its importance on long-term 
health is still unclear. LF group showed a significantly increased proportion of 
Romboutsia, Faecalibaculum, and Lactococcus belonging to the Firmicutes phylum. 
Romboutsia is an obesity-related genus that is positively associated with lipogenesis 
in the liver (Zhao et al., 2018). Faecalibaculum and Lactococcus are lactic acid 




extent (Lim et al., 2016 and Yu et al., 2017). Furthermore Yu et al. assessed the 
genomic characteristics of ten Lactococcus species to reveal the ability of most of the 
strains to hydrolyse sucrose to d-glucose-6P and d-fructose. The authors also found 
that all the strains of Lactococcus have genes encoding fructokinase, a key enzyme in 
fructose metabolism. Therefore, increased presence of refined carbohydrates in the 
LF diet may explain the higher abundance of Lactococcus observed in the LF fed 
mice. Although, the relative abundance of Proteobacteria phylum was not different 
between the two diets, the relative abundance of pathogenic genera Cronobacter and 
Stenotrophomonas within the Gamma Proteobacteria group was increased in the LF 
fed mice (Trifonova and Strateva, 2019).  
LPS is a product of gram-negative bacteria that are mostly found in the Bacteroidetes 
and Proteobacteria phylum. However, the endotoxin activity of LPS in Bacteroidetes 
is less effective compared with that of Proteobacteria. Studies have reported that 
bacteria in the Enterobacteriaceae family (Gamma Proteobacteria) possess 
markedly increased LPS endotoxin activity than LPS extracted from the envelope of 
bacteria of the Bacteroidetes phylum which can inhibit the host immune response 
(Salguero et al., 2019). We observed increased proportions of Enterobacteriaceae 
family in the LF compared to chow group in the first study (Supplementary Fig. 3.1). 
Altogether, our study shows that ileal microbiota composition is significantly 
influenced by the chow and LF diet. However, it remains unclear if the microbiota 
also contributes to the ‘unhealthy state’ of the LF fed mice, or if it itself was shaped 
by metabolic dysregulation as a result of the LF diet.  
The gut microbiota and bile acids interaction play an important role in regulating 
enterohepatic bile acid metabolism. Primary bile acids are synthesised from 
cholesterol in the liver, conjugated with glycine or taurine and further metabolised by 
the gut microbiota into secondary bile acids (Ticho et al., 2019). We determined ileal 
bile acid profiles of the chow and LF fed mice by liquid chromatography-mass 
spectrometry. The total bile acids were shown to be significantly enhanced in the 
ileum of LF fed mice. We observed an increase in ileal primary bile acids in response 
to the LF diet, while, the secondary bile acids were not changed between the diet 
groups. Analysis of the bile acids at the individual level showed primary conjugated 
bile acid; TβMCA and conjugated secondary bile acid; TUDCA to be significantly 
increased in the LF group. Removal of glycine/taurine conjugates by the microbiota 
relies on their bile salt hydrolase (BSH) activity. BSH is expressed in some strains of 
Lactobacillus, Bacteroides, Clostridium, and Bifidobacterium (Song et al., 2018). 
Although, the abundance of Lactobacillus varied among the groups, we observed a 
consistent increased abundance of Bacteroidales S24-7 from Bacteroides group in 
the chow fed mice. The increased levels of taurine conjugated bile acids might be due 
to the decreased abundance of BSH containing bacteria in the LF mice. Further 
experiments to measure BSH enzyme activity in the ileal content of chow and LF fed 
mice can help confirm this hypothesis. Sayin et al. (2013) proposed TβMCA to be an 
antagonist of FXR, however, we did not observe difference in the ileal Fxr 
expression between the diet groups. In contrast, the gene expression of FXR target, 
the enterokine Fgf15 showed an increasing trend in LF diet fed mice. These 




was not enough to function as FXR antagonist. Sayin et al. used ileal explants and 
germ-free mice to show the FXR inhibition by TβMCA, which eliminates the 
competition that exists between bile acid agonist and antagonist for the activation or 
suppression of FXR expression in ileum. Moreover, our previous studies have 
demonstrated increased ileal glucose concentration to be associated with upregulation 
of Fgf15, possibly by GlcNAcylation of ileal FXR independent of bile acids. FGF15 
binds to its hepatic membrane receptor FGFR4 to suppress the expression of 
CYP7A1, the rate limiting enzyme in the bile acid synthesis pathway in the liver. The 
LF diet did not alter the gene expression of Fgfr4 and Cyp7a1. Moreover, we did not 
observe changes in the gene expression levels of bile acid transporters in the ileum.  
Quantity and the quality of macronutrients has been shown to influence the ileum 
morphology in several animal models (Kieffer et al., 2016; Alonso and Yilmaz, 
2018). In the current study we observed the expression levels of barrier function 
genes Muc2, Cldn3 and Zo-1 to be decreased in response to the LF diet. Mucin gel-
forming glycoprotein (MUC2) is secreted by goblet cells and serves to physically 
segregate the microbiota from gut epithelium. Further, Claudins and Zonula 
occludens control the diffusion of water, ions, and nutrients, and restrict the entry of 
pathogens and pathogen derived endotoxins such as LPS, that can lead to chronic 
inflammation observed in metabolic syndromes (Chu et al., 2019). The 
downregulation of barrier function genes may be linked to reduced fibre content 
and/or the higher starch and sucrose present in the LF diet. The association of 
improved barrier function with a high fibre diet has been attributed to the microbial 
production of SCFAs in the gut (Hung et al., 2016). We have previously observed 
decreased concentrations of SCFAs in the ileal luminal content in response to 2 
weeks LF feeding compared to chow (Supplementary Fig. 3.2).  Moreover, Thaiss et 
al. (2018) showed hyperglycaemia could drive alterations in tight junction and 
leading to immune-stimulatory microbial products and systemic inflammation. 
Although, the study focused on the impact of systemic hyperglycaemia on the 
intestinal barrier, similar effects may be observed by a high refined carbohydrate diet 
resulting in high glucose concentrations in the ileum and thus induce changes in the 
intestinal permeability. Recent study by Jang et al. (2018) has shown that the small 
intestine plays a crucial role in controlling fructose that enters the liver by converting 
fructose into glucose and other metabolites and thus shielding the liver from fructose 
exposure. Due to the increased amount of simple carbohydrates present in the LF 
diet, we measured the expression of ileal genes related to carbohydrate metabolism to 
show increased expression of carbohydrate digesting enzymes Mgam, Sis and 
glucose transporters Sglt1 and Glut2 and gluconeogenesis enzyme G6pc. Our data 
suggests, the increase in the expression of carbohydrate metabolism related genes in 
the ileum of LF fed mice could be a result of the increased amount of starch and 
sucrose present in the LF compared to the chow diet.  
The increased accumulation of triglycerides, abundance of pathogenic bacteria and 
decreased expression of barrier function genes in LF group led us to hypothesise that 
these mice may be more susceptible to a proinflammatory challenge compared to 
chow fed mice. To test this hypothesis, we administered low dose LPS via i.p. 




state in mice. We observed decreased weight gain in LF LPS compared to other 
groups, although no difference in calorie intake was observed. Histological analysis 
of the liver sections reproduced our previous findings to show increased lipid 
deposition in LF group, which was confirmed by increased Fasn gene expression. 
Apoptosis plays an important role in inflammation. Therefore, we quantified the 
amount of apoptosis by caspase 3 assay in the liver, to reveal increased caspase 3 
activity in the livers of LF LPS group compared to the other groups. Apoptosis by 
caspase 3 activation in hepatocytes plays a key role in non-alcoholic steatohepatitis 
(NASH) pathogenesis (Thapaliya et al., 2014). The increased levels of caspase 3 
activity in the LF LPS mice compared to chow LPS group suggests increased 
sensitivity of the LF compared to chow fed mice. The exogenous administration of 
LPS is associated with the activation of TLR4 complex. Although, we did not 
observe difference in the gene expression of Tlr4 in the liver (Supplementary Fig. 
3.3), its downstream genes, Saa1, Tnfα, F4/80 and Nlrp3 were found to be 
upregulated in the liver of both diet + LPS groups. Upon analysing the expression of 
inflammation related genes, no significant difference was observed between chow 
LPS and LF LPS group, however, the response of LF liver was more pronounced to 
the LPS challenge compared to chow LPS. The increased trend in the expression of 
proinflammatory genes coincides with infiltration of monocytes observed in the 
histological analysis of the LF LPS group. The increased inflammation response in 
the LF LPS mice as indicated by hepatic caspase 3 activity may be a factor in the 
decreased weight gain observed in these mice, as increased inflammation response 
has been associated with weight loss (Seemann et al., 2017).  
To confirm the LF diet effect on the barrier function genes, we measured intestinal 
permeability by quantifying FITC-dextran in the serum of mice. LF fed mice (control 
and LPS treated) showed increased FITC-dextran serum concentration compared to 
chow counterparts. The FITC-dextran assay results agreed with Cldn3 and Ocln gene 
expression of the ileum, which suggested a stronger diet effect than low dose LPS 
treatment. Next, we questioned if the LPS treatment influenced nutrient uptake in the 
ileum. In agreement with our first study we observed increased gene expression 
levels of Mgam, Sis and Glut2 in the ileum of LF fed mice and LPS treatment did not 
affect the expression levels of these genes. The ileal expression levels of LPS-TLR4 
driven genes Myd88, Il1b and Tnfα were found to be significantly increased in LF 
LPS compared to chow LPS. Our results suggest that the LPS treatment in LF fed 
mice caused significant intestinal inflammation, which was not observed in chow 
LPS mice. Increased consumption of DF has been reported to reduce the 
concentrations of proinflammatory cytokines associated with age or model of 
endotoxemia, possibly by the anti-inflammatory properties of SCFAs (Matt et al., 
2018; Zhang et al., 2019). However, more work is needed to understand the mode of 
action of SCFAs in the ileal enterocytes. Altogether, our data suggests LPS elicited a 
stronger response in LF fed compared to chow fed mice. The decreased weight gain 
together with greater inflammation response in the liver and ileum of LF group to 
LPS challenge could be attributed to the scarce amount of fibre and increased starch 




Chapter 4: The response of the ileum to lifelong calorie restriction of 







Calorie restriction (CR) is a dietary regimen that reduces food intake without 
incurring malnutrition. CR has been shown to increase lifespan in a number of 
species ranging from single-celled organisms to mammals (Mair and Dillinas, 2008), 
as well as improve general health and decrease the onset of age-related diseases 
including cardiovascular and neurodegenerative diseases, diabetes and cancer (Most 
et al., 2017). Potential mechanisms associated with metabolic reprogramming may 
contribute to the beneficial health outcomes of CR. Several studies have suggested a 
complex network of signalling pathways, including SIRT1, mTOR, AMPK, IGF-1, 
to contribute towards health benefits of CR (Pan and Finkel, 2017; Komatsu et al., 
2019). Previous studies have provided knowledge into the effects of CR on 
individual organs such as white adipose tissue (Fujii et al., 2019), liver (Rusli et al., 
2017) and colon (Kok et al.,2018).  
Although, the small intestine is a major responsive organ to food, it has not been well 
studied in the context of CR. The ileum is an important part of the small intestine 
because of its crucial homeostatic interactions with a diverse population of 
microbiota and its role in utilising the macro- and micronutrients. CR has been 
shown to alter the level of bile acids in the plasma, liver and small intestine of mice 
(Fu and Klaassen, 2013), which may also be associated with changes in the ileal 
microbiota. Therefore, the limited information on the impact of CR in the ileum 
prompted us to characterise the changes in the ileal microbiota, gene expression and 
bile acid levels in response to short- and long-term CR. In collaboration with the 
group of Dr Wilma Steegenga (Wageningen University, NL), we aimed to investigate 
ileal morphology, ileal gene expression via microarrays, bile acid metabolism and the 
ileal microbiota composition in response to lifelong CR in 6 and 24 months old mice. 
This project is known as the IDEAL study (Integrated Research on Developmental 
Determinants of Ageing and Longevity). The mice in the IDEAL study were fed the 
purified American Institute of Nutrition 93W (AIN-93W) diet which is variant of 
AIN-93M and is similar to the low-fat (LF) diet used in the previous chapter 
(composition of the diet is shown in Methods Table 2.2). The ileal samples from 6 
and 24 months of age gave us the opportunity to differentiate the effects of CR at 
young and old age. The study also provided us with an opportunity to describe the 
long-term effects of LF diet on the ileal microbiota and gene expression during 
ageing.  
In Chapter 3 of this thesis, we have shown differential effects of the two control diets 
on the gut-liver. In line with this, we hypothesised that the compositional differences 
in the chow and LF diet may result in altered gut and liver response to CR. We 
designed a short-term (8 weeks) CR study to compare the effects of CR on two 
different background diets (chow and LF). The study aimed to characterise 
differences in the gut-liver gene expression and bile acids levels in response to CR of 
the chow and LF diet. IDEAL study showed that mice needed approximately 8-10 
weeks to adapt to CR feeding schedule and reach a relatively stable weight. 
Therefore, we chose dietary intervention period of 8 weeks to test the effects of 





4.2.1 Physiological effects of long-term CR on the gut and liver of mice 
Adaptations to the CR diet were observed in the weekly body weight measurements. 
At the time of sacrifice lifelong LFCR fed mice showed lower body weight (by 
40±1%, P< 0.0001) compared to the LF control group (Fig. 4.1A). Fat deposition in 
the liver was examined by quantification of the hepatic triglycerides content and 
showed decreased triglycerides levels in the livers of mice exposed to CR compared 
to control diet at 6 and 24 months of age (37.9±0.1%, P=0.01 and 65±0.4%, 
P<0.0001 respectively). Furthermore, we observed 73±0.3% (P=0.001) increase in 
the triglycerides content with age in the control group, whereas, triglycerides content 
was not significantly different between CR6m and CR24m mice (P= 0.2) (Fig. 4.1B).  
Histological analysis with haematoxylin and eosin (H&E) staining of ileum from LF 
and LFCR, 6- and 24 months old mice was performed, and the villi height and crypt 
depth were measured using the Image J software. Our data showed shrinkage of villi 
height by 19±0.04% and 8±0.03% (P= 0.01, 0.04) in CR exposed 6 and 24 months 
old mice compared to respective control group (Fig. 4.1C). Analysis of the crypt 
depth showed expansion by 23±0.04% (P<0.001) in 6m and 36±0.05% (P< 0.0001) 
in 24m old CR fed mice compared to control (Fig. 4.1D). The crypt depth was also 
increased with age in the CR group (15±0.04%, P=0.001), whereas no difference in 



































































































































Figure 4.1 Body composition of mice in response to lifelong CR. Weekly measurements of body 
weight showed reduction in body weight in the lifelong CR mice (A). CR exposure led to decrease in 
the liver triglycerides content in 6- and 24-months old mice (B). Analysis of villi and crypt lengths in 
the ileum of mice revealed modifications in response to the diet and age (C, D). Micrograph shows 
haematoxylin and eosin (H&E) stained ileum section at magnification 4x and the distance used to 
measure v=villus height and c=crypt depth (E). Significance was tested using 2-way ANOVA with 
Bonferroni post-hoc test for both diet and time (*** = p<0.001, **= p<0.01, *= p<0.05). Values are 
the means ± SEM of n=13-16 mice (Body weight and IHTG) and n=5-6 mice (ileal histological analysis) 














4.2.2 Ileal gene expression of lifelong CR exposed mice resembles that of young 
mice 
Gene expression profiles were measured in ileal samples (n=4 per group) to identify 
biological pathways regulated between the diets. A sample from LF24m group was 
excluded due to adipose tissue contamination. At 6 and 24 months, microarray 
analysis revealed 153 and 135 significantly differentially expressed genes (P<0.05) 
between the LFCR and LF control diet exposed mice (Fig. 4.2A). Ingenuity pathway 
analysis (IPA) revealed that affected canonical pathways for the comparison between 
LFCR against LF control were predominantly related to immune responses at 6 
months and cell cycle regulation at 24 months of age. In the top canonical pathways 
B cell development was the major difference between the two diets at 6 months, 
while ‘mitotic roles of Polo-Like kinase’, ‘cell cycle’ and ‘ATM signalling’ were 
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Figure 4.2 Gene expression in the ileum of 6- and 24-months old mice fed with LF control and LFCR 
diet. The number of differentially expressed genes at 6 and 24 months based on an intensity based 
moderated (IBMT) P value=0.05 (A). The top 5 canonical pathways revealed by Ingenuity pathway 
analysis (IPA), that were differentially regulated in mice fed the LFCR versus LF control diet at 6 
(black) and 24 months (grey) of age (B). For microarrays analysis n=3-4 in each group. LF: Low-fat 
diet ad libitum, LFCR: Calorie restriction of LF diet.  
 
IPA revealed inhibited activation state (negative Z score) for pathways involved in T 
lymphocytes signalling for comparison of LFCR Vs LF control at 6 months. 
Consistent with the IPA results we observed attenuation of gene expression related to 
inflammation in the ileum of mice exposed to CR diet (various T cell antigen and 
receptor genes, and lymphotoxin beta, Ltb) (Table 4.1). Top 10 genes upregulated 
with 6 months CR diet included; genes involved with inhibition of immune response 
(Nt5e) (Kordaß et al., 2018), B cell development related genes (immunoglobulins 
Iglv1 and 2) (Spencer and Sollid, 2016), cell proliferation related gene (Tppp), 
Lingo4, Col6a3 , Ly96 and lipid metabolism related genes (Acsl3, Lpcat4 and Scd2) 
(GeneCards, 2020). At 24 months, genes related to antimicrobial peptides and cell 
cycle regulation (e.g. Mptx2, Cdca3) were among the most upregulated genes (Table 




related gene Dusp1 (also known as MAPK phosphatase 1, Mkp1), Slfn8, member of 
the epidermal growth factor (EGF) ligand family, Areg (Chen et al., 2018), cancer 
associated gene Sprr1a (Deng et al., 2020), Phlda1 (Kastrati et al., 2015), 
extracellular matrix related gene Fras1 (Beck et al., 2013), microRNA mir1247, 
Sodium/phosphate co-transporter, Slc34a2 and olfactory related gene Vmn2r29. The 
importance of miR-1247, Slc34a2 and Vmn2r29a in the intestine has not yet been 
explored. Full names of the genes in Table 4.1 and 4.2.  
 
Table 4.1 Differentially regulated genes in the ileum for the comparison of LFCR and LF control diet 
at 6 months. The genes were selected based on the most pronounced differential expression (fold 
change of >1.5 from CR6m to LF6m). Significance of change was calculated from the mean signal 
intensities and difference between diet groups was analysed using IBMT statistics implementing 
Bayes correction. N=3-4 per group. LF: Low-fat diet ad libitum, LFCR: Calorie restriction of LF diet. 
Gene Description Fold Change Adjusted 
P value 
Top up-regulated genes 
Iglv2 immunoglobulin lambda variable 2 2.5 0.0159 
Nt5e 5' nucleotidase, ecto 2.2 0.0092 
Iglv1 immunoglobulin lambda variable 1 2.1 0.0087 
Tppp tubulin polymerization promoting protein 2.0 0.0066 
Lingo4 leucine rich repeat and Ig domain containing 4 1.9 0.0006 
Col6a3 collagen, type VI, alpha 3 1.9 0.0347 
Ly96 lymphocyte antigen 96 1.9 0.0067 
Acsl3 acyl-CoA synthetase long-chain family member 3 1.9 0.0051 
Lpcat4 lysophosphatidylcholine acyltransferase 4 1.7 0.0069 
Scd2 stearoyl-Coenzyme A desaturase 2 1.7 0.0018 
Top down-regulated genes 
Trgj2 T Cell Receptor Gamma Joining 2 -2.6 0.00125 
Dio1 Deiodinase, Iodothyronine Type I -2.1 0.00318 
Cd79b B-Cell Antigen Receptor Complex-Associated Protein Beta Chain -2.1 0.00227 
Trgj4 T Cell Receptor Gamma Joining 4 -2.0 0.00009 
Tcrg-C4 T cell receptor gamma, constant 4 -1.9 0.00011 
Cd7 CD7 antigen -1.9 0.00060 
Tcrg-C2 T cell receptor beta, constant region 1 -1.9 0.00207 
Trbc1 T cell receptor beta, constant region 1 -1.9 0.00186 
Cd3g CD3 antigen, gamma polypeptide -1.9 0.00024 









Table 4.2 Differentially regulated genes in the ileum for the comparison of LFCR and LF control diet 
at 24 months. The genes were selected based on the most pronounced differential expression (fold 
change of >1.5 from CR24m to LF24m). Significance of change was calculated from the mean signal 
intensities and difference between diet groups was analysed using IBMT statistics implementing 
Bayes correction. N=3-4 per group. LF: Low-fat diet ad libitum, LFCR: Calorie restriction of LF diet. 
Gene Description Fold change Adjusted 
 P value 
Top up-regulated genes 
Mptx2 Mucosal pentraxin 2 3.9 5.96E-05 
Defa-rs1 Defensin, alpha, related sequence 1 2.0 0.000366 
Cdca3 Cell division cycle associated 3 1.9 0.000591 
Cdca5 Cell division cycle associated 5 1.8 0.000797 
Utp14b UTP14, U3 small nucleolar ribonucleoprotein, homolog B 1.8 0.004697 
Mmp7 Matrix metallopeptidase 7 1.7 0.003251 
Ang4 Angiogenin, ribonuclease A family, member 4 1.7 0.001653 
Prr11 Proline rich 11 1.7 0.002233 
Aurkb Aurora kinase B 1.7 0.001837 
Ccna2 Cyclin A2 1.7 0.000712 
Top down-regulated genes 
Fgf15 fibroblast growth factor 15 -3.9 0.0097 
Dusp1 dual specificity phosphatase 1 -2.3 0.0028 
Sprr1a small proline-rich protein 1A -2.1 0.0073 
Areg amphiregulin -1.9 0.0088 
Phlda1 pleckstrin homology-like domain, family A, member 1 -1.8 0.0173 
Fras1 Fraser syndrome 1 homolog (human) -1.8 0.0007 
Mir1247 microRNA 1247 -1.8 0.0016 
Slfn8 schlafen 8 -1.7 0.0153 
Slc34a2 solute carrier family 34 (sodium phosphate), member 2 -1.6 0.0117 















Figure 4.3 shows various ileal genes implicated in the immune response, cell cycle 
regulation and energy metabolism that were modulated between the diet groups of 6- 
and 24-months old mice. Genes related to Paneth cells (Mptx2, Defa-rs1, defa3, 
Dmbt1) (Fig. 4.3A), cell cycle regulation (Cdca3, Cdca8, Cenpe, Prr1) (Fig. 4.3B) 
were observed to be decreased with age in the LF control group, whereas, no 
significant difference was observed in their gene expression levels between CR6m 
and CR24m old mice.  
Lipid metabolism genes (Acsl3, Scd2, Lpcat4, Elovl6) are suggested to be increased 
in response to CR compared to LF control at both 6m and 24m of age (Fig. 4.3C). 
Genes involved in carbohydrate metabolism (Chrebp, Sis, Khk, Fbp1, Sglt1, Glut2 
and Glut5) were upregulated in the ileum of CR24m compared to CR6m group (Fig. 
4.3D) (Full names of the genes in Table 4.3). Whereas, no such effect on 
carbohydrate metabolism genes was observed between the ages in LF control group. 
Genes related to bile acid metabolism, Fgf15, Asbt and Ostα show a decreasing trend 
with age in CR exposed mice (Fig. 4.3E). Although no difference was observed in 
the gene expression of ileal Fxr, its downstream regulator Fgf15 was significantly 
downregulated in CR24m compared to LF24m old mice. Taken together, 6 and 24m 
CR intervention modulated gene expression of various pathways, however, most 
differences in gene expression were observed in CR24m old mice. Summary of 


































































































































































































































































































Figure 4.3 Microarray profiles of differentially regulated genes between diet and age. Genes related 
to Paneth cells (A), cell cycle regulation (B) lipid metabolism (C) carbohydrate metabolism (D) and 
bile acids metabolism (E) in the ileum. Significance was tested using 2-way ANOVA with Bonferroni 
post-hoc test for both diet and time (**= p<0.01, *= p<0.05). Values are the means ± SEM of n=3-4 
mice in each group. LF: Low-fat diet ad libitum, LFCR: Calorie restriction of LF diet. 
 
Table 4.3 Full names of the carbohydrate and bile acid metabolism genes regulated during CR. 
Gene abbreviation Full name 
Chrebp Carbohydrate response element binding protein 
Mgam Maltase-Glucoamylase 
Sis Sucrase isomaltase 
Khk Ketohexokinase 
Fbp1 Fructose-1,6-bisphosphatase 1 
Sglt1 Sodium/glucose cotransporter protein 1 
Glut2/5 Glucose transporter 2/5 
Fxr Farnesoid X receptor 
Asbt Apical sodium–bile acid transporter 






4.2.3 Bile acids in the ileum are decreased as a result of lifelong CR diet 
Since we observed modulation in the expression of genes involved in bile acid 
metabolism, we next measured levels of bile acids in the ileum samples from the diet 
groups at 6 and 24 months of age. We did not observe a significant difference in total 
bile acid levels between LF and CR mice at both timepoints (P= 0.5 and P=0.1 at 6 
and 24 months respectively). The total bile acid levels were significantly decreased 
with age (by 74±591%, P= 0.005) in CR24m compared to CR6m mice (Fig. 4.4A). 
Deeper analysis of individual bile acids revealed significant decrease in most major 
bile acids, primary bile acids: βMCA (P= 0.04), CA (P= 0.03), TβMCA (P= 0.01), 
TCA (P= 0.01), and secondary bile acids: TDCA (P= 0.02), and TUDCA  (P= 0.04) 




















































































































































































































































Figure 4.4 Bile acids were measured in ileal tissue samples from LF and LFCR diet fed mice at 6 and 
24 months. Total bile acids (A), Individual bile acid profiles, Primary bile acids: αMCA, βMCA and CA, 
taurine conjugated primary bile acids: TαMCA, TβMCA and TCA, secondary conjugated bile acids: 
TDCA and TUDCA, secondary unconjugated bile acid: DCA (B). Significance was tested using 2-way 
ANOVA with Bonferroni post-hoc test (*= p<0.05). Values are the means ± SEM of n=4-6 mice in each 







4.2.4 Calorie restriction of the LF diet alters the microbiota profile in the ileum 
The microbial 16S rRNA sequencing analysis was performed on samples from the 
ileal content of mice. The groups contained sample size of n=4-6. A sample from 
CR24m (m6) was excluded from the analysis by performing the Grubbs' outliers test 
at the genera level. Differences in overall microbiota communities (β diversity) were 
determined by Bray-Curtis Index. Permutational multivariate analysis of variance 
(PERMANOVA) test found that microbiota communities differed significantly 
between LF and CR condition (R: 0.83; P < 0.003) in 6 months old mice. However, 
the microbiota differences by diet are not as pronounced in 24 months old mice 
(PERMANOVA, R:0.16; P<0.2) (Fig. 4.5A and B). Examination of α diversity by 
observed species and Shannon index showed similar diversity between the groups 
(Fig. 4.5C). 
We identified specific taxa (at the phylum to genus level) that changed with CR at 
the different time points (Fig. 4.5D). Mice were individually housed throughout the 
course of the study to eliminate cage effects and coprophagy. The abundance of 
Firmicutes and Bacteroidetes was observed to be similar among the diet and age 
groups (P >0.1). We observed an increase in the abundance of Actinobacteria 
(80±1.3%, P= 0.01) in CR6m compared to LF6m mice. The levels of Actinobacteria 
were decreased with age in CR exposed mice (91±1%, P=0.007), whereas no 
difference was observed in Actinobacteria levels between LF6m and LF24m mice.   
A decrease in the abundance of Proteobacteria (70±0.2%, P= 0.02) was observed in 
CR6m compared to LF6m mice, while the levels of Proteobacteria were not changed 
with age in control LF or CR exposed mice.  
The different genera present in the ileum of each mouse was examined to provide a 
more in-depth observation into the ileum microbiota. The profiles of genera present 
are shown for each individual mouse and show clear differences between LF and CR 
fed mice (Fig. 4.5E). At 6 months, genera within Firmicutes including Allobaculum 
(99% similar to Faecalibaculum) and unknown Clostridiaceae (similar to 
Romboutsia) were shown to be highly abundant in the LF compared to CR fed mice 
(P= 0.004 and P=0.02 respectively). Within the CR6m group, there was an increasing 
trend in the abundance of Lactobacillus (phylum Firmicutes) and Bifidobacterium 
(phylum Actinobacteria) in the ileum (P= 0.001 and P=0.05 respectively) (Table 
4.4). At the age of 24 months, we observed an increasing trend in the abundance of 
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Figure 4.5 Microbiota composition in the ileum is different between LF and CR fed mice. PCoA plots 
show the separation of the two diet groups (β diversity) which is most prominent at 6 months of age 
(A and B). Alpha diversity was calculated by observed species and Shannon diversity score (C). 
Phylum levels show differentially distinct profiles with more Actinobacteria in the CR fed mice (D). 
Genera abundance in the ileum are presented for each individual mouse, showing a clear difference 
between the diets (E). Significance in β diversity was calculated by PERMANOVA tests. Significance 
for α diversity measures was tested using Kruskal-Wallis statistical test. N= 4-6 for each group. LF: 





Table 4.4 Summary of changes in the abundance at the genus level between LF and LFCR at 6 months. 
Significant difference between the groups was calculated by unpaired t-test. Values are the means 
of n=5-6 mice in each group. LF: Low-fat diet ad libitum, LFCR: Calorie restriction of LF diet. 
Genera Mean LF Mean LFCR SE of 
difference 
P value 
Akkermansia 1.67 1.60 1.08 0.95 
Allobaculum 59.3 14.40 11.79 **0.004 
Bifidobacterium 2.33 15.40 5.83 0.05 
Lactobacillus 6.50 64.20 11.73 **0.001 
Unknown Clostridiaceae 22.8 2.00 7.01 *0.02 
  
Table 4.5 Summary of changes in the abundance at the genus level between LF and LFCR at 24 
months. Significant difference between the groups was calculated by unpaired t-test. Values are the 
means of n=4-5 mice in each group. LF: Low-fat diet ad libitum, LFCR: Calorie restriction of LF diet. 
Genera Mean LF Mean LFCR SE of 
difference 
P value 
Akkermansia 0.25 0.50 0.47 0.61 
Allobaculum 30.00 29.33 21.26 0.98 
Bifidobacterium 0.50 0.83 0.55 0.56 
Lactobacillus 8.75 26.6 10.7 0.13 
Unknown Clostridiaceae 23.8 20.5 12.8 0.8 
 
4.2.5 Impact of short-term CR on the gut-liver axis of mice under chow and LF diet 
Next, we performed a short term (8 weeks) study to observe the initial effects of CR 
on the gut-liver axis. In addition to CR on the purified LF diet (LFCR), we included a 
group of chow calorie restriction (chowCR) to investigate the response to CR on 
different diet background on the gut-liver axis. To determine the physiological 
features of mice after exposure to the CR diet, body weight was recorded twice a 
week. As expected, the average body weight of CR mice was lower than control mice 
in both diet groups. At the end of 8 weeks, the body weights of chowCR mice was 
20±0.8% lower (P< 0.0001) compared to chow ad libitum fed mice, and the average 
body weight of LFCR mice at the time of sacrifice was 16±0.4% (P< 0.0001) lower 
than the control LF fed mice (Fig. 4.6A). Figure (4.6B) shows the calculated average 
daily caloric intake of one mouse per day, which was reduced by 30±0.4% in the CR 
mice compared to their control counterparts. Triglyceride content levels in the liver 
showed a decreasing trend in chowCR mice (reduced by 27±0.1%, P=0.1) compared 
to chow control, whereas this effect was more pronounced in the LFCR group when 
compared to LF control (decreased by 67±0.1%, P= 0.005) (Fig. 4.6C). We did not 
observe changes in the ileal villi height and crypt depth in response to CR in chow or 









































































































































Figure 4.6 Effects of CR intervention on physiological parameters under chow and LF conditions. 
Weekly measurement of body weight (A). Calorie intake measurements of chow and LF and their 
calorie restricted groups (B). Liver triglycerides content is reduced in CR groups (C). Villi height and 
crypt depth was measured in the ileum of mice (D and E). Significance was tested using 2-way 
ANOVA with Bonferroni post-hoc test (**= p<0.01, *= p<0.05). Values are the means ± SEM of n=5 
(control group) and 6-7 (CR group) mice in each group. Mice in the CR group were divided into two 
cages (as 3-4 mice per cage), calorie intake was measured per cage and divided by 3-4 to calculate 













4.2.6 Effect of CR on total bile acid levels in different compartments of the 
enterohepatic circulation 
Due to the difference in ileal bile acids observed in the long-term CR study, we next 
examined the changes in bile acid levels in the organs involved in enterohepatic 
circulation (ileum and liver) in the present study. Total bile acids were measured in 
the ileum and liver samples from the mice in all the diet groups (Fig. 4.7A). In the 
ileum, we observed increased total bile acid levels in LF compared to chow mice 
(49±0.2%, P= 0.04), and increased levels of total bile acids in LFCR compared to 
chowCR mice (44±0.3%, P= 0.03). We did not observe changes in the total ileal bile 
acid levels between control and their CR counterpart for both chow and LF group 
(P>0.5). In the liver, total bile acid levels were similar among chow and chowCR 
groups (P >0.5), whereas, the LFCR showed a trend towards increased total liver bile 
acids compared to LF control diet fed mice (27±0.4%, P= 0.1).  
The expression of genes related to bile acid metabolism in the ileum and liver 
samples from mice was quantified by quantitative polymerase chain reaction (q-
PCR). In the chow fed mice, CR intervention did not change the gene expression 
levels of Fgf15, Fxr and bile acid transporter, fatty acid binding protein 6, (Fabp6) in 
the ileum (Fig. 4.7B). Whereas CR on the LF diet significantly reduced the 
expression of Fgf15 in the ileum (by 74±0.6%, P= 0.004). The gene expression of 
Fxr and Fabp6 was not altered in response to the LFCR intervention (Fig. 4.7B).  
In the liver, the gene expression of rate limiting bile acid synthesis enzyme 
cholesterol 7 alpha-hydroxylase, (Cyp7a1) was significantly increased in mice fed 
with chowCR (by 53±0.4%, P= 0.04). Whereas, the gene expression of bile acid 
receptor Fxr, its target, small heterodimer partner (Shp), and fibroblast growth factor 
receptor 4 (Fgfr4) the receptor for FGF15 were not changed in the liver of chow fed 
mice exposed to CR (Fig. 4.7C). The bile acid transporters, Na+-taurocholate 
cotransporting polypeptide and bile salt export pump (Ntcp and Bsep) were not 
altered in the livers of chowCR compared to chow control diet fed mice. In the LF 
group, the gene expression levels of Cyp7a1, Fxr, Shp, Fgfr4, Ntcp and Bsep were 




































































































































































































































































































































Figure 4.7 Bile acid metabolism in response to CR on chow and LF background diet. Total bile acids 
were measured in the ileum and liver of mice from all diet groups (A). Expression levels of bile acid 
metabolism related genes in the ileum (B) and liver of mice (C). Significance was tested using 2-way 
ANOVA with Bonferroni post-hoc test (**= p<0.01, *= p<0.05). Values are the means ± SEM of n=5-




4.2.7 Response of metabolic homeostasis related genes to CR differed in chow and 
LF conditions 
CR resulted in increased gene expression of ileal glucose transporters Glut2 
(83±1.2%, P= 0.003), Glut5 (33±0.1%, P= 0.01), and carbohydrate enzyme Sis 
(54±0.6%, P= 0.04) in the ileum of chowCR mice compared to chow control. CR 
under the LF diet condition, also resulted in an increasing trend for the expression of 
ileal carbohydrate metabolism genes, however this increase did not reach 
significance (P values for Glut2: 0.1, Glut5:0.1, Mgam:0.5 and Sis 0.5) (Fig. 4.8A). 
Under the chow diet condition, genes in the liver related to lipogenesis were not 
altered by CR (P > 0.5) (Fig 4.8B). While, the gene expression of peroxisome 
proliferator activated receptor alpha (Pparα) which is the main controlling factor for 
fatty acid oxidation and its target, cluster of differentiation 36 (Cd36) were found to 
be increased in the livers of chowCR compared to chow control diet fed mice 
(42±0.2%, P=0.03 and 50±0.3%, P=0.03 respectively). LFCR diet led to an increase 
in the lipogenic gene expression in the liver, fatty acid synthase (Fasn) and acetyl-
coA carboxylase (Acaca) were increased in the LFCR compared to LF control fed 
mice (by 75±0.5%, P= 0.01 and 67±0.2%, P=0.0002). In agreement with our 4 weeks 
chow Vs LF study, the gene expression of liver Fgf21 was increased in response to 
the LF compared to chow diet (79±0.7%, P= 0.001). Whereas, Fgf21 levels were 
significantly decreased in response to CR under the LF diet condition (65±0.7%, 
P=0.001). Furthermore, the gene expression of sirtuin 1 (Sirt1) (35±0.8%, P= 
0.0007), Pparα (45±0.3%, P=0.01) was significantly increased in LFCR fed mice. 
The gene expression of Cd36 was not altered in response to LFCR compared to LF 



























































































































































































































































































Figure 4.8 Differential effect of CR on the energy metabolism gene expression in chow and LF fed 
mice. Carbohydrate metabolism genes in the ileum (A), and lipid metabolism genes in the liver (B) 
were tested by qPCR. Significance was tested using 2-way ANOVA with Bonferroni post-hoc test (**= 
p<0.01, *= p<0.05). Values are the means ± SEM of n=5-7 mice in each group. Qpcr: Quantitative 







In this chapter we have presented changes in the gene expression profile and 
microbiota composition of the ileum in response to long-term feeding of the LF diet. 
We also show that CR intervention on the LF diet background prevented these age-
related changes induced by purified diet.   
Fasting and feeding may induce structural alterations in the intestine, such as changes 
in villi height and crypt depth. Our results showed increased crypt depth in the ileum 
in response to 6 and 24 months intervention of CR. These results are consistent with 
research carried out by Yilmaz et al. (2012) that report crypt expansion in the small 
intestine of mice that were subjected to CR for 7 months, the authors propose 
increased crypt size resulted from increased number of stem cells per crypt in 
response to CR.   
Gene expression profiling of ileum samples showed decreased expression of Paneth 
cells and cell cycle regulation related genes in LF24m compared to LF6m mice, 
whereas expression of these genes remained unaffected with age, between CR6m and 
CR24m mice. Paneth cells release stimulatory factors for intestinal stem cells growth 
and secrete antimicrobial peptides to provide host defence against pathogens (Yilmaz 
et al., 2012). Our results suggest reduced function of Paneth cells in aged mice may 
be due to age associated decline in intestinal regenerative capacity and organ 
maintenance (Nalapareddy, et al., 2018). Moreover, research has shown changes in 
gut microbiota with age (Langille et al., 2014; Kok et al., 2018), therefore the 
decrease in the expression of antimicrobial peptides (Mptx2, Defars1, Defa3, and 
Dmbt1) may be an adaptive response to the age-associated changes in microbiota 
described in this chapter. Further analysis to quantify the number of Paneth cells per 
crypt by lysozyme or MMP7 staining in the aged ileum on control and CR diet will 
provide more information on the effect of age and CR intervention. We were unable 
to perform lysozyme immunohistochemistry analysis due to the limited ileum tissue 
available for this study.  
We observed decreased expression of cell cycle regulatory genes (Cdca3, Cdca8, 
Cenpe and Prr1) upon ageing under control LF diet, whereas long-term CR resisted 
this decline in cell cycle genes and resembled the gene expression levels of young 6 
months old mice. Nalapareddy et al. (2018) reported downregulation of cell 
proliferation genes as a consequence of reduced canonical Wnt signalling in 
intestinal stem cells during ageing. CR has been shown to increase the number of 
proliferating stem cells in the intestinal crypt base, in response to signals sent from 
neighbouring Paneth cells that sense nutrient availability (Igarashi and Guarente, 
2016; Yilmaz et al., 2012). Therefore, the increase in cell cycle regulation gene 
expression levels indicates enhanced regenerative capacity of the aged CR 
epithelium. CR has been shown to reduce the accumulation of DNA damage that 
occurs during ageing and thus prevent diseases such as age-related cancer. Bruens et 
al. (2020) has recently shown that damaged and less fit cells in the intestinal 
epithelium have reduced chance of survival under CR conditions due to competition 
by CR-induced stem cells which promote the elimination of mutated and weak cells. 




cell regulators, which might be one of the mechanisms that drives intestinal tissue 
health and increased lifespan of CR mice as observed in the IDEAL study (Rusli et 
al., 2015; Kok et al., 2018).  
Interestingly, we observed increased expression of genes involved in lipid and 
carbohydrate metabolism under long-term CR. A possible explanation for this effect 
is that the limited access to food during CR conditions can enhance the capacity of 
the ileum to uptake nutrients leading to increased gene expression of glucose sensing 
transcription factor Chrebp, disaccharidase Sis, fructose metabolism Khk and Fbp1, 
and glucose transporters Sglt1, Glut2 and Glut5 (Peña-Villalobos et al., 2019). The 
gene expression of PPARγ and PPARα targets involved in lipid metabolism Acsl3, 
Scd2, Lpcat4 and Elovl6 was increased in response to CR. Similar to our findings, 
Duszka, et al. (2016) showed increased expression of PPARγ target genes in the 
intestine of mice exposed to two weeks, 25% CR. These data suggest mechanisms 
through which PPARs may contribute to energy mobilization during metabolically 
stressful conditions as CR.  
Bile acid metabolism has been previously shown to be influenced by CR (Fu and 
Klaassen, 2013; Green et al., 2018) which may directly impact lipid, glucose, and 
energy metabolism, however the effect of CR on bile acid levels and metabolism in 
the ageing ileum is still scarcely known. Our results show a significant decrease in 
the gene expression of Fgf15, Asbt and Ostα with age in the CR mice. In line with 
this, we also observed decreased total and major individual bile acids including 
secondary bile acid DCA in CR24m mice compared to LF24m mice. Secondary bile 
acid, DCA is generated by the gut microbiota, increased DCA in intestine may 
induce inflammatory signalling that is associated with the development of cancer, 
therefore reduction in DCA levels may be one of the mechanisms that promotes 
healthy gut ageing under CR conditions (Wang et al., 2020). In agreement with 
previous research on the impact of CR on enterohepatic circulation (Fu and Klaassen, 
2013; Green et al., 2018), our results showed that CR6m mice tended to have 
increased levels of primary bile acids, βMCA, CA and TCA in the ileum compared to 
6 months old mice on the control diet. Bile acids in the ileum are known to promote 
lipid breakdown and therefore increased levels of bile acids may promote enhanced 
lipid absorption and metabolism from the limited nutrients present under CR 
conditions. Ageing is associated with decreased activity of enzymes related to bile 
acid synthesis pathway (De Guzman et al., 2013). Although, we observed decreased 
levels of ileal bile acids in response to 24 months of CR feeding, microarrays data 
from the liver samples of this study showed significantly increased gene expression 
of Cyp7a1 and Cyp8b1 enzymes (Supplementary Fig. 3.4) involved in bile acid 
synthesis pathway in CR24m compared to LF24m mice, indicating that CR prevents 
the decline of the bile acid synthesis pathway with age.  
We observed distinct microbial profiles in the ileum of young mice exposed to CR 
compared to the control group. Intervention with 6 months of CR resulted in 
increased abundance of beneficial bacteria, Bifidobacterium and Lactobacillus. The 
difference in ileal microbiota composition of old mice in response to CR was not as 




the mice. Despite variation, we observed increased presence of Lactobacillus in the 
CR24m group compared to LF24m, wherein the Lactobacillus seemed to be absent. 
The effects of increased abundance of Lactobacilli and Bifidobacteria have been 
extensively researched to show associated improvement of intestine mucosal 
physiology and regulation of the host innate and adaptive immunity (Pyclik et al., 
2020).  
Research on the impact of CR on mouse physiology is often performed on different 
background diets, for instance, Green et al. (2018) used high carbohydrate purified 
control diet (based on the LF diet) to assess the role of CR on the body composition 
and global metabolomic changes, whereas, Gibbs et al. (2018) used a background 
chow diet to investigate the metabolomic profiles of C57BL/6J mice exposed to CR. 
The compositional differences in the diet may result in differential effects of CR on 
the metabolomics profiles, other factors such as length of time and grade of CR 
should also be considered. 
To test our hypothesis, we performed a preliminary 8 weeks CR study based on chow 
and LF diet background in order to characterise differences in the gene expression 
and bile acids levels in the gut and the liver. Under CR conditions, the mice from 
both diet groups lost weight in the first 2 weeks, and the body weight seemed to 
plateau in the remaining weeks, which may indicate a state of energy balance in the 
CR mice (Guijas et al., 2020). We have previously observed increased liver 
triglyceride levels in response to 4 weeks feeding with the LF compared to chow diet. 
This effect was reproduced in the current study with 8 weeks LF feeding, while, 
intervention with LFCR successfully decreased liver triglyceride levels. One of the 
reasons for this may be the reduced amount of refined carbohydrates presented 
during CR feeding.  
We observed an increase in the total ileal bile acids in LF and LFCR fed mice 
compared to chow and chowCR respectively, which indicates a stronger LF effect 
rather than CR. We did not observe differences in the total bile acids in the liver 
among the diet groups. However, we observed a decrease in Fgf15 gene expression 
in the ileum of LFCR compared to LF mice, whereas no difference in its gene 
expression was observed between chow and chowCR. Blokker et al. (2019, PhD 
thesis) has indicated that the induction of Fgf15 expression may be associated with 
increased glucose concentration in the ileum, in the context of high carbohydrate 
diet. Therefore, the reduced expression of Fgf15 in LFCR mice may be a result of 
low glucose concentration present in the ileum during CR conditions. 
Although, we did not observe changes in the total bile acid levels in the liver of chow 
and chowCR mice, the expression of Cyp7a1 was increased in response to chowCR 
diet. While, this effect was not observed in LFCR compared to LF fed mice. The 
increased expression of liver Cyp7a1 in the LF mice despite increased Fgf15 
expression in the ileum might be due to the possible fasted state of LF mice as fasting 
of mice has been known to induce Cyp7a1 expression in the liver (Ikeda et al., 2014). 
On the morning of the sacrifice day, we found the food hopper of the LF group to be 
empty. We are uncertain on the duration of fasting for the LF mice, as the hopper 




in the expression of ileal Fgf15 and liver Cyp7a1 in the LF group, although, the mice 
with low expression of ileal Fgf15 negatively correlated with liver Cyp7a1 
expression. The variation maybe explained by dominance hierarchies within the 
cage, when mice compete for access to limited food (Varholick et al., 2019).  
Similar to our previous 6 and 24 months CR study, we observed increased expression 
of ileal carbohydrate metabolism genes in response to chowCR and LFCR, which 
may be an adapting mechanism to low nutritional state of these mice. In agreement 
with research that shows increased fatty acid β oxidation under CR condition (Green 
et al., 2018), we observed an increase in the hepatic expression of Sirt1, Ppara and 
Cd36 in response to the CR intervention. Increased β oxidation of fatty acids in CR 
mice indicate increased breakdown of lipids for energy to maintain stable weight.  
Surprisingly, we observed increased expression of lipogenic genes Fasn, and Acaca 
in the liver of LFCR mice compared to LF. This effect was not observed between 
chow and chowCR mice. We believe that the increased expression of liver lipogenic 
genes may be LF diet exclusive effect, since we also observed increased expression 
of Srebp1, Fasn and Acaca in the liver of CR6m, and CR24m mice (Microarrays data 
from IDEAL, Supplementary Fig. 3.4). The increase in the hepatic lipogenic gene 
expression did not correlate with the triglyceride levels in the liver. Therefore, we are 
unsure if the increased hepatic lipogenic gene expression is an adaptive effect of 
LFCR. 
We did not take into account the role of circadian rhythm during the CR studies. The 
CR mice were fed at 15:30 every day, which may be a different feeding time 
compared to control mice, as ad libitum fed mice have been known to become active 
in the dark cycle after 19:30 (Ellacott et al., 2010). Changes in the diet intake pattern 
due to the fact that the CR mice received their daily food at one timepoint, that was 
rapidly consumed may also have an effect on the metabolic genes in the gut and the 
liver (Yamamuro et al., 2020). Therefore, a repetition of this experiment with 
controlled environmental factors, such as feeding of CR mice at night time (20:00 or 
21:00) and well stocked food hoppers for control groups, is required to further 












Chapter 5: Addition of dietary fibres (DF) improves the low-fat diet 


































Increased de novo lipogenesis in hepatocytes is a typical feature of non-alcoholic 
fatty liver disease (NAFLD). The pathology of NAFLD can be negatively influenced 
by dietary components such as higher intake of refined carbohydrates (starch, 
sucrose), and decreased consumption of dietary fibres (DF) (Romero-Gómez et al., 
2017; Worm, 2020). Preclinical studies report microbiota disturbances and increased 
intestinal permeability to be associated with NAFLD (Luther et al., 2015). Indeed, in 
our previous chapters we have reported that 4 and 8 weeks feeding of mice with the 
purified high refined carbohydrate LF diet resulted in hepatic lipid deposition and 
changes in the ileal microbiota composition compared to a fibre rich chow diet. The 
liver and the ileum are connected via the enterohepatic circulation of bile acids, 
therefore, any disturbance in the ileal microbiota are likely to influence the 
functioning of the liver. The pathophysiology of NAFLD is highly complex and 
involves numerous pathways including the inflammation of the adipose tissue and 
gastrointestinal dysbiosis (Tilg et al., 2020). In the recent years, the technological 
advancement for microbiome analysis has driven researchers to study the interactions 
between the gut microbiota and dietary factors that influence NAFLD (Aron-
Wisnewsky et al., 2020).  
DF are known to improve metabolic diseases such as NAFLD through regulation of 
glucose and cholesterol metabolism and decreased gut and systemic inflammation 
(Hamaker and Cantu-Jungles, 2020, Shtriker et al., 2018). The underlying 
mechanisms for these health effects have been suggested to be associated with 
decreased gastric emptying, altered composition of the gut microbiota and SCFAs 
(Makki et al., 2018; Canfora et al., 2019). Consumption of DF alters the niche 
environment in the gut lumen by providing substrates for microbial growth, thereby, 
enhancing the abundance of bacterial species that are able to utilize these DF 
(Deehan et al., 2017). For example, inulin has been known to induce the abundance 
of Bifidobacteria levels that possess enzymes to efficiently utilise this substrate. 
Increased abundance of Bifidobacteria is strongly correlated with reduced 
endotoxemia and improved glucose tolerance (Cani et al., 2007). Further, DF have 
been reported to play a part in regulating and maintaining host immune system via 
SCFAs as well as microbiota independent effects (Makki et al., 2018). Despite the 
abundant research on the beneficial effects of DF, the mode of action of structurally 
different DF on the gut-liver axis (specifically the ileum) remains unclear. 
In the current study we fed mice five different diets with varying types of DF for the 
duration of 10 weeks. The mice were fed with chow (16% fibre), LF (5% non-soluble 
fibre), LS (LF diet with reduced sucrose content, 5% fibre), LS enriched with inulin 
(LS+In, 11.3% fibre) and LS enriched with a combination of inulin, pectin and 
psyllium (LS+Comb, 11.3% fibre). We hypothesised that a higher sucrose content 
was one of the major drivers for LF induced liver phenotype (Jang et al., 2018). 
Hence, we aimed to prevent the detrimental effects of the LF diet by reducing the 
content of sucrose from 17% in LF to 7% in the new LS diet (sucrose was 
compensated with starch). Further, we enriched the LS diet with DF to investigate 
their effect on the gut-liver axis. The fibres were chosen due to their popularity as 




milkshakes, and readymade meals (Capuano, 2017). The first aim of this study was 
to investigate the effects of reduced sucrose and addition of DF in the LS diet on the 
pathophysiology of gut-liver axis. Secondly, we hypothesised that the varying 
structure of DF used in our new diets may result in different gut microbiome 
outcomes due to bacteria having distinct specificities to different chemical and 
physical structures (Singh and Vijay-Kumar, 2020). Therefore, we also aimed to 
describe the effects of different DF on the ileal gene expression and microbiota 
profile. To fulfil this aim, we performed RNA sequencing and 16S rRNA sequencing 
on ileal tissue and luminal content samples from chow, LS, LS+In and LS+Comb 




























5.2.1 Addition of DF mitigates LF induced triglyceride accumulation in the liver  
At the end of the experiment the LF fed mice showed increased trend in weight gain 
compared to chow (26± 0.9%, P=0.1), LS, LS+In and LS+Comb fed mice (30± 
0.9%, P=0.05; 41 ±0.8, P=0.002; 55 ±0.8%, P=0.001 respectively) (Fig. 5.1A and B). 
The food intake did not differ between the diet groups (Fig 5.1C). To investigate the 
morphological differences between the diet groups, we measured the small intestine 
length of mice immediately after sacrifice to show increased length in the LS+In and 
LS+Comb group compared to LS (9 ±1%, P=0.01; 16.6 ±1%, P=0.01 respectively) 
(Fig. 5.1D). We did not observe a significant difference between the liver to body 
weight ratio of mice in the different diet groups (Fig. 5.1E).  
Due to the previously observed effects of the LF diet on the liver phenotype, we 
investigated if reduced sucrose content and addition of fibres prevented the 
development of this pathophysiological phenotype. We observed an increase in the 
liver triglycerides content of mice fed with the LF and an increasing trend for the LS 
diet (68 ±0.7%, P=0.001 for LF and 55 ±0.3%, P=0.1 for LS) compared to the chow 
group (Fig. 5.2A). The reduced sucrose content in the LS diet resulted in decreasing 
trend of liver triglycerides levels compared to LF diet (28±0.5%), however, the 
difference was not significant P>0.5. The reduced sucrose content and addition of 
fibres resulted in a significant decrease in liver triglycerides content in LS+In and 
LS+Comb compared to LF diet group (59 ±0.5%, P=0.01, similar percentage 
decrease in both fibre groups).  Moreover, the analysis of livers in LS+In and 
LS+Comb groups suggested lower triglycerides levels compared to the LS diet 
(43±0.5%, P=0.2) (Fig. 5.2A). The expression analysis of lipogenic genes sterol 
regulatory element-binding protein 1 (Srebp1) and acetyl-coA carboxylase (Acaca) in 
the liver coincided with triglyceride levels to show significantly increased expression 
in the LF and LS group compared to chow (Srebp1: 78±0.6%, 41 ±0.3%, P<0.001; 
Acaca: 124±0.6% ,70±1%, P<0.001, LF and LS respectively). The gene expression 
of Srebp1 was significantly decreased with the LS enrichment of fibres by 44 ±0.2% 
P<0.001 for LS+In and 52 ±0.2%, P<0.001 in LS+Comb compared to LS group (Fig. 
5.2B). While, the gene expression of Acaca was decreased by 49 ±0.3%, P=0.01 for 
both LS+In and LS+Comb groups compared to LS. The gene expression of 
ketohexokinase (Khk) was measured to show a trend towards increase in the LF 
compared to other groups, although, it did not reach significance (P=0.3). The 
expression of Khk was found to be decreased in the LS+Comb group compared to LF 
(71±0.2%, P=0.02). Figure 5.2 C ,D, E and F shows haematoxylin and eosin (H&E) 
stained liver samples of mice fed the different diets, although LF and LS diet both 
revealed accumulation of lipid droplets, the histology of LF liver sections shows 
presence of monocytes which indicates inflammation in the liver. In agreement with 
the triglycerides content and lipogenic gene expression, the reduced sucrose content 
























































































































































































































Figure 5.1 The effect of diets on body composition. Mice were fed with chow, LF, LS, LS+In and 
LS+Comb diet, body weight was measured every week for 10 weeks (A). After 10 weeks feeding, we 
analysed, body weight gain (B) the amount of calories consumed per day per mouse (C), small 
intestine length (D), and liver weight (g) relative to body weight (g) ratio of mice (E). Significance 
was tested using 1-way ANOVA with Tukey’s multiple comparison test (*** = p<0.001, **= p<0.01, 
*= p<0.05). Values are the means ± SEM of n=10 mice in each group. Mice per group were divided 
into two cages (as 5 mice per cage), calorie intake was measured per cage and divided by 5 to 
calculate the intake of one mouse. LF: Low-fat diet, LS: Low sucrose version of LF diet, LS+In: LS diet 

















































































































































































Figure 5.2 The effect of diets on the liver phenotype of mice. Liver phenotype was examined by 
quantification of liver triglyceride levels (A), expression analysis of lipogenic gene in the liver (B). 
Significance was tested using 1-way ANOVA with Tukey’s multiple comparison test (*** = p<0.001, 
**= p<0.01, *= p<0.05). Values are the means ± SEM of n=9-10 mice in each group. LF: Low-fat diet, 
LS: Low sucrose version of LF diet, LS+In: LS diet enriched with inulin, LS+Comb: LS diet enriched with 










Figure 5.2 (Cont.) The effects of diets on the liver phenotype of mice. Liver phenotype was examined 
by histological analysis via haematoxylin and eosin (H&E) staining of livers from mice fed the LF (C), 
LS (D), LS+In (E) and LS+Comb (F) diets (Magnification 10x). LF: Low-fat diet, LS: Low sucrose version 







5.2.2 Addition of DF upregulates the expression of ileal carbohydrate metabolism 
genes 
Ileal gene expression was quantified by quantitative polymerase chain reaction 
(qPCR) (Fig. 5.3A). Both LF and LS diet led to an increase in the expression of 
maltase-glucoamylase (Mgam), sucrase-isomaltase (Sis) and glucose transporter 2 
(Glut2) compared to chow (P<0.05). The reduced sucrose content in the LS diet, did 
not affect the expression levels of carbohydrate related genes compared to the LF 
diet. Interestingly, we observed an increase in the carbohydrate metabolism genes in 
the fibre groups compared to chow fed groups (P<0.001) and an increasing trend 
compared to the LS group (P=0.1 for Mgam and Sis, P=0.01 for Glut2) (Summary of 
statistics in Table 5.1). The barrier function was analysed by testing the gene 
expression of claudin 3 and occludin (Cldn3 and Ocln) (Fig. 5.3B). LF and LS diet 
led to decreased Cldn3 and Ocln expression compared to chow (33 and 27±0.1, LF 
and LS respectively, P<0.03). Addition of fibres in LS+In and LS+Comb diet did not 
significantly improve Cldn3 gene expression. We noticed an increasing trend in Ocln 
gene expression in the fibre groups, however, the difference did not reach 
significance compared to LF and LS diet groups (P>0.05). We observed increased 
gene expression of Fgf15 in both LF and LS diet groups (P<0.02). Whereas, the 
Fgf15 gene expression was significantly decreased with the addition of fibres to the 




















































































































































































































































Figure 5.3 Qpcr gene expression analysis of ileum. Significance was tested using 1-way ANOVA with 
Tukey’s multiple comparison test (*** = p<0.001, **= p<0.01, *= p<0.05). Values are the means ± 
SEM of n=9-10 mice in each group. Qpcr: Quantitative polymerase chain reaction. LF: Low-fat diet, 
LS: Low sucrose version of LF diet, LS+In: LS diet enriched with inulin, LS+Comb: LS diet enriched with 




Table 5.1 Summary of statistics for ileal gene expression analysis. Significance was tested using 1-
way ANOVA with Tukey’s multiple comparison test. Values are the means of n=9-10 mice in each 
group. LF: Low-fat diet, LS: Low sucrose version of LF diet, LS+In: LS diet enriched with inulin, 
LS+Comb: LS diet enriched with a combination of fibres. 
Test details Mean 1 Mean 2 SE of diff. 
 
P Value 
Mgam      
chow vs. LF 1.0 2.4 0.5 * 0.05 
chow vs. LS 1.0 2.3 0.5 * 0.05 
chow vs. LS+In 1.0 3.3 0.5 *** 0.0005 
chow vs. LS+Comb 1.0 3.2 0.5 *** 0.0009 
LS vs. LS+In 2.3 3.3 0.5 ns 0.1 
LS vs. LS+Comb 2.3 3.2 0.5 ns 0.1 
Sis 
     
chow vs. LF 1.0 2.5 0.5 * 0.04 
chow vs. LS 1.0 2.6 0.6 * 0.04 
chow vs. LS+In 1.0 3.8 0.5 **** 0.0001 
chow vs. LS+Comb 1.0 3.3 0.5 ** 0.001 
LS vs. LS+In 2.6 3.8 0.5 ns 0.07 
LS vs. LS+Comb 2.6 3.3 0.6 ns 0.1 
Glut2 
     
chow vs. LF 1.0 7.4 1.5 *** 0.0008 
chow vs. LS 1.0 5.6 1.5 * 0.02 
chow vs. LS+In 1.0 10.6 1.4 **** 0.0001 
chow vs. LS+Comb 1.0 10.2 1.4 **** 0.0001 
LS vs. LS+In 5.6 10.6 1.5 * 0.02 
LS vs. LS+Comb 5.6 10.2 1.4 * 0.02 
Cldn3 
     
chow vs. LF 1.0 0.7 0.1 ** 0.004 
chow vs. LS 1.0 0.7 0.1 * 0.01 
Ocln 
     
chow vs. LF 1.0 0.7 0.1 * 0.03 
chow vs. LS 1.0 0.6 0.1 * 0.01 
Fgf15 
     
chow vs. LF 1.0 2.6 0.5 * 0.02 
chow vs. LS 1.0 3.2 0.5 *** 0.0008 
LF vs. LS+In 2.6 0.3 0.5 *** 0.0004 
LF vs. LS+Comb 2.6 0.1 0.5 **** 0.0001 
LS vs. LS+In 3.2 0.3 0.5 **** 0.0001 







5.2.3 RNA sequencing analysis revealed differential gene regulation between fibres  
RNA sequencing analysis was performed on ileum samples from chow, LS, LS+In 
and LS+Comb fed mice. Sequences were mapped using the HISAT2 software to the 
reference genome. HTSeq software was used to analyse gene expression levels using 
the union mode. Expression values were calculated as FPKM (Fragments Per 
Kilobase of transcript sequence per Millions base pairs sequenced). Further analysis 
on the RNA sequencing data was performed on Network Analyst 3.0 (Zhou et al., 
2019). The data was filtered for low variance (variance genes based on IQR <15) and 
low relative abundance (average expression signal < 15) and unannotated genes, and 
normalization was selected for Log2-counts per million, which resulted in 45, 9 and 
58 differentially expressed genes (DEGs) (EdgeR based method, FDR adjusted P 
value cut-off: 0.05; logFC ≥1.0) between chow Vs LS, LS+In Vs LS and LS+Comb 
Vs LS diet groups (Fig. 5.4A). Next, we compared the chow and LS fibre enriched 
groups together against LS to reveal 61 DEGs (adjusted P value cut-off :0.05; logFC 
≥1.0). We performed gene set enrichment analysis (GSEA) on the 61 DEGs to find 
out the biological functions or pathways associated with the genes by using Kyoto 
Encyclopedia of Genes and Genomes (KEGG) database that annotates genes to 
pathway level. The KEGG pathway analysis revealed that the 61 DEGs were 
significantly enriched in immune related pathways (Herpes simplex infection, 
Epstein-Barr virus infection, Influenza A, Antigen processing and presentation, 
Allograft rejection, Toxoplasmosis, Graft-versus-host disease, Type I diabetes 
mellitus, Autoimmune thyroid disease) and metabolic pathways. Figure 5.4B shows 
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Figure 5.4 RNA sequencing analysis on ileal samples (n=5 per group) from chow, LS, LS+In and 
LS+Comb fed mice. RNA sequencing analysis revealed 45, 9, and 58 differentially expressed genes 
when chow, LS+In and LS+Comb were compared against LS diet group (A). KEGG pathway analysis 
of differentially expressed genes revealed significant enrichment of genes related to immune and 
metabolic pathways (B). Differential analysis was performed by EdgeR method, FDR adjusted P value 
cut-off of 0.05; logFC ≥1.0).  LF: Low-fat diet, LS: Low sucrose version of LF diet, LS+In: LS diet enriched 





Figure 5.5A shows the immune related genes that were altered between the diets. 
Interferon induced oligoadenylate synthetases (Oas1g, Oas3 and Osal2), interferon 
induced protein with tetratricopeptide repeats 1(Ifit1) were shown to be upregulated 
in chow and LS+Comb diet groups. Adaptive immune response, major 
histocompatibility complex class II genes (H2-aa, H2-ab1, and H2-dmb1) were 
increased in fibre rich groups, however the significance was limited to LS+Comb 
group. Other genes related to immunity such as lipopolysaccharide (LPS) induced 
ubiquitin D (Ubd), gene involved in transport of antigens, T cell specific gene, 
granzyme B (Gzmb) and Z DNA binding protein, a cytosolic bacterial DNA sensor 
and activator of interferon (IFN)-regulatory factors (Zbp1) were also increased in 
chow and LS+Comb groups, however significantly in the latter. Gene coding for 
interferons such as Ifn-α, Ifn-γ and interferon alpha and beta receptor subunit 1 Ifnar1 
were not altered between the diets (Shulzhenko et al., 2011).  
The changes in the expression levels of genes involved in carbohydrate digestion and 
absorption in the ileum are shown in Figure 5.5B. Similar to our results from the 
qPCR gene expression analysis, significant upregulation in the expression levels of 
carbohydrate metabolism genes, Mgam, Sis and Khk was observed after 10 weeks of 
LS diet feeding. While, the addition of fibre groups (LS+In and LS+Comb), further 
enhanced the gene expression of Mgam, Sis, Khk (only in LS+In), aldolase B 
(Aldob), and fructose-bisphosphatase 1 (Fbp1) compared to chow and LS diet 
groups. The absorption of the resultant glucose in the small intestine is primarily 
driven by two separate transport proteins, sodium-dependent glucose cotransporter 
(SGLT1) and glucose transporter 2 (GLUT2). The expression levels of Sglt1 and 
Glut2 gene in the ileum were significantly increased in mice fed the LS and LS+In 
compared to chow diet group. The gene expression levels of Sglt1 and Glut2 were 
decreased in the LS+Comb when compared to LS and LS+In groups. We have 
previously shown that LF and LS induced the expression of Fgf15 in the ileum. 
While, the addition of fibres blunted the LS induced expression of Fgf15 (Fig. 5.5B) 















































































































































































Figure 5.5 Ileal expression profiles of immune related genes in response to the different diets. 
Significance was tested using 1-way ANOVA with Tukey’s multiple comparison test (*** = p<0.001, 
**= p<0.01, *= p<0.05). Values are the means ± SEM of n=5 mice in each group. LF: Low-fat diet, LS: 
Low sucrose version of LF diet, LS+In: LS diet enriched with inulin, LS+Comb: LS diet enriched with a 












































































































































Figure 5.5 (Cont.) Ileal expression profiles of carbohydrate related genes in response to the different 
diets. Significance was tested using 1-way ANOVA with Tukey’s multiple comparison test (*** = 
p<0.001, **= p<0.01, *= p<0.05). Values are the means ± SEM of n=5 mice in each group. LF: Low-fat 
diet, LS: Low sucrose version of LF diet, LS+In: LS diet enriched with inulin, LS+Comb: LS diet enriched 






5.2.4 DF differentially impact the composition of ileal microbiota 
Considering the differential impacts of DF on ileal gene expression, we next 
investigated the changes in ileal microbiota composition via 16S rRNA sequencing. 
The alpha diversity measured by Shannon index was significantly decreased in LS 
based diets (30 ± 0.2% LS, 26 ± 0.2% LS+In and 43 ± 0.2% LS+Comb, P<0.01) 
compared to chow diet. While, the observed species was significantly increased in 
the LS compared to LS+fibre groups (16 ±9% P<0.001 LS+In and 13±10% P=0.02) 
(Fig. 5.6A)  At the phylum level, we observed a significant decrease in the relative 
abundance of Bacteroidetes (by 55± 0.02%, P<0.0001) and a significant increase (by 
33± 0.02%, P<0.0001) in the relative abundance of Firmicutes in the LS fed mice. 
Whereas, the addition of inulin to the LS diet resulted in increased relative 
abundance of Bacteroidetes (34 ± 0.02%, P<0.001) and a decreased relative 
abundance of Firmicutes (28.5± 0.02%, P<0.0001) compared to LS fed mice. The 
LS+Comb diet also decreased the relative abundance of Firmicutes (10± 0.02%, 
P=0.04), however, the combination of fibres did not influence the Bacteroidetes 
levels compared to LS group. Notably, the addition of inulin and fibre combination 
suggested enhanced levels of Actinobacteria by 74± 0.02% P <0.001 and 64± 0.02%, 
P=0.06 respectively compared to LS fed mice (Fig. 5.6B).  
Within the Firmicutes phylum, we observed increasing trend in the levels of 
Lactobacillus in the chow compared to LS and significantly increased levels 
compared to other groups (32% P=0.1 LS, 90% and 91% P<0.0001 LS+In and 
LS+Comb) (Fig. 5.6C and 5.7A). While, the levels of Faecalibaculum from the 
Erysipelotrichidae family were significantly increased in the LS, LS+In and 
LS+Comb compared to chow (52%, 43% and 56% respectively, P<0.01) (Fig. 5.6C 
and 5.7B). Levels of genus Bacteroidales S24-7 group from the Bacteroidetes 
phylum were increased (57%, P=0.01) in the chow compared to LS fed mice. 
Furthermore, the levels of the Bacteroidales S24-7 group suggested an increase by 
33%, P=0.1 in the LS+In compared to LS diet group. The levels of Bacteroidales 
S24-7 group were not affected by LS+Comb feeding (Fig. 5.6C and 5.7C). The genus 
Akkermansia from the Verrucomicrobia phylum was significantly increased in 
LS+Comb compared to chow (84%, P=0.04) and LS diet groups (90%, P=0.006). 
Although the mean levels of Akkermansia in LS+In group suggested an increase 
compared to chow and LS fed mice, the difference did not reach significance (58% 
compared to chow, 65% compared to LS, P>0.1, due to large interindividual 
variation). The levels of Akkermansia were significantly different between the LS+In 
and LS+Comb diet groups (70%, P=0.03) (Fig. 5.6C and 5.7D).  The addition of DF 
to the LS diet resulted in significantly increased levels of Bifidobacteria (98% in 
LS+In and 97% in LS+Comb, P<0.001) compared to the LS diet (Fig. 5.6C and 
5.7E). Altogether, our results show modified profiles of the ileal microbiota in 
response to addition of DF. We also show fibre specific differences in the ileal 
microbiota, especially the levels of Akkermansia were found to be different between 






































































































































































































Figure 5.6 Altered profiles of the ileal microbiota in response to addition of dietary fibres (DF). Alpha 
diversity (Shannon index) was decreased in LS and LS+DF compared to chow fed mice (A). 
Summarization of the changes in bacteria at the phylum level between the different diet groups (B). 
Bar graph displays the relative abundance of bacteria at the genus level in the individual mice in the 
four diet groups (D). Significance for α diversity was tested using a Kruskal–Wallis non-parametric 
test (*** = p<0.001, **= p<0.01, *= p<0.05). Values are the means ± SEM of n=4-5 mice in each group. 
LF: Low-fat diet, LS: Low sucrose version of LF diet, LS+In: LS diet enriched with inulin, LS+Comb: LS 

















































































































Figure 5.7 Ileal microbiota composition at the genus level that was significantly altered between the 
diet groups. Significance was tested using 1-way ANOVA with Tukey’s multiple comparison test (*** 
= p<0.001, **= p<0.01, *= p<0.05). Values are the means ± SEM of n=4-5 mice in each group. LF: Low-
fat diet, LS: Low sucrose version of LF diet, LS+In: LS diet enriched with inulin, LS+Comb: LS diet 





In the first part of this chapter we compared chow, LF (high sucrose), LS (LF diet 
with low sucrose), LS enriched with inulin and LS enriched with a combination of 
inulin, pectin and psyllium to investigate the effects of these diets on the liver 
phenotype of mice. In the second part, we compared the effects of the fibre groups on 
the ileal gene expression and microbiota composition to show differential effects of 
the fibres. 
We observed a decrease of body weight gain in LS fibre enriched groups compared 
to the LF group. The decreased weight gain in these groups may be a result of 
reduced sucrose as well as high fibre intake compared to the LF group. The presence 
of soluble fibres as in the LS+In and LS+Comb groups, has been known to increase 
food viscosity and decrease appetite in mice, which may result in weight loss (Muller 
et al., 2018). We did not observe a difference in the calorie intake of mice in different 
diet groups, which may be due to the lack of sensitive methods used to measure food 
intake in this study. The mice were not housed individually therefore, food 
consumption was calculated as average intake per mouse. Moreover, a large amount 
of food crumbs often gets mixed with bedding in the cage, which makes food intake 
difficult to be measured accurately (Ellacott et al., 2010). It is worth noting that we 
have not observed difference in weight gain between chow and LF feeding 
experiments performed for 4 and 8 weeks. The difference in weight gain (although 
did not reach significance) between chow and LF groups in this study, may have 
been affected by the source of the mice (Charles River UK) used in this experiment, 
as previously our studies have been conducted on mice sourced from inhouse Disease 
Modelling Unit (DMU) facility. This has been further discussed in Chapter 6.  
We observed an increase in the small intestinal length in response to the fibre 
enriched LS diets. Several studies have found inulin supplementation to increase the 
small intestine length in poultry animals (Bucław et al., 2016). Further morphological 
analysis on the villi length can provide information on this adaptive response of the 
small intestine.  
The liver triglyceride levels were found to be increased in LF and LS groups 
compared to the high fibre group, chow, LS+In and LS+Comb. Our results showed 
that reduction of sucrose content of the LF diet did not improve the liver triglyceride 
levels in the LS group (possibly due to high levels of refined starch present in the LS 
diet). Whereas, the addition of fibres to the LS diet prevented lipid accumulation in 
the liver, and matched liver triglyceride levels to that of the chow fed mice. We were 
able to confirm these results by quantifying Srebp1, Acaca gene expression and 
haematoxylin and eosin (H&E) stained histology of liver samples. Our results 
suggest a protective role of soluble fibres to early signs of liver steatosis observed in 
purified LS diet feeding. Soluble DF are able to form gels in the presence of water 
which may impact intestinal motility and absorption rates of glucose and fructose 
(breakdown products of sucrose and starch) from the LS diet leading to reduced de 
novo lipogenesis in the liver (Muller et al., 2018).  
We observed increased gene expression of the brush border enzymes responsible for 




Glut2 in LS+In and LS+Comb compared to the LF and LS diet fed mice. Neyrinck et 
al (2016) has demonstrated an inhibitory action on the intestinal sucrase activity for 
the inulin extract from chicory root in vitro and proposed a mixed non-competitive 
inhibitory mode for inulin. This may be an inulin or purified fibres specific effect, 
since the gene expression of Sis and Mgam was not upregulated by the grain-based 
crude fibres in the chow diet. In line with the glucosidase inhibitory effect of refined 
fibres, we observed a significant decrease in the Fgf15 gene expression in the fibre 
rich diets compared to the LF and LS diet. Our results are in agreement with findings 
from Blokker et al. (2019, PhD thesis) that suggested high intracellular glucose 
concentration in the epithelial cells to induce Fgf15 expression in the ileum. We did 
not observe a difference between the ileal gene expression levels of Fgf15 between 
LF (high sucrose) and LS (low sucrose) fed mice, which fits with Blokker et al.’s 
hypothesis that Fgf15 induction is due to increased glucose concentration from starch 
in the ileum of LF fed mice. The Fgf15 ileal expression is decreased in the added 
fibre diets possibly due to inhibition of MGAM, thereby, reducing the glucose 
absorption from starch in the LS diet. Altogether, the decreased absorption of glucose 
in the ileum may be the reason for reduced triglycerides levels and lipogenic gene 
expression in the liver of LS+fibre groups. 
The gene expression of Cldn3 and Ocln was decreased in response to the LF as well 
as the LS diet compared to chow, which suggests that the reduced sucrose content of 
the LS did not improve the barrier function in mice. Although, we observed some 
improvement in the gene expression of Cldn3 and Ocln with the addition of fibres to 
the LS diet, the increase did not reach significance. These results indicate that there 
may be other components lacking in the LS+In and LS+Comb, compared to the chow 
diet. Postal et al. (2020) showed that aryl hydrocarbon receptor (AHR) activation 
protected barrier integrity in the intestinal epithelium of diet induced obesity (DIO) 
mice models. Thus, the absence of AHR ligands in the purified diets compared to 
chow may be one of the factors for reduced expression of barrier function genes. We 
observed significantly decreased expression of duodenal cytochrome P450, family 1, 
subfamily A, polypeptide 1 (Cyp1a1 target gene for AHR), in the LF, LS and 
LS+fibre groups compared to chow (Supplementary Fig. 3.5).  
RNA sequencing analysis of ileum samples suggested an increase in the interferon 
induced genes (Oas1g, Oas3 and Osal2, Ifit1, Zbp1) and immune related genes (H2-
aa, H2-ab1, H2-dmb1, Ubd, Gzmb) in mice fed with chow and LS+Comb diet. The 
MHC class II molecules, H2-AA, H2-AB1, H2-DMB1 are distinctive markers for 
ILC3e (Type III Innate lymphoid cells) (Hepworth et al., 2015). Activation of 
antigen-presenting ILC3e subset have been shown to inhibit commensal bacteria 
associated T cell responses rather than inducing T-cell proliferation (Hepworth et al., 
2015). These findings are indicative of the role of ILCs in maintaining intestinal 
homeostasis through MHC II-dependent interactions with T cells to inhibit 
pathological adaptive immune responses to gut microbiota. Our data suggests that the 
activity of ILCs might be influenced by complex fibres present in LS+Comb and 
chow diet. Recent research has shown that that in addition to the fibre’s effect on the 
gut microbiota composition, fibres can also directly impact signalling in the intestinal 




complex structured soluble fibres with increased branching, whereas the LS+In diet 
solely contains chicory inulin, a long-chain linear fructan. The presence of the variety 
of polysaccharides in the chow and LS+Comb diet may differentially interact with 
the intestinal epithelial cells (IECs) compared to LS+In and thus causing the 
differential expression of immune related genes (Tiwari et al., 2020).   
Similar to our Q-PCR results, RNA sequencing analysis of the ileal samples showed 
increase in the gene expression Mgam and Sis, in the LS group compared to chow. 
The gene expression of Mgam Sis, Khk Aldob and Fbp1 was further increased in the 
added fibre groups compared to LS. The structure of inulin is made up of a chain of 
fructose monomers, which may bind to enzymes involved in fructose metabolism 
(KHK, ALDOB, FBP) and thus affect their activity. Further experiments are required 
to measure the activity of enzymes involved in carbohydrate metabolism to draw 
firm conclusions on their interaction with different fibres.  
We have previously reported differences in the ileal microbiota composition of mice 
fed with chow and purified LF diet. In the current chapter, we described the effects of 
purified LS and LS diet supplemented with different soluble fibres on the ileal 
microbial composition. We observed a decrease in the Shannon α diversity index in 
the LS group compared to chow. In contrast to literature, the addition of fibres did 
not increase the microbiota α diversity in the LS+In and LS+Comb fed mice (Deehan 
et al., 2017). Further, we found increased observed species (another measure of α 
diversity) in the LS compared to other groups. The observed species represent the 
amount of unique OTUs present in a sample (Novogene, 2020). The increased 
observed species may be due to increased abundance of various sugar degrading 
microbes (Faecalibaculum and Romboutsia species) present in the ileum of LS fed 
mice. Therefore, we counter the notion that gut microbiota with lower diversity is 
less resilient to environmental challenges, and is less beneficial for the host, as the 
unique OTUs present within a sample may not always have beneficial effects for the 
host (Canfora et al., 2019). At the phylum level, we observed a decreased 
Bacteroidetes: Firmicutes ratio in the LS diet. While, LS+In decreased the levels of 
Firmicutes and increased the levels of Bacteroidetes, LS+Comb did not have a 
significant effect on the levels of Bacteroidetes compared to the LS diet. We noticed 
an increase in the abundance of Actinobacteria in both LS+In and LS+Comb group. 
The beneficial genus Bifidobacterium belongs to the Actinobacteria phylum and the 
levels of Bifidobacteria were significantly increased in the mice fed with LS+In and 
LS+Comb diet fed mice. Furthermore, we also observed increased levels of 
Akkermansia in the LS+Comb fed mice. Although, Akkermansia has been 
investigated for its effects on host metabolism, Ansaldo et al. (2019) has recently 
reported Akkermansia to induce adaptive immune and antigen specific T cell 
responses in mice during homeostasis. The study supports the hypothesis that T 
follicular helper (TfH) cell responses against physiological microbiota can be 
context-dependent, and not just in the setting of gastrointestinal infection by 
pathogens or inflammation. Melo-Gonzalex et al. (2019) demonstrated interactions of 
multiple immune cell types within the interfollicular niche of the intestinal 
mesenteric lymph nodes including TfH, B cells, and ILC3 that may regulate IgA 




health. Accordingly, the upregulation of MHC II molecules (ILC3e markers) may be 
associated with the increased abundance of Akkermansia in the LS+Comb group. 
Similar to Akkermansia, Ansaldo et al also reported Bacteroidales S24-7 to induce T 
cell-dependent IgA response in mice, however this response was not further 
characterised. The genus Bacteroidales S24-7 was significantly increased in chow 
compared to other groups. The functionality of Bacteroidales S24-7 has been 
associated with degrading complex dietary carbohydrates. Similarly, reports have 
shown decreased abundance of this genus in the rodent feeding trials using high 
refined carbohydrate diets (Lagkouvardos et al., 2019).  
Taken together we report prevention of a pathophysiological liver phenotype as a 
result of addition of fibres to the purified LS diet. We propose that DF cause slow 
uptake of simple carbohydrates and regulate the glucose that enters the liver via the 
portal vein and hence prevent steatosis in liver. Moreover, we report increased 
expression of ileal immune related genes in chow and LS+Comb groups which may 
be linked to microbiota composition or the direct effect of complex fibres present in 
the chow and fibre combination diet. Further experiments are required to determine 
which variable, structure or the amount of fibre is more important in context of liver 
disease. Our results support the notion that immune responses against microbial and 
environmental (such as dietary) signal can be context-dependent and does not 
necessary translate to gastrointestinal abnormality. The differential effect of fibre rich 
diets on the ileal immune response highlight that consideration should be given to the 
composition of fibre diets when consumed as therapeutics.   




Chapter 6: Differential effect of sourcing locations on the gut-liver 







Inbred mice strains such as C57BL/6J and controlled environments are often applied 
to minimize inter-individual differences in phenotypes. However, recent data 
questions whether inbred mice have lower inter-individual differences compared to 
outbred mice, and traits previously thought to be caused by genetics have been 
reported to be also partly related to the gut microbiota composition (Franklin and 
Ericsson 2017). It is well known that the genetic background of mice has a 
considerable impact on the composition of the gut microbiota (Hufeldt et al., 2010; 
Tran et al., 2019). In the recent years, studies have shown that the composition of gut 
microbiota can vary between the same mice strain obtained from different vendors, 
which may directly influence the mouse phenotype (Hansen et al., 2014; Hilbert et 
al., 2017; Sadler et al., 2017). Differences in the colonising gut microbiota can lead 
to variation in not only the phenotype but also, susceptibility to disease, and 
responsiveness to drug therapy (Alegre et al., 2019). For example, presence of 
segmented filamentous bacteria (SFB) in mice from some vendors was reported to 
stimulate T-helper 17 (Th17) cells in the small intestine (Ivanov et al., 2008). 
Presence of SFB has been suggested to provide protection against the development of 
autoimmune type 1 diabetes (T1D) in SFB-positive female non-obese diabetic 
(NOD) mice (Kriegel et al., 2011). Therefore, such differences of individual 
commensal bacteria can influence results for labs that use NOD mice for diabetes 
research, as reported in a preclinical immunotherapy study by Gill et al. 2016. 
The research on the influence of environmental variables on the composition of the 
gut microbiota and their functionality remains incomplete. Studies have suggested 
the potential of husbandry-induced changes in the gut microbiota that could 
contribute to a lack of reproducibility between mice models from different research 
institutes. The gut microbiota of a mouse has been shown to be influenced by various 
factors; place of birth, (Korte et al., 2020), shipping and acclimatisation (Montonye 
et al., 2018), differences in bedding (compressed paper and aspen chips) and caging 
ventilation (static microisolators or individually ventilated caging) (Ericsson et al., 
2018).  
In the current study, we aimed to characterise the differences in the gut-liver axis of 
mice sourced from different locations. We performed 16S rRNA sequencing analysis 
on ileal content of mice from external vendor Charles River, UK (CRUK) and 
inhouse animal facility, Disease Modelling Unit (DMU) at University of East Anglia 
(UEA) fed with chow and/or LF diet. We also aimed to study the ileal gene 
expression and bile acid profile of mice. We hypothesised that mice from different 
locations may contain distinct ileal microbiota composition, which may result in 









6.2.1 Physiological changes in CRUK and DMU mice in response to different diets 
Body weight analysis at the end of the experiment revealed significantly increased 
weight gain in CRUK LF compared to CRUK chow fed mice (weight difference: 
2.7g, 212±0.8%, P=0.01) (Fig. 6.1A and B). The mice from CRUK and DMU were 
fed the same LF diet, however, the CRUK LF mice gained more weight compared to 
DMU LF (weight difference 2.4g, 155±0.9%, P=0.03) (Fig. 6.1B). The average 
starting weight of CRUK LF group was slightly lower than the DMU LF group, 
29.53g and 30.78g respectively (Mean difference -1.25g SE of diff. ±0.9), however, 
this difference was not statistically significant. We did not observe any statistical 
difference in food intake between the groups (P=0.5).  
There was no statistical difference observed in the liver weight to body weight ratio 
of mice between the groups (P> 0.9) (Fig. 6.1D). As observed in the previous 
experiments, the mice fed with the LF diet had increased levels of liver triglyceride 
content (CRUK: 81±238%, P=0.009; DMU: 60±189%, P=0.004) compared to chow 


















































































































































































































































Figure 6.1 Comparison of physiological changes in mice from different vendors. C57BL/6J mice from 
CRUK and DMU were fed with chow and LF diet for 4 weeks. Weekly body weight of mice during the 
4 weeks experiment (A), body weight gain of individual mice in different groups (B), calorie intake 
per mouse per day (C), liver weight (g) relative to body weight (g) ratio (D), and levels of liver 
triglycerides (E). Significance was tested by using 2-way ANOVA with Tukey’s multiple comparison 
test (***=p<0.001, **= p<0.01, *= p<0.05). Values are the means ± SEM of n=6 mice in each group. 
Mice per group were divided into two cages (as 3 mice per cage), calorie intake was measured per 
cage and divided by 3 to calculate the intake of one mouse. LF: Low-fat diet, Charles River 













6.2.2 Differential gut microbiota composition of C57BL/6J mice from two vendors  
To assess the effect of vendors and dietary intervention, we generated amplicon 
libraries from V3-V4 region of 16S rRNA gene in bacterial DNA from ileal content 
of mice. Each group contained sample size of n=6. The microbial DNA from mouse 
3 in CRUK LF group was excluded from the analysis due to low DNA yield and 
integrity quantified on Nanodrop. Sequencing data processed resulted in total read 
counts of 1,474,281 and average counts per sample of 64,099.  
Alpha diversity of the ileal bacterial communities did not differ between the diet 
groups in CRUK and DMU mice (Shannon diversity index, P=0.4, Fig. 6.2A). 
Further, the bacterial richness (number of observed species) was found to be similar 
between the two diet treatments in CRUK mice (P= 0.9) (Fig. 6.2B). Whereas, the 
observed species were significantly increased in ileal gut microbiota of DMU LF 
compared to DMU chow mice (17±11%, P= 0.04).  Principal coordinate of analysis 
(PCoA) plot of the bacterial community structure based on Bray–Curtis distances at 
the genus level showed distinct separation between CRUK and DMU chow groups, 
whereas the LF fed mice from both vendors are clustered closer together. In 
agreement with our previous report we found distinct separation between chow and 
LF fed microbiota profile in DMU mice, whereas the distance between CRUK chow 
and LF microbiota was not as pronounced (Permutational multivariate analysis of 
variance, PERMANOVA, R Squared:0.47, P <0.001).    
In all groups, bacterial communities at the phylum level were predominantly 
composed of Bacteroidetes and Firmicutes (Fig. 6.3A and Table 6.1). Analysis of the 
phyla shows increased abundance of Firmicutes (68±7.7% and 102±4% CRUK and 
DMU respectively) and decreased abundance of Bacteroidetes (percentage decrease 
by 68.5±5% and 82.7±5% CRUK and DMU respectively) in the ileum of LF fed 
mice from both vendors. Comparison of ileal microbial profiles between the mice 
from the different groups suggested increased levels of Verrucomicrobia in the 
CRUK chow mice compared to other groups (6.2 mean relative abundance in CRUK 
chow compared to relative abundance of approximately 1.5 in other groups) (Fig. 
6.3A and summary of statistics in Table 6.1).  
We analysed raw OTU counts per samples to gain a deeper knowledge of the 
microbiota composition and their abundance among different samples. Within the 
Firmicutes phylum (Fig. 6.4A) average levels of genus Faecalibaculum were higher 
in DMU LF mice compared to CRUK LF, although the increase was not significant 
due to high interindividual differences (P=0.1).  Similarly, levels of Lactobacillus 
showed high heterogeneity between the samples within the LF groups. Overall, 
analysis of ileal microbiota from CRUK mice suggested increased levels of 
Lactobacillus compared to DMU mice (Difference between CRUK chow and DMU 
chow Lactobacillus levels: 37±4773% P= 0.1, and difference between CRUK LF and 
DMU LF: 48±9975%, P=0.2). Levels of Lactococcus were increased in LF compared 
to chow fed mice in both vendors (P value for difference between chow and LF; 
CRUK: P=0.05 and DMU: P= 0.003). Levels of Turicibacter were similar in all 
groups (around 1000 counts per OTU), except that the microbiota composition of 2 




and 16,000 counts). Two genera from the Lachnospiraceae family, 
Lachnoclostridium and Lachnospiraceae NK4A136 group were observed to be 
present at high levels in CRUK chow compared to CRUK LF group (P value for 
Lachnoclostridium and Lachnospiraceae NK4A136 group: P=0.04 and P=0.002 
respectively). The levels of Lachnospiraceae NK4A136 group were significantly 
higher in CRUK chow and LF fed mice compared to their DMU counterparts (P 
value CRUK chow Vs DMU chow: P=0.0006 and CRUK LF Vs DMU LF: P=0.01). 
The levels of an unknown genus from Peptostreptococcaceae family were increased 
in CRUK LF compared to CRUK chow (P=0.004) and DMU LF mice (P=0.04). The 
levels of Romboutsia, also from the Peptostreptococcaceae family were increased in 
LF compared to chow fed mice in both vendors (P value for chow Vs LF in CRUK: 
P=0.04 and DMU: P=0.01).  
The unknown genus from the Bacteroidales S24-7 family within the Bacteroidetes 
phylum was found to be highly abundant in chow compared to LF fed mice, 
regardless of the vendors (P value for chow Vs LF in CRUK: P=0.0002 and DMU: 
P<0.0001) (Fig. 6.4B). We did not observe a difference in the levels of genus from 
Bacteroidales S24-7 family between CRUK and DMU chow fed mice (P=0.3). 
Whereas, the levels of Bacteroidales S24-7 were found to be significantly increased 
in the CRUK LF compared to DMU LF mice (P=0.02). Within the Verrucomicrobia 
phylum, the levels of Akkermansia showed an increasing trend in the CRUK chow 
and LF groups compared to its DMU counterparts (P value for CRUK chow Vs 
DMU chow: P=0.07 and CRUK LF Vs DMU LF: P=0.008) (Fig. 6.4C). The mean 
value of Akkermansia levels in CRUK chow mice was higher compared to CRUK LF 
group, 3938 and 944.8 counts respectively, however the difference did not reach 
significance. The mean value of Akkermansia counts in DMU chow and LF mice was 
found to be below 60 counts and the levels of Akkermansia between the two diet 
groups were not found to be significantly different (P= 0.2). We did not observe a 
difference in the levels of genus Pseudomonas and Enterobacteriaceae from the 
Proteobacteria phylum between chow and LF diet groups in both CRUK and DMU 
mice. However, the DMU LF mice showed increased levels of these genera 
compared to CRUK LF mice (P= 0.01 and 0.03 for Pseudomonas and 
Enterobacteriaceae respectively). The CRUK chow group suggested decreased 
levels of Pseudomonas and Enterobacteriaceae compared to DMU chow, however, 
the difference did not reach significance (P=0.2 and 0.07 respectively) (Fig. 6.4D).  
Altogether, we observed distinct differences in the microbiota composition between 
the mice from the two sources: CRUK and DMU. We also demonstrate that while 
there were no clear patterns of variation in the Firmicutes between the vendors, there 
appeared to be OTUs that differed in abundance between CRUK chow compared to 









































































































































Figure 6.2 Diversity and richness of gut microbiota. Alpha diversity was measured via Shannon index 
(A) and observed species (B) and Principal coordinate analysis of the ileal microbiota in chow and LF 
fed C57BL/6J mice purchased from CRUK and DMU facility. Data points are coloured to indicate 
vendor and diet: CRUK chow: blue, CRUK LF: red, DMU chow: green and DMU LF: purple (C). 
Significance was determined by Kruskal-Wallis test for Shannon index and observed species. 
PERMANOVA statistical method with Bray-Curtis index for distance was used for PCoA. 
(***=p<0.001, **= p<0.01, *= p<0.05). Values are the means ± SEM of n=5-6 mice in each group. 
Mouse 3 from CRUK LF group was excluded due to low DNA yield. LF: Low-fat diet, Charles River 










































































































































Figure 6.3 Composition of the ileal microbiota at phylum and genus levels (n=5-6 per group). Relative 
abundance at taxonomic level of phylum (A) and genus (B) in the ileum content of chow and LF fed 
mice from two vendors (CRUK and DMU). Mouse 3 from CRUK LF group was excluded due to low 
DNA yield. LF: Low-fat diet, Charles River Laboratories (CRUK) and inhouse Disease Modelling Unit 
(DMU). 
 
Table 6.1 Summary of phyla that were significantly different between the four groups. Significance 
was tested by using 2-way ANOVA with Tukey’s multiple comparison test (***=p<0.001, **= 
p<0.01, *= p<0.05). Values are the means of n=5-6 mice in each group. Mouse 3 from CRUK LF 
group was excluded due to low DNA yield. LF: Low-fat diet, Charles River Laboratories (CRUK) and 
inhouse Disease Modelling Unit (DMU). 
Phyla Mean 1 Mean 2 SE of diff. Summary P value 
Bacteroidetes 
     
CRUK chow vs. CRUK LF 41.6 13.1 2.0 **** 0.0001 
CRUK chow vs. DMU chow 41.6 48.1 1.9 ** 0.004 
CRUK LF vs. DMU LF 13.1 8.3 2.0 ns 0.08 
DMU chow vs. DMU LF 48.1 8.3 1.9 **** 0.0001 
Firmicutes 
     
CRUK chow vs. CRUK LF 49.2 82.6 2.0 **** 0.0001 
CRUK chow vs. DMU chow 49.2 42.7 1.9 ** 0.004 
CRUK LF vs. DMU LF 82.6 86.1 2.0 ns 0.3 
DMU chow vs. DMU LF 42.7 86.1 1.9 **** 0.0001 
Verrucomicrobia 
     
CRUK chow vs. CRUK LF 6.2 1.5 2.0 ns 0.09 
CRUK chow vs. DMU chow 6.2 0.0 1.9 ** 0.008 
CRUK LF vs. DMU LF 1.5 0.1 2.0 ns 0.9 














































































































































































































































































































































































































































Figure 6.4 Differences in the composition of the gut microbiota at the genus level between diet and 
vendor. Significance was tested by using 2-way ANOVA with Tukey’s multiple comparison test 
(***=p<0.001, **= p<0.01, *= p<0.05). Values are the means ± SEM of n=5-6 mice in each group. 
Mouse 3 from CRUK LF group was excluded due to low DNA yield. LF: Low-fat diet, Charles River 






6.2.3 Differential expression of ileal barrier function and inflammation related genes 
in response to diet and vendor 
Expression of barrier function genes mucin 2 (Muc2), claudin 3 (Cldn3) and zonula 
occludens-1 (Zo-1) was suggested to be downregulated in response to LF feeding in 
mice from both vendors, (Muc2: 32±0.1%, P=0.05; Cldn3: 43±0.1, P=0.02; Zo-1: 
39±0.1%, P=0.01) (Fig. 6.5A). The gene expression of Muc2 and Cldn3 was 
observed to be significantly decreased in DMU LF compared to CRUK LF mice 
28±0.1%, P=0.02 and 25±0.1%, P=0.03 respectively. Inflammation related genes in 
the ileum were not changed between the diets or vendors, although a trend towards 
increased Serum Amyloid A1 (Saa1) gene expression was observed in LF fed mice 




























































































































































































































































































































Figure 6.5 Ileal gene expression in response to the different diet and vendors. Barrier function (A) 
and inflammation related (B) gene expression in the ileum of mice from CRUK and DMU. Significance 
was tested by using 2-way ANOVA with Tukey’s multiple comparison test (***=p<0.001, **= p<0.01, 
*= p<0.05). Values are the means ± SEM of n=5-6 mice in each group. LF: Low-fat diet, Charles River 





6.2.4 Bile acid metabolism in the ileum reveals vendor-associated differences 
The gene expression analysis revealed significantly increased fibroblast growth 
factor 15 (Fgf15) expression in the CRUK LF compared to CRUK chow group 
(84±0.3%, P=0.02), whereas the increase in Fgf15 expression did not reach 
significance in the DMU LF compared to DMU chow fed mice (54±0.3%, P= 0.1) 
(Fig 6.6A). We did not observe a difference in the expression of ileal basolateral 
transporter, organic solute transporter alpha (Ostα) between the diet and vendor 
groups. In line with the increase in ileal Fgf15 expression, we observed a significant 
decrease in the expression of cytochrome P450 7A1 (Cyp7a1) in the livers of CRUK 
LF compared to CRUK chow fed mice (66±0.2%, P=0.01). The hepatic expression of 
Cyp7a1 was not changed between chow and LF fed DMU mice (20±0.3%, P= 0.5) 
(Fig. 6.6C). 
We observed increasing trends in the levels of total bile acids in the ileum of CRUK 
LF (by 21.5±7185%, P=0.4) and significant increased bile acid levels in the DMU LF 
(by 41.7±851%, P=0.03) compared to chow fed CRUK and DMU mice respectively 
(Fig. 6.6B). We also observed a trend towards increased bile acid levels in CRUK 
chow compared to DMU chow mice (29.5±662%, P=0.09), whereas no vendor 
difference was observed between the CRUK and DMU mice fed with LF diet 
(P=0.7).  
Further examination of the individual bile acids revealed differential bile acids 
profile between mice from different groups (Fig. 6.7A, B, C, and D). In the ileum of 
CRUK mice, we observed significantly increased levels of primary unconjugated bile 
acids αMCA (by 240±52%, P=0.01), βMCA (by 179±119%, P=0.007) in the CRUK 
LF compared to CRUK chow mice (Fig. 6.7A). Interestingly, the levels of secondary 
bile acid, DCA were found to have an increasing trend in DMU chow compared to 
CRUK chow (207±10%, P= 0.06). The difference in the DCA levels between LF fed 
CRUK and DMU mice did not reach significance (P= 0.2) despite the mean of DMU 
LF (22µmol/g) being higher than CRUK LF group (11µmol/g) (Fig. 6.7B).  
The levels of taurine conjugated bile acids TαMCA, TβMCA, TCA, TCDCA, and 
TUDCA were significantly increased in CRUK chow compared to DMU chow 
(115±111%, 108±207%, 72±215%, 165±5% and 177±% respectively, P <0.05) (Fig. 
6.7C and D).  
Although the levels of TβMCA showed an increasing trend in CRUK LF compared 
to CRUK chow, this increase did not reach significance (40±296%, P= 0.1). Whereas 
the levels of TβMCA were observed to be significantly higher in DMU LF compared 
to DMU chow (196±338%, P= 0.003). The subtle difference observed in the levels of 
TβMCA between diets in CRUK group is possibly due to already high levels of 
TβMCA levels found in the CRUK chow fed mice. Lastly, we observed increased 
levels of TUDCA in LF fed mice from both vendors (386±45%, P=0.02 and 
991±48%, P=0.03, in CRUK and DMU respectively) compared to chow fed mice 

































































































































































































































































Figure 6.6 Bile acid metabolism in CRUK and DMU diet groups. Expression of genes involved in bile 
acids signalling in ileum (A), total bile acids in the ileum (B), gene expression of Cyp7a1 in the liver 
(C). Significance was tested by using 2-way ANOVA with Tukey’s multiple comparison test 
(***=p<0.001, **= p<0.01, *= p<0.05). Values are the means ± SEM of n=5-6 mice in each group. LF: 



























































































































































































































































































































































Figure 6.7 Ileal composition of individual bile acids. Primary unconjugated bile acids αMCA, βMCA, 
CA, CDCA (A), secondary unconjugated bile acid DCA (B), Taurine conjugated primary bile acids 
TαMCA, TβMCA, TA, TCDCA (C) and secondary taurine conjugated bile acid TUDCA (D). Significance 
was tested by using 2-way ANOVA with Tukey’s multiple comparison test (***=p<0.001, **= p<0.01, 
*= p<0.05). Values are the means ± SEM of n=5-6 mice in each group. LF: Low-fat diet, Charles River 






The reproducibility of preclinical biomedical research using mice models is currently 
being scrutinised by the National Institutes of Health (NIH). Several possibilities for 
lack of reproducibility have been discussed including randomisation, sex differences, 
poor experimental power, and environmental differences between animal facilities 
(Ericsson, 2015). In the previous chapters of this thesis, we have investigated the 
effects of commonly used control diets (chow and purified LF diet) which may be a 
major factor for lack of reproducibility in preclinical research, and highlighted some 
major differences of these diets on the gut-liver axis.  
In the current chapter, we investigated the variation in the gut microbiota and 
consequently the gut-liver axis of mice from an external vendor CRUK and inhouse 
animal facility, DMU. We propose that the differences observed in the gut 
microbiota of mice between animal facilities may be one of the environmental factors 
contributing to poor reproducibility of research using mice models. 
Four weeks feeding of the LF diet resulted in increased weight gain compared to 
chow fed mice in the CRUK group. Whereas, no difference in weight gain was 
observed in the DMU mice between the two diet groups. We did not observe a 
difference between the average calorie intake in the LF fed mice from CRUK and 
DMU. We were unable to access metabolic chambers to measure precise daily 
calorie intake and energy expenditure in mice; therefore, we cannot assess the direct 
calorimetry for metabolic rate of the CRUK LF mice which may provide the 
reasoning for weight gain.  
Previous literature has highlighted substantial differences between the gut microbiota 
of mice purchased from different vendors (Ericsson et al., 2015; Franklin and 
Ericsson, 2017). In the current study, PCoA plot revealed two distinct vendor specific 
microbiota clusters in the chow fed mice. The DMU LF microbiota cluster was 
distinctly separate from DMU chow cluster with no overlap between the groups. 
Whereas, CRUK LF cluster had some overlapping microbiota composition with 
CRUK chow. These data show that there was complete division of the composition 
of microbiota between samples at the diet level in DMU mice. However, the effect of 
diet on cluster separation did not seem as distinct as in the CRUK mice. Further 
analysis at the genus level showed mice from CRUK LF group harboured increased 
levels of Unknown genus S24-7 from Bacteroidales family and Lactobacillus 
compared to the DMU LF mice. Both these genera are highly prevalent in 
homeothermic animals; however, their differential abundance suggests the ability of 
the surrounding microbial milieu and other environmental factors that may affect the 
gut microbiota (Ng et al., 2019). 
The level of Firmicutes did not differ between the CRUK and DMU LF fed mice. 
However, the analysis of the genera within the Firmicutes phylum revealed increased 
Faecalibaculum and Romboutsia in the DMU LF, while, increased levels of 
Lactobacillus and Peptostreptococcus were found in the CRUK LF group. The high 
abundance of Lactobacillus in the CRUK mice may provide resistance to 
colonization by Faecalibaculum and Romboutsia in response to LF diet. The genus 




from young to adult age (Ke et al., 2019). The CRUK mice were 10 weeks old when 
they arrived at the animal facility, after 2 weeks quarantine period, the feeding 
experiment was started at the age of 12 weeks for all mice from CRUK and DMU. 
Therefore, the increased levels of Lactobacillus and decreased levels of 
Faecalibaculum found in the CRUK mice is not due to the age differences and may 
be due to the stronger vendor effect than diet.  
We observed increased levels of Enterobacteriaceae and Pseudomonas from the 
Gamma Proteobacteria group in DMU LF mice. The average of Enterobacteriaceae 
and Pseudomonas in DMU chow mice was also observed to be higher than CRUK 
chow and CRUK LF group. Our results suggest that the abundance of these 
pathogenic bacteria is higher in DMU mice compared to CRUK mice and the 
exposure of the DMU mice to a low fibre and high refined carbohydrate (LF) diet 
promoted the abundance of these pathogenic bacteria. Under high fibre chow diet 
conditions, this effect may be supressed by the increased levels of SCFAs (butyrate) 
that promote consumption of oxygen in the intestine, leading to anaerobic milieu 
which prevents the growth of facultative anaerobe and optimises conditions for 
anaerobic commensal strains. Whereas, under the decreased SCFAs conditions with 
LF diet, anaerobic glycolysis in the intestine leads to increased oxygen levels in the 
gut lumen that promote the growth of facultative anaerobes such as 
Enterobacteriaceae and Pseudomonas (Byndloss et al., 2017). Tennoune et al. 
(2014) identified Clp heat-shock disaggregation chaperone protein in the 
Enterobacteriaceae strain to decrease body weight in mice via production of anti-Clp 
immunoglobulins (Igs). Both Enterobacteriaceae and Pseudomonas express Clp (Lee 
et al., 2018), which may be associated with reduced weight gain observed in the 
DMU LF fed mice.  
We observed decreased ileal expression levels of barrier function genes Cldn3, Zo-1 
and Muc2 in response to the LF diet in both vendors. In addition, the ileal gene 
expression levels of Cldn3 and Muc2 in DMU LF fed mice were significantly 
decreased compared to CRUK LF group. The ileal expression of inflammation 
related genes such as Tumour necrosis factor alpha (Tnfα), Serum amyloid A1 (Saa1) 
and Nitric oxide synthase (Nos2) did not differ between groups, which suggests that 
the colonisation of the gut with Enterobacteriaceae and Pseudomonas did not induce 
an inflammatory response. Low levels of Enterobacteriaceae have been known to 
inhabit healthy murine gut (Velazquez et al., 2019), however, further studies are 
required to ascertain whether increased colonisation of these strains in the gut of 
DMU mice, make the gut-liver more susceptible to an inflammatory challenge (as 
shown in Chapter 3) compared to CRUK mice.  
We observed an increase in the genera Lachnoclostridium and Lachnospiraceae 
NK4A136 group (Phylum: Firmicutes) and Akkermansia from phylum 
Verrucomicrobia in the CRUK chow compared to other groups. A possible 
explanation for differences in microbiota could be the maintenance diet used in the 
CRUK facility before their arrival at the DMU. The mice at CRUK were fed VRF1 




(SDS diets, UK). The summary composition of the diets is shown in the Table 6.2 
below. 
 
Table 6.2 Summary composition of RM3 diet fed to mice at the DMU and VRF1 diet fed to mice at 
the CRUK facility. RM3: Rat and mouse number 3, VRF1: Very high nutrient rodent diet. 
 
RM3 (DMU) VRF1 (CRUK) 
Fat (kcal%) 11.5 13 
Protein (kcal%) 26.9 22 
Carbohydrate (kcal%) 61.2 65 
Total Dietary Fibre(g/Kg) 161.5 151.4 
Pectin(g/Kg) 15.3 13.7 
Hemicellulose(g/Kg) 96.1 87.6 
Cellulose(g/Kg) 41.3 39.5 
Lignin(g/Kg) 15.4 10.6 
Starch(g/Kg) 338.8 354.1 
Sugar(g/Kg) 43.7 46.4 
Ingredients Wheat, Wheatfeed, De-hulled 
Extracted Toasted Soya, Barley, 
Macro Minerals, Yeast, Potato 
Protein, Hydrolised Wheat Gluten, 
Full Fat Soya, Soya Oil, Maize 
Gluten Meal, Dextrose 
Monohydrate, Vitamins, Micro 
Minerals, Amino Acids. 
Wheat, Dehulled Extracted Toasted 
Soya, Wheatfeed, Barley, Dehulled 
Cooked Soya, Soya Oil, Vitamins, 
Micro Minerals 
 
Although, the RM3 and VRF1 diets vary slightly in terms of level of energy from 
macronutrients, the amount and source of dietary fibre (DF) in both diets is very 
similar. One of the major differences between the diets is the source of protein. 
Dietary protein in the RM3 diet is sourced from soya, potato protein, wheat and 
maize gluten meal, whereas, the VRF1 dietary protein source is derived solely from 
soya. The same amount of protein but different digestibility may lead differential gut 
microbiota. Further, the microbes in the gut have been shown to synthesise proteases 
and are also known to catabolise amino acids (Zhao et al., 2020; Gentile and Weir, 
2018). Kar et al. (2017) investigated the effects of different dietary protein sources on 
the ileal microbiota composition to show increased levels of Erysipelotrichaceae 
family (genus Faecalibaculum) and decreased levels of Lactobacillaceae (genus 
Lactobacillus) in mice fed a diet enriched with wheat gluten meal compared to 
soybean meal. These results agree with the differential genera profile observed in the 
DMU and CRUK mice and suggest that early life dietary composition may be the 
reason for these differences.  
Analysis of ileal bile acids showed differential profiles between the mice from 
different vendors and diet groups. In CRUK mice, we observed significant increased 
levels of αMCA and βMCA in response to LF feeding. Whereas, in agreement with 




the LF fed DMU mice. While, CRUK chow fed mice displayed increased levels of 
taurine conjugated bile acids such as, TαMCA, TβMCA, TCA, TCDCA, and 
TUDCA compared to DMU chow fed mice. The significant increase in taurine 
conjugated bile acids suggests decreased bile salt hydrolases (BSH: involved in 
removal of amino acid group from bile acids) activity within the gut microbiota of 
the CRUK chow mice. Although, Lactobacillus species have been shown to express 
increased BSH enzymes (Song et al., 2019), the increase in taurine conjugated bile 
acids did not correlate with increased abundance of Lactobacillus in the CRUK chow 
group. We also observed increased levels of secondary bile acid DCA in the ileum of 
DMU mice, whereas its primary bile acid CA was generally unaffected between the 
groups. Certain species of Clostridium can carry out 7α-dehydroxylation of cholic 
acid to produce DCA which has potential pro-carcinogenic and pro-inflammatory 
actions (Xu et al., 2020). However, deeper analysis at the species level with shotgun 
metagenomic techniques are required to identify the species responsible for CA 
modifications to DCA by 7α‐dehydroxylation reactions. Metagenomics analysis can 
also identify the Lactobacillus species present in the CRUK mice and the abundance 
of BSH encoding genes expressed in these species. Different species of Lactobacilli 
have been reported to contain varying number of BSH genes that may affect their 
enzyme activity (Horackova et al., 2020).   
The gene expression of organic solute transporters, Ostβ and Ostα and intestinal bile 
acid transporter of apical sodium bile acid transporter, Asbt did not show any 
significant alterations between the groups. However, we found ileal Fgf15 expression 
to be significantly increased in the CRUK LF compared to CRUK chow mice. In 
agreement with literature, the upregulation of Fgf15 gene expression suppressed the 
hepatic Cyp7a1 gene expression which leads to decrease de novo bile acid synthesis 
in the liver (Sayin et al., 2013). In the DMU group, we observed a slight increase in 
the ileal Fgf15 expression (not significant) in the LF fed mice while, the gene 
expression of liver Cyp7a1 remained unchanged between the diets. The sustained 
expression of Cyp7a1 in the liver suggests maintained synthesis of bile acids in 
DMU LF compared to CRUK LF fed mice. These results are in line with 
significantly reduced serum cholesterol observed in the DMU LF compared to 
CRUK LF group (Supplementary Fig. 3.6). 
Our results highlight the need to acknowledge vendor associated differences in the 
gut microbiota composition and their effects on the gut-liver axis. Further studies that 
utilise metagenomics can enhance our knowledge on species differences which may 
be involved in modulating the metabolic health. To the best of our knowledge, this is 
the first study to investigate the differential effect of diets in mice from different 
vendors, on the composition of gut microbiota and subsequent gut-liver axis of 













The interactions within the gut-liver axis play a crucial role in regulating the host 
response to diet. The diet-gut-liver axis in the context of microbiota has been shown 
to be involved in the development of type II diabetes (Qin et al., 2012), liver 
cholestasis (Isaacs-Ten et al., 2020) and more recently several studies have explored 
the contribution of the gut microbiome to the pathophysiology of non-alcoholic fatty 
liver disease (NAFLD) (Roychowdhury et al., 2018; Aron-Wisnewsky, 2020). Most 
of the studies investigating the diet-gut-liver axis during NAFLD have focused on the 
colon due to its highest microbiota density. Although, the ileum has the second 
largest microbiota population to colon, and it provides a direct link to the liver via the 
enterohepatic circulation of bile acids (Ticho et al., 2019), it has not been well 
studied in the context of diet-gut-liver axis. The scarce literature on the effects of diet 
on the ileum-liver axis prompted us to explore this part of the gastrointestinal (GI) 
tract to investigate its role on metabolic health and prevention of disease.  
Our results have highlighted the negative effects of a high refined carbohydrate, low 
fibre diet on the liver compared to a high fibre grain-based diet. We used two control 
diets, chow and LF to investigate the effects of 1) increased easily metabolisable 
carbohydrates, and 2) the lack of fermentable soluble fibres in the LF diet. We 
showed that mice fed with LF diet for as short as 4 weeks exhibited early 
development of hepatic steatosis, a precursor of non-alcoholic steatohepatitis 
(NASH), compositional changes in the ileal microbiota, an increase in the gut 
permeability and changes in the bile acid metabolism. We also showed that LF fed 
mice exposed to low dose lipopolysaccharide (LPS) had increased sensitivity to this 
proinflammatory challenge. This was reflected by increased caspase 3 activity in the 
liver and upregulation of inflammatory related genes in the ileum compared to their 
chow counterparts. Reduced consumption of the LF diet in a calorie restricted model, 
protected the liver from LF induced hepatic triglycerides accumulation in short and 
long-term dietary intervention study. We further examined the effects of addition of 
soluble fibres to counteract the detrimental effects of the LF diet and revealed that 
the liver phenotype of LF induced early steatosis was successfully prevented, despite 
the same quantity of refined carbohydrates present.  
7.1.1 Increased levels of easily accessible carbohydrates in LF diet drive hepatic de 
novo lipogenesis in mice 
The easily accessible carbohydrates present in the LF diet are refined starch and 
sucrose. Sucrose is a disaccharide formed of glucose and fructose, whereas starch 
(amylose) is formed of a long chain of glucose monomers linked through α-(1-4) 
glycosidic bonds (Goodman, 2010). Under physiological conditions, glucose and 
fructose only reach the ileum when the small intestine is overloaded with 
carbohydrates (Jang et al., 2018). We found increased ileal gene expression of 
disaccharidases maltase-glucoamylase and sucrase-isomaltase (Mgam and Sis) and 
glucose transporters (Sglt1 and Glut2) in response to the 4, 8 and 10 weeks feeding of 
the LF diet, indicating overloading of the capacity of duodenum and jejunum to 
digest the carbohydrates in the LF diet and leading to ileal starch/fructose exposure. 




observed in response to the LF diet may be explained by the following potential 
mechanisms: 
Under LF conditions, glucose from starch and sucrose is rapidly absorbed in the 
small intestine, however, some fructose may reach the liver due to either, overloading 
the capacity of the small intestine, or by increased gut permeability observed in LF 
fed mice.  
LF diet contains 17% sucrose compared to experimental high sucrose (>50%) diets 
used to induce NAFLD in mice. However, our results show that the 17% sucrose was 
sufficient to induce an increased gene expression of hepatic fructokinase Khk, 
suggesting exposure of the liver to fructose. Furthermore, the increased Glut2 
expression observed in response to the LF diet suggested increased absorption of 
glucose in the ileal enterocytes, which may lead to high glucose concentrations in the 
portal circulation. We propose that increased glucose as well as fructose exposure of 
the liver under LF conditions contributes to de novo lipogenesis. As suggested by 
increased gene expression of Srebp1, that plays a major role in driving the 
transcription of lipogenic genes Fasn and Acaca indicating increased lipogenesis in 
response to the LF feeding.  
Another way fructose may reach portal circulation could be through the increased gut 
permeability observed in the LF diet as indicated by increased serum fluorescein 
isothiocyanate dextran (FITC-dextran) in (Chapter 3) and consistently decreased ileal 
expression of barrier function genes like claudin 3 (Cldn3), and zonula occluden 1 
(Zo-1) in response to LF diet feeding of mice. Exposure of the liver to unmetabolised 
fructose can lead to production of fructose metabolism intermediate glycerol-3-
phosphate (G3P) which can directly enter the lipogenesis pathway (Macdonald et al., 
2016). 
Exposure of intestinal microbiota to refined carbohydrates can lead to production of 
hepatotoxic metabolites. Although, most of the refined carbohydrates are mainly 
taken up by the proximal small intestine, excess unabsorbed starch and sucrose may 
reach the distal part of the intestine and interact with the microbiota (Howe et al., 
2016; Jang et al., 2018). In line with this, we observed an increased relative 
abundance of Romboutsia and Lactococcus in the ileum of LF fed mice. These 
bacteria have been shown to encode genes related to carbohydrate transport and 
metabolism. Romboutsia can utilise a wide variety of simple carbohydrates and have 
good growth in high sucrose conditions to produce end products of fermentation such 
as, acetate, lactate and formate (Gerritsen et al., 2017). In the context of high sucrose 
conditions, microbial metabolism of simple carbohydrates has been shown to 
promote de novo lipogenesis in the liver by providing acetate for production of 
hepatic acetyl-CoA and fatty acids (Zhao et al., 2020). Although, the authors also 
showed that acetate is insufficient to trigger an increase in lipogenesis in the absence 
of the sugar-derived lipogenic transcriptional signal. In addition to acetate, dominant 
SCFAs from Faecalibaculum, butyrate has also been suggested to contribute to liver 
lipogenesis depending on the metabolic state of the cells. Donohoe et al. (2012) 
showed that butyrate can serve as a carbon source for β-oxidation and the TCA cycle 




Therefore, it is possible that in the context of high carbohydrate conditions, LF diet 
may promote lipogenic gene expression in the liver and microbial metabolisation of 
starch and sucrose produce microbial metabolites such as acetate, which can act 
together to support de novo lipogenesis in the liver of LF fed mice. SCFAs have been 
considered beneficial for human health, however, it is becoming increasingly 
accepted that their precise mechanisms can differ between tissues and metabolic 
conditions (Koh et al., 2016).  
 
Figure 7.1 High starch and sucrose in the low-fat (LF) diet leads to a pathophysiological liver 
phenotype in mice.  
 
7.1.2 Composition and amount of dietary fibres have differential ileal 
immunomodulatory properties 
Soluble dietary fibres (DF) are a major component lacking in the LF diet, therefore, 
in chapter 5, we enriched the LF diet with various DF to investigate their role on the 
gut-liver axis. We showed that addition of the DF protected the livers from the LF 
induced lipid accumulation as demonstrated by lower hepatic triglyceride levels and 
liver histology. The amelioration of the liver phenotype may be due to fibre impacted 
slower starch and sucrose hydrolysis by MGAM and SIS, hence, reduced 
glucose/fructose passage into the intestine resulting in efficient intestinal clearance. 
We observed increased ileal gene expression of carbohydrate digestion enzymes (α 
glucosidases) Sis, Mgam, and glucose and fructose transporters Sglt1, Glut2, and 
Glut5 in the fibre groups, that indicates increased delivery of nutrients to the ileum. 
Another reason for the increased expression of the α glucosidases and 




binding to digestive enzymes and transporters, thereby, delaying the digestion and 
uptake of carbohydrates (Grundy et al., 2016; Neyrinck et al., 2016).  
The LF diet was enriched with either 6.8% inulin alone (LS+In) or a combination of 
2.3% inulin, pectin and psyllium each (LS+Comb). We performed RNA sequencing 
on the ileal samples from this study to show differential effects of fibre enriched 
groups on the ileal immune related genes; interferon induced and major 
histocompatibility complex (MHC) class II genes were most upregulated in the fibre 
combination group compared to inulin alone. Our results highlight that not all DF 
provide similar effects on host GI health. We did not find major differences in the 
ileal microbial composition between the groups. However, the heterogeneity in the 
structures of inulin, pectin and psyllium can influence the rate of fermentation of 
these fibres by the microbiota and hence, lead to different concentration ratios of 
SCFAs; acetate, propionate and butyrate, and consequent physiological effects 
(Singh and Vijay-Kumar, 2020). Time-of-flight mass-spectrometry based 
metabolomics analysis of the caecal content from mice in this experiment can reflect 
the changes of the metabolome in response to the different diets. We hypothesise 
varying concentrations of SCFAs in the caecal content in response to the distinct 
fibres in our diets, may influence the gut immune response (Singh et al., 2018).  
Shotgun metagenomic assessment of ileal content samples from the different diet 
groups can provide us with a taxonomic resolution down to the species level and 
identify the variety of host undigestible carbohydrate-active enzymes present in the 
gut microbiota of each group. The metagenomics approach can not only give us a 
comprehensive description of the gut microbiota, but also characterise the viruses 
present in the gut virome, which is highly important for the regulation of the host 
immunophenotype (Rampelli, et al., 2016). However, shotgun metagenomics 
techniques are far more expensive than the 16S rRNA analysis and were not in the 
scope of this PhD thesis.  
Many DF can also directly interact with the gut immune cells, such as macrophages 
or dendritic cells independent of the microbiota (Beukema et al., 2020). Mouse 
studies have shown that DF are transported into the Peyer’s patches through 
microfold (M) cells and can activate immune cells (Suh et al., 2013; De Jesus et al., 
2014). Moreover, the structural characteristics such as degree of polymerisation 
(complexity of the structure) of the fibres also play a role in the host immune 
response (Beukema et al., 2020; Vogt et al., 2016). Therefore, the heterogeneity in 
the structure of pectin, inulin and psyllium may explain the varied immune response 
in the groups. This effect may be due to the complexity of these fibres which is in the 
order inulin < pectin < psyllium (Alexander et al., 2019). Further research on germ 
free mice needs to be carried out to understand the precise mechanisms through 
which DF affect immune response in the gut independent of the microbiota.  
We performed bulk RNA sequencing on the ileum samples which reflects the 
average gene expression across thousands of cells. In the future, single cell RNA 
sequencing can allow us to identify the immune cells that are expressing genes 
related to interferon induction and MHC Class II molecules (Zhao et al., 2020). For 




play a critical role in maintaining gut homeostasis by supporting the mutualism with 
commensal bacteria  (Melo-Gonzalez et al., 2019), therefore, by measuring the gene 
expression of H2-aa, H2-ab1, and H2-dmb1 in sort-purified ILC3, we may be able to 
confirm if the gene signal is indeed coming from ILC3 to maintain tissue 
homeostasis. 
7.1.3 Calorie restriction (CR) improves the LF induced phenotype in mice 
In collaboration with Dr Steegenga (Wageningen University and Research), we 
analysed the ileal samples from the IDEAL study to describe the long-term effects of 
the LF diet on ileal gene expression and microbiota composition. We also used this 
opportunity to investigate if CR intervention can reverse these LF induced effects. 
Long-term (24 months) feeding of the LF diet led to increased liver triglycerides 
(Rusli et al., 2017), decreased Paneth cells and cell cycle related genes and altered 
microbiota composition in the ileum, whereas CR intervention prevented this age-
related effect of purified diets fed ad libitum.   
Various intracellular mechanisms have been proposed by which CR can reduce the 
age-related cell and DNA damage including decreased oxidative stress and enhanced 
DNA repair (Heydari et al., 2007; Bruens et al., 2020). The stable expression of 
genes related to Paneth cells and cell cycle regulation suggests that 1) CR provides 
protection against age associated dysregulation of antimicrobial peptides 
secretion/production in the ileum (Tremblay et al., 2017), 2) CR maintains 
regeneration of the intestinal tissue which can eliminate age-related mutations of 
weak and damaged cells through niche competition, thereby contributing to the 
beneficial healthy ageing effect of CR (Bruens et al., 2020).   
Studies on CR have been performed on chow (Guijas et al., 2020) as well as purified 
diet background (Green et al., 2018). We anticipated that the difference in the 
composition of the background diet may have an effect on the gut-liver axis in 
response to CR. We showed that 8 weeks CR on the LF background successfully 
reduced hepatic lipid accumulation in mice, whereas no difference in hepatic 
triglycerides was observed between chow control and its CR counterpart. In 
agreement with previous CR studies (Green et al., 2018; Guijas et al., 2020), we 
observed upregulation of peroxisome proliferator-activated receptor alpha (Pparα) in 
the liver of chowCR and LFCR mice, which is involved in the regulation of lipid β 
oxidation to provide energy (Zheng et al., 2018). However, the differential 
expression of hepatic lipogenic genes between chowCR and LFCR requires further 
investigation. 
Moving forward with this study, it will be important to perform longer CR 
experiments with controlled variables to investigate if the diets affect the circulatory 
and intestinal luminal metabolites (e.g. free fatty acids) profile differently. Another 
important factor that may contribute to the differences observed between chow and 
LF, is the involvement of the gut microbiota and SCFAs that may affect the host’s 
response to CR. Determining these gut-liver related changes that take place during 
CR can provide us with fundamental information to develop CR mimetics to promote 




7.1.4 Challenges of using mice as research models 
In chapter 6, we compared mice that were bred in different locations to show 
differential effects of the chow versus LF intervention on the microbiota composition 
and bile acid metabolism. In brief, we found increased abundance of Proteobacteria 
in the inhouse disease modelling unit (DMU) mice, which is further enhanced when 
these mice were exposed to the LF diet. Furthermore, we also show differential 
profiles of ileal bile acids, specifically increased levels of taurine conjugated bile 
acids in the externally sourced CRUK mice which indicates decreased bile salt 
hydrolase (BSH, involved in deconjugation of bile acids) activity in the ileal 
microbiota of these mice. Our results did not correlate with the abundance of genus 
Lactobacillus in this group, which is known to contain high amount of BSH enzymes 
(Song et al., 2019). Therefore, chemoproteomic approaches for interrogating the 
metabolic activities of the gut microbiota may shed some light on the measure of 
activity of the BSH present in gut of CRUK and DMU mice.  
A limitation of this study was that due to cost and time restrictions, we were unable 
to sequence the gut microbiota of CRUK mice before they arrived at the University 
of East Anglia (UEA) facility. In the future, a baseline measure of ileal microbiota of 
mice from different locations at timepoint zero would give us further information on 
the original microbiota of these mice and how the microbiota has shifted over the 
course of the experiment (week 1, 2, 3 and 4) under chow and LF dietary conditions. 
Our results highlight that despite the mice being genetically identical and exposed to 
the same dietary conditions, heterogeneity in the gut microbiota composition in mice 
due to their source can have profound implications in the field of biomedical 
research. The ever-increasing research on disease mechanisms and host processes 
that are impacted by gut microbiota make it abundantly clear that properly 
controlling for gut microbiota variation is critical for reproducibility. The scientific 
community and commercial vendors need to work together in order to address these 
realities. Scientists could help facilitate clear and consistent publishing of mouse 
husbandry details by providing information on the vendor name, mouse strain, barrier 
room, and inhouse husbandry conditions such as type of water, dietary compositional 
details, bedding, type of cages and light cycle. Smith et al. (2017) published the 
PREPARE guidelines: Planning Research and Experimental Procedures on Animals: 
Recommendations for Excellence to address the widespread concerns about 
reproducing and translating animal research.  
Another challenge that we faced during our mouse studies was the presence of inter-
individual variation in phenotype and microbiota results between the mice from the 
same group or cage dependent effects. For example, in chapter 6, we found presence 
of the genus Akkermansia in all mice from cage number 2 (that contained m4, m5, 
m6) within the CRUK chow group. The increased abundance of this mucus 
degrading genus Akkermansia is associated with the health status of mice and a 
reduced body weight (Depommier et al., 2020). However, presence of Akkermansia 
within these mice lacked correlation with factors such as body weight, Muc2 or 
inflammation related gene expression. We also noticed low and high body weight 




dominance status, social interaction and stress. Moreover, some of these 
environmental factors may favour inter-individual differences via early life 
programming of the individual mouse dependent on litter size, and induction of 
epigenetic modifications of the genome (such as, DNA methylation, histone 
acetylation, or microRNA modifications) which can have major effects on the 
microbiome of the mouse (De Francesco et al., 2019).  
Although, we did not observe strong correlations for abundance of Akkermansia with 
other phenotype or gene expression data for the mice. It would be interesting to see 
whether these inter-individual variations have long-term effects, such as healthy 
ageing or protection against diet induced metabolic syndrome (Biagi et al., 2016).  
Recently, human intestinal organoids or organ on a chip technology have been 
demonstrated as powerful tools to understand unresolved mechanisms underlying 
physiology and disease progression. For example, De Gregorio et al. (2020) utilised 
integrated microfluid intestine-liver device as a tool to reproduce the first-pass 
metabolism of ethanol. Given the rapid technological advancement in the field, the 
variety of organoid models and organ on a chip options available will provide a 
powerful platform to research host-microbiota-gut-liver interactions for preclinical 
studies, and help scientists produce reproducible and translatable data in the field of 
metabolic research. 
7.2 Human relevance 
The consumption of ultra-processed foods, which are high in added starch and 
sucrose, and low in DF, are strongly linked with a 62% increased hazard for mortality 
(Rico-Campà et al., 2019). Detrimental effects have also been shown in this thesis 
with the development of early signs of NASH when the mice were exposed to the 
highly refined LF diet, that resembles a high refined carbohydrate, and low-fat 
Western style diet. Our studies further confirm the emerging epidemiological 
consensus that reduced fat processed foods such as low-fat desserts, fruit juices that 
were once viewed as healthy because of their low-fat content, can have dangerous 
outcomes in the liver because of the easily accessible carbohydrates present in these 
foods.  
To avoid these detrimental effects, recently food manufacturers have started to fortify 
processed foods with refined DF such as inulin and pectin in various products (baked 
goods, fruit yoghurts) to promote them as health foods and increase the public’s fibre 
intake. Indeed, high intake of fibres can provide many health benefits, such as 
improved barrier function (as shown in Chapter 3) and abundance of beneficial 
Bifidobacterium as reported in Chapter 5 of this thesis. Moreover, we also observed 
increased immune response in chow and fibre combination diet, but not in solely 
inulin enriched LF fed mice, which suggests that not all DF effect the GI health 
equally. The activation of an immune response to DF may be beneficial to the host 
under different circumstances. During physiological conditions, mild activation of 
immune responses by a high fibre intake can be beneficial because it promotes 
intestinal immunity. However, under gut inflammatory conditions (Irritable bowel 
disease, IBD), the activation of the immune response may add to the injury in the gut 




understand whether the different fibre products provide similar health benefits in all 
human population.  
Numerous studies have demonstrated various benefits of microbial metabolites such 
as SCFAs, from serving as fuel for colonocytes to improving intestinal inflammation. 
However, several studies have also shown that persistent elevation of SCFAs in the 
gut could prove harmful to gut and metabolic health (Singh and Vijay-Kumar, 2020). 
An intriguing study by Zhang et al. (2016) demonstrated aggravated colitis in DSS 
treated mice that received butyrate producing bacteria, while no detrimental effect 
was observed in healthy controls. Therefore, the differential impact of fibres on the 
gut immune response supports the paradigm that fibres are a ‘double edged sword’ 
that could promote or deter health depending on the health status of the host. 
Moreover, our research also highlights the need for careful consideration when 
selecting prebiotic interventions to alter levels of SCFAs. As dysregulated levels of 
SCFAs may promote or dampen inflammation depending on the microbiota 
composition (healthy or dysbiotic) and level of gut inflammation in humans.  
7.3 Future perspectives 
7.3.1 Susceptibility of LF mice to infection 
In Chapter 3, we demonstrated that the gut and liver of LF fed mice were more 
sensitive to the LPS challenge compared to chow fed mice. In order to confirm this 
hypothesis future mouse studies with Clostridium difficile infection can further 
explain health effects of the two control diets. C. difficile is known to cause 
gastrointestinal infections, with symptoms ranging from diarrhoea in mild infections 
to ulcerative colitis in severe cases (Magill et al., 2014). The infection model rather 
than dextran sulfate sodium (DSS) colitis or LPS model, will allow us to study the 
normal host immune and gut microbiota response to the pathogen. 
Four weeks chow and LF fed mice can be challenged with C. difficile strain such as 
R20291 (known to be enhanced in conditions of high simple sugars) and monitored 
daily for a further 4 weeks for signs of C. difficile infection (such as weight loss, 
temperature). Mice will be sacrificed at the end of the experiment, or if the infection 
symptoms reached a severity endpoint as described by Chrisabelle et al. (2020), so 
that no mice experienced severe distress. After sacrifice, the effect of diet on the 
outcome of C. difficile infections would be assessed by analysing changes in gut 
permeability by FITC-dextran in the serum, microbiota composition by shotgun 
metagenomics, metabolomics of luminal content and portal vein, caspase 3 activity in 
the liver, and gene expression analysis in the liver and gut for inflammatory markers.  
7.3.2 The impact of dietary fibres on the gut-liver axis 
Based on the results presented in chapter 5 of this thesis, the addition of DF inulin, 
and a combination of inulin, pectin and psyllium improves the lipid accumulation in 
the liver induced by the LF diet. In order to understand the 1) microbiota independent 
and 2) microbiota dependent mechanisms by which fibres have these beneficial 





1. To elucidate microbiota independent mechanisms 
Firstly, we could assess how glucose/fructose under the LF diet reaches the 
liver, and the possible mechanisms by which addition of inulin and fibre 
combination could prevent it. We could utilise isotope tracer experiments and 
administer mice with a solution of 1g sucrose (comprised of 1:1 mixture of 
labelled [U-13C] glucose and [U-13C] fructose) via oral gavage and quantify 
the levels of labelled sugars in the portal circulation at different time points 
(30 and 60 minutes) in mice. The mice will be fed a variant of the LF diet 
with 0g of sucrose. The amount of 1g per mouse is similar to the amount 
consumed on the LF diet per mouse per day. Additional groups with labelled 
sucrose solution with supplementation of inulin and/or combination fibres can 
demonstrate whether the fibres aid slower fructose/glucose uptake in the liver 
by measuring the levels of labelled glucose and fructose in the portal blood. 
 
2. To elucidate microbiota dependent mechanisms  
Feeding experiments with the LF and LF + Fibre diets to mice with depleted 
gut microbiota (by using antibiotics treatment or germ-free mice) can give us 
further information about the role of microbiota in the development of the 
detriment liver phenotype in LF fed mice. 
 
Furthermore, lifelong studies of feeding with the LF diet, and LF diet 
enriched with different fibres will give us deeper knowledge on the long-term 
effect of these diets. Liver phenotype via histology, intestinal permeability 
measurements via FITC-dextran, bile acids in the ileum and serum, 
metabolomics in the portal vein blood, serum and the intestine, microbiota 
composition analysis via shot gun metagenomics sequencing and 
transcriptomics in both the intestine and liver could give us comprehensive 
data to form robust conclusions on the role of DF in the gut-liver axis. 
Within this experiment, time point analysis of all the above measures at 6, 12 
and 24 months can also provide us information on the effects of different 
fibres during ageing and if some fibre via microbiota mechanisms are better 
than others in increasing health in aged mice (or life expectancy). 
 
FMT techniques can be used to inoculate mice with faecal human microbiota 
from healthy adults to assess the effects of different DF in improving diet 
induced NASH phenotype. Furthermore, inoculation of mice with faecal 
microbiota from NASH patients, could provide us with information on the 
role that the original (preintervention) microbiota may play in the 
effectiveness of DF in improving NASH phenotype. These strategies can help 
explain why some adults respond more positively to a dietary intervention 
than others and pave the way towards personalised dietary strategies 





7.4 Further Limitations 
Chow and LF diet have major differences in their carbohydrate composition. Another 
difference between the diets is in terms of their protein content and source. Chow diet 
contains slightly more protein (26.9 kcal%) compared to the LF diet (20 kcal%). 
Protein in the chow diet comes from a plant-based source (soya, potato protein, 
hydrolysed wheat gluten and maize gluten meal) and the protein in the LF diet comes 
from casein alone, which is mainly sourced from dairy. Protein source and amino 
acid balance has been known to influence gut microbiota and its metabolites. For 
example, plant proteins such as soy protein has been linked to a greater abundance of 
Bacteroidetes, and decreased circulating LPS levels compared to meat, dairy, and 
casein-protein consumption (Prokopidis et al., 2020). Furthermore, chow diet 
contains dietary aryl hydrocarbon receptor (AhR) ligands from phytochemicals 
(daidzein and genistein) in grains and soya oil, whereas the LF diet lacks such 
phytochemicals. Schanz et al. (2020) has demonstrated that dietary AhR ligands have 
a profound influence on intestinal immune cells as well as gut microbiota 
composition. Therefore, the lack of DF as well as AhR ligands in the LF diet may be 
one of the reasons underlying the ‘unhealthy’ phenotype caused by the LF diet. The 
target gene of AhR, cytochrome P450, family 1, subfamily A, polypeptide 1 
(Cyp1a1) is highest in the proximal parts of the small intestine and almost none in the 
ileum. We have analysed gene expression of Cyp1a1 in the duodenum of chow vs LF 
study to show downregulation of Cyp1a1 in the LF groups (Supplementary Fig. 3.5). 
Therefore, the quality of the diet is just as important as the quantity, in order to 
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Supplementary data 1 
 






Supplementary Table 1.2 Composition of LS (LF Low sucrose, D12450J), LS+Inulin (D18012101), 














Supplementary data 2 
Bile acid (BA) method and conditions 
Each sample (5µl) was analysed using an Agilent 1260 binary HPLC couples to an 
AB sciex 4000 QTrap triple quadrupole mass spectrometer. HPLC was achieved 
using a binary gradient of solvent A (Water + 5mM Ammonium Ac + 0.012% 
Formic Acid) and solvent B (Methanol + 5 mM Ammonium Ac + 0.012% Formic 
Acid) at a constant flow rate of 600µl/min. Separation was made using a Supelco 
Ascentis Express C18 150 x 4.6, 2.7µm column maintained at 40˚C. Injection was 
made at 50% B and held for 2 min, ramped to 95%B at 20 min and held until 24 
minutes. The column equilibrated to initial conditions for 5 minutes. The mass 
spectrometer was operated in electrospray negative mode with capillary voltage of -
4500V at 550˚C. Instrument specific gas flow rates were 25ml/min curtain gas, GS1: 
40ml/min and GS2: 50ml/min.  
BA standards: d4 Internal standards: Each d4 internal standard is prepared at 1 
mg/ml in methanol. Prepare 5 solutions of these all at 40µg/ml by taking 400µl of 
each stock standard to 10ml in 70% methanol. 
INT Std # Int Std(s) 







Each BA is prepared at 1mg/ml in methanol and stored refrigerated. 
A 10µg mix of the BAs is prepared in 70% methanol by taking 100µl of each 
individual BA (at 1mg/ml) into a pooled vial and making to 10ml total volume. Make 
all to total volume of 500µl with methanol. 
Std (ng/ml) Vol (µl) Of what std Make up vol (µl) 
Methanol 
Notes 
4000 200 10µg/ml mix 300  
2000 100 10µg/ml mix 400  
1000 50 10µg/ml mix 450 Prep x 2 
500 25 10µg/ml mix 475  
200 10 10µg/ml mix 490  
100 50 1000ng/ml mix 450 Prep x 2 
25 12.5 1000ng/ml mix 487.5  
15 75 100ng/ml mix 425  
10 50 100ng/ml mix 450  
5 25 100ng/ml mix 475  









Column: Supelco Ascentis Express C18 150 x 4.6, 2.7µm 
Flow: 600µl/min 
Mobile phase A: Water + 5mM Amm. Ac + 0.012% Formic acid 
Mobile Phase B: Methanol + 5mM Amm. Ac + 0.012% Formic acid 
Inj: 5µl 
Column: 40°C 
Mobile phase preparation 
In one litre of methanol or Water: 
5 mM Ammonium Acetate = 0.385g 










Source Conditions (negative mode) 
SOURCE 
 
CUR:  25 
TEM:  550 
GS1:  40 
GS2:  50 
ihe:  ON 
CAD:  -2 









Multiple reaction monitoring (MRM) settings 
ID Q1 Q3 Dwell DP CE RT 
LCA 375.3 375.3 20 -90 -
10 
22.70 








































GLCA 432.3 432.3 20 -80 -
10 
19.77 
GCDCA 448.3 448.31 20 -80 -
10 
17.72 
GDCA 448.3 448.32 20 -80 -
10 
18.28 
GCA 464.3 464.3 20 -80 -
10 
15.70 


































       




















d4-GCA 468.4 74 20 -80 -
40 
15.71 
       
P lipid 
query 










ID Q1 Q3 Dwell DP CE RT 
GLCA 432.3 74 20 -80 -
40 
20.59 
GCDCA 448.3 74.11 20 -80 -
40 
18.31 
GDCA 448.3 74.12 20 -80 -
40 
18.93 
GCA 464.3 74 20 -80 -
40 
16.03 








































Microbiota analysis at Novogene                                                                       
Microbial DNA was isolated from approximately 50mg ileal luminal content with the 
Qiagen DNA mini kit. Additional steps were added to the DNA mini kit protocol to 
ensure breakage of all bacterial samples. Briefly, the samples were homogenised 
using silica glass beads for 4x 30 seconds at 6000 rpm in a Precellys®24 (Bertin 
Technologies, France) and heated to 95°C for 5 minutes. Additionally, samples were 
incubated with a lysis buffer containing 20mg/ml lysozyme (Lysozyme from chicken 
egg white, Sigma-Aldrich) after which the homogenising was repeated. The 
lysozyme was used to help effectively capture usually difficult to lyse taxa, such as 
gram-positive bacteria. Consequently, DNA was isolated using the Qiagen DNA 
mini kit following instructions from the manufacturer. DNA quantity was assessed 
using a Nanodrop 2000 Spectrophotometer (Fisher Scientific, UK). 
A minimum of 50ng of DNA was sent to Novogene (Cambridge, UK). Quality 
assessment was performed by agarose gel electrophoresis to detect DNA integrity, 
purity, fragment size and concentration. The 16S rRNA amplicon sequencing of the 
V4 region was performed with an Illumina MiSeq (paired-end 250 bp; San Diego, 
CA). Paired-end reads was assigned to samples based on their unique barcodes and 
trimmed by cutting off the barcode and primer sequences. Paired-end reads were 
merged using FLASH (V1.2.7). Quality filtering on the raw tags were performed 
using specific filtering conditions to obtain the high-quality clean tags according to 
the Quantitative Insights into Microbial Ecology (QIIME) (version 1.7.0) quality-
controlled process (Caporaso et al., 2011). The tags were compared with the 
reference database (Gold database) using UCHIME algorithm to detect chimera 
sequences and then the chimera sequences were removed, and Effective Tags were 
obtained. Sequences analysis were performed by Uparse software (Uparse v7.0.1001) 
(Edgar, 2013) using all the effective tags. OTUs were picked with 97% sequence 
similarity. For each representative sequence, Mothur software was performed against 
SSUrRNA database of SILVA database. Alpha and beta diversity were calculated by 
QIIME and displayed with R software (Novogene, Cambridge). Comprehensive 
statistical and meta-analysis including differential analysis of taxa abundance was 




























Supplementary figure 3.1 Differences in the abundance of Enterobacteriaceae family from the 
Gammaproteobacteria group. Significance was tested by using unpaired T test (***=p<0.001, **= 



























































































Supplementary figure 3.2 Differential metabolite profiles in the ileal content after 2 weeks feeding 
with chow and LF diet. Significance was tested by using unpaired T test (***=p<0.001, **= p<0.01, 














































Supplementary figure 3.3 Gene expression of Tlr4 in response to chow and LF fed mice treated with 





























































































































































Supplementary figure 3.4 Liver gene expression analysis from adult (6 months) and old mice (24 
months) mice exposed to lifelong CR diet.  Significance was tested using a 2-way ANOVA with 


















































































Supplementary figure 3.5 Gene expression of Cyp1a1 in the duodenum in response to different diets. 
Significance was tested by using unpaired T test (A) and 1-way ANOVA (B) (***=p<0.001, **= p<0.01, 
*= p<0.05. LF: Low-fat diet, LS: low sucrose version of the LF diet, LS+In: LS diet enriched with inulin, 





































































Supplementary figure 3.6 Comparison of serum cholesterol levels in response to the LF diet in mice 
from different sources; CRUK and DMU. Significance was tested by using 1-way ANOVA and unpaired 
t test (***=p<0.001, **= p<0.01, *= p<0.05. CRUK: Charles River, UK. DMU: Disease modelling unit 

















Supplementary data 4 
 
Supplement 4.1 Ileal gene expression regulated between LF and LFCR at adult and old age. 
Significance was tested using a 2-way ANOVA with Bonferroni post-hoc test for both diet and time 




95.00% CI of diff. P Value 
Mptx2 6m:LF vs. 6m:LFCR 41.66 -1154 to 1238 1.00 
 
6m:LF vs. 24m:LF 1614 322.1 to 2906 0.01 
 
6m:LFCR vs. 24m:LFCR 336.7 -859.4 to 1533 0.95 
 
24m:LF vs. 24m:LFCR -1236 -2527 to 56.21 0.04 
     
Defa-rs1 6m:LF vs. 6m:LFCR -30.85 -847.0 to 785.3 1.00 
 
6m:LF vs. 24m:LF 1100 218.8 to 1982 0.01 
 
6m:LFCR vs. 24m:LFCR 337.7 -478.4 to 1154 0.61 
 
24m:LF vs. 24m:LFCR -793.5 -1675 to 88.04 0.04 
     
Defa3 6m:LF vs. 6m:LFCR 307.7 -864.7 to 1480 0.86 
 
6m:LF vs. 24m:LF 1908 641.9 to 3175 0.00 
 
6m:LFCR vs. 24m:LFCR 580.9 -591.5 to 1753 0.47 
 
24m:LF vs. 24m:LFCR -1020 -2286 to 246.7 0.05 
     
     
Dmbt1 6m:LF vs. 6m:LFCR 2.475 -426.7 to 431.6 1.00 
 
6m:LF vs. 24m:LF 465.3 1.746 to 928.9 0.05 
 
6m:LFCR vs. 24m:LFCR 122.4 -306.8 to 551.6 0.94 
 
24m:LF vs. 24m:LFCR -340.4 -804.0 to 123.1 0.05 
     
Cdca3 6m:LF vs. 6m:LFCR -0.4258 -39.83 to 38.97 1.00 
 
6m:LF vs. 24m:LF 52.3 9.746 to 94.86 0.02 
 
6m:LFCR vs. 24m:LFCR -11.04 -50.44 to 28.36 0.83 
 
24m:LF vs. 24m:LFCR -63.77 -106.3 to -21.22 0.00 
     
Cdca8 6m:LF vs. 6m:LFCR 6.973 -13.78 to 27.72 0.75 
 
6m:LF vs. 24m:LF 30.51 8.101 to 52.92 0.01 
 
6m:LFCR vs. 24m:LFCR -0.9638 -21.71 to 19.78 1.00 
 
24m:LF vs. 24m:LFCR -24.5 -46.91 to -2.092 0.03 
     
Cenpe 6m:LF vs. 6m:LFCR 10.46 -21.21 to 42.13 0.76 
 
6m:LF vs. 24m:LF 28.05 -6.162 to 62.25 0.05 
 
6m:LFCR vs. 24m:LFCR -11.97 -43.64 to 19.70 0.68 
 
24m:LF vs. 24m:LFCR -29.56 -63.77 to 4.649 0.05 
     





6m:LF vs. 24m:LF 23.7 -0.3931 to 47.79 0.04 
 
6m:LFCR vs. 24m:LFCR 0.6571 -21.65 to 22.96 1.00 
 
24m:LF vs. 24m:LFCR -25.61 -49.70 to -1.516 0.04 
     
Acsl3 6m:LF vs. 6m:LFCR -176.2 -375.8 to 23.30 0.05 
 
6m:LF vs. 24m:LF -0.8748 -216.4 to 214.6 1.00 
 
6m:LFCR vs. 24m:LFCR -23.32 -222.9 to 176.2 0.98 
 
24m:LF vs. 24m:LFCR -198.7 -414.2 to 16.84 0.05 
     
Scd2 6m:LF vs. 6m:LFCR -951.6 -1810 to -93.23 0.03 
 
6m:LF vs. 24m:LF 262.2 -664.9 to 1189 0.95 
 
6m:LFCR vs. 24m:LFCR 632.9 -225.4 to 1491 0.21 
 
24m:LF vs. 24m:LFCR -580.9 -1508 to 346.2 0.16 
     
Lpcat4 6m:LF vs. 6m:LFCR -251.1 -404.0 to -98.26 0.00 
 
6m:LF vs. 24m:LF 142.4 -22.67 to 307.5 0.06 
 
6m:LFCR vs. 24m:LFCR 273.6 120.7 to 426.4 0.00 
 
24m:LF vs. 24m:LFCR -120 -285.1 to 45.15 0.06 
     
Elovl6 6m:LF vs. 6m:LFCR -321.8 -810.3 to 166.6 0.05 
 
6m:LF vs. 24m:LF -78.98 -606.6 to 448.6 0.97 
 
6m:LFCR vs. 24m:LFCR 26.56 -461.9 to 515.0 1.00 
 
24m:LF vs. 24m:LFCR -216.3 -743.9 to 311.3 0.62 
     
Chrebp 6m:LF vs. 6m:LFCR 61.02 -180.8 to 302.8 0.87 
 
6m:LF vs. 24m:LF -144.3 -405.5 to 116.9 0.39 
 
6m:LFCR vs. 24m:LFCR -253.7 -495.5 to -11.84 0.04 
 
24m:LF vs. 24m:LFCR -48.33 -309.5 to 212.9 0.94 
     
Mgam 6m:LF vs. 6m:LFCR -182.5 -1158 to 792.9 0.94 
 
6m:LF vs. 24m:LF 286.6 -688.8 to 1262 0.82 
 
6m:LFCR vs. 24m:LFCR -199.5 -1175 to 775.9 0.93 
 
24m:LF vs. 24m:LFCR -668.6 -1644 to 306.8 0.23 
     
Sis 6m:LF vs. 6m:LFCR -312.8 -969.1 to 343.5 0.51 
 
6m:LF vs. 24m:LF 212.4 -496.5 to 921.3 0.80 
 
6m:LFCR vs. 24m:LFCR -214.4 -870.8 to 441.9 0.76 
 
24m:LF vs. 24m:LFCR -739.6 -1449 to -30.73 0.04 
     
Khk 6m:LF vs. 6m:LFCR 11.63 -373.9 to 397.2 1.00 
 
6m:LF vs. 24m:LF -413.2 -829.6 to 3.282 0.05 
 
6m:LFCR vs. 24m:LFCR -515.9 -901.5 to -130.4 0.01 
 
24m:LF vs. 24m:LFCR -91.13 -507.6 to 325.3 0.91 




Fbp1 6m:LF vs. 6m:LFCR -8.73 -89.66 to 72.20 0.99 
 
6m:LF vs. 24m:LF -56.57 -144.0 to 30.85 0.26 
 
6m:LFCR vs. 24m:LFCR -86.26 -167.2 to -5.331 0.04 
 
24m:LF vs. 24m:LFCR -38.43 -125.8 to 48.99 0.57 
     
Sglt1 6m:LF vs. 6m:LFCR -126.9 -1099 to 844.7 0.98 
 
6m:LF vs. 24m:LF -562.5 -1612 to 487.0 0.41 
 
6m:LFCR vs. 24m:LFCR -918.1 -1890 to 53.52 0.05 
 
24m:LF vs. 24m:LFCR -482.5 -1532 to 566.9 0.53 
     
Glut2 6m:LF vs. 6m:LFCR -183.9 -1111 to 743.5 0.93 
 
6m:LF vs. 24m:LF -860.7 -1862 to 141.0 0.10 
 
6m:LFCR vs. 24m:LFCR -1060 -1988 to -132.9 0.02 
 
24m:LF vs. 24m:LFCR -383.5 -1385 to 618.2 0.67 
     
Glut5 6m:LF vs. 6m:LFCR 333.7 -184.6 to 852.0 0.27 
 
6m:LF vs. 24m:LF 92.19 -426.1 to 610.5 0.95 
 
6m:LFCR vs. 24m:LFCR -497.5 -1016 to 20.81 0.04 
 
24m:LF vs. 24m:LFCR -256 -774.3 to 262.3 0.49 
     
Fgf15 6m:LF vs. 6m:LFCR -149.6 -473.8 to 174.7 0.53 
 
6m:LF vs. 24m:LF -118.7 -468.9 to 231.5 0.74 
 
6m:LFCR vs. 24m:LFCR 217.6 -106.7 to 541.8 0.24 
 
24m:LF vs. 24m:LFCR 186.7 -163.5 to 536.9 0.12 
     
Fxr 6m:LF vs. 6m:LFCR 73.58 -295.1 to 442.3 0.93 
 
6m:LF vs. 24m:LF 267.2 -131.0 to 665.5 0.24 
 
6m:LFCR vs. 24m:LFCR 193.6 -175.1 to 562.3 0.43 
 
24m:LF vs. 24m:LFCR -0.02196 -398.3 to 398.2 1.00 
     
Asbt 6m:LF vs. 6m:LFCR -400.1 -1282 to 481.5 0.54 
 
6m:LF vs. 24m:LF 552 -400.3 to 1504 0.35 
 
6m:LFCR vs. 24m:LFCR 1116 234.2 to 1997 0.01 
 
24m:LF vs. 24m:LFCR 163.7 -788.5 to 1116 0.95 
     
Osta 6m:LF vs. 6m:LFCR -47.55 -703.8 to 608.8 1.00 
 
6m:LF vs. 24m:LF 656.5 -52.38 to 1365 0.05 
 
6m:LFCR vs. 24m:LFCR 615.4 -40.91 to 1272 0.06 
 







Supplement 4.2 Ileal expression profiles of immune and carbohydrate related genes in mice fed 
with chow, LS, LS+In and LS+Comb. Significance was tested using a 1-way ANOVA with Tukey’s 
multiple comparison test. LS+In: LS diet enriched with inulin, LS+Comb: LS diet enriched with a 
combination of fibres. LS: Low sucrose version of the LF diet.  
 
 
Mean Diff. 95.00% CI of diff. P Value 
Oas1g 
    
 Chow vs. LS 13.9 2.825 to 24.91 0.01 
 Chow vs. LS+In 9.7 -1.322 to 20.77 0.09 
 Chow vs. LS+Combination -1.0 -12.07 to 10.02 0.99 
 LS vs. LS+In -4.1 -15.19 to 6.896 0.71 
 LS vs. LS+Combination -14.9 -25.94 to -3.850 0.01 
 LS+In vs. LS+Combination -10.8 -21.79 to 0.2978 0.06 
 
    
Oas3 
    
 Chow vs. LS 26.6 6.019 to 47.16 0.01 
 Chow vs. LS+In 22.1 1.496 to 42.64 0.03 
 Chow vs. LS+Combination 10.8 -9.731 to 31.41 0.46 
 LS vs. LS+In -4.5 -25.10 to 16.05 0.92 
 LS vs. LS+Combination -15.8 -36.32 to 4.822 0.17 
 LS+In vs. LS+Combination -11.2 -31.80 to 9.346 0.43 
 
    
Oasl2 
    
 Chow vs. LS 75.6 -14.79 to 166.0 0.12 
 Chow vs. LS+In 66.2 -24.23 to 156.5 0.20 
 Chow vs. LS+Combination 0.8 -89.59 to 91.18 1.00 
 LS vs. LS+In -9.4 -99.82 to 80.94 0.99 
 LS vs. LS+Combination -74.8 -165.2 to 15.58 0.04 
 LS+In vs. LS+Combination -65.4 -155.7 to 25.02 0.21 
 
    
H2-aa 
    
 Chow vs. LS 866.3 -95.74 to 1828 0.09 
 Chow vs. LS+In 456.4 -505.6 to 1418 0.54 
 Chow vs. LS+Combination -254.6 -1217 to 707.4 0.87 
 LS vs. LS+In -409.8 -1372 to 552.2 0.62 
 LS vs. LS+Combination -1121.0 -2083 to -158.9 0.02 
 LS+In vs. LS+Combination -711.1 -1673 to 250.9 0.19 
 
    
H2-ab1 
    
 Chow vs. LS 806.7 -132.5 to 1746 0.11 
 Chow vs. LS+In 406.7 -532.5 to 1346 0.61 
 Chow vs. LS+Combination -303.1 -1242 to 636.2 0.79 
 LS vs. LS+In -400.0 -1339 to 539.3 0.62 
 LS vs. LS+Combination -1110.0 -2049 to -170.5 0.02 





    
H2-dmb1 
    
 Chow vs. LS 45.8 -26.03 to 117.5 0.30 
 Chow vs. LS+In 7.8 -63.94 to 79.62 0.99 
 Chow vs. LS+Combination -39.8 -111.6 to 31.97 0.41 
 LS vs. LS+In -37.9 -109.7 to 33.88 0.45 
 LS vs. LS+Combination -85.6 -157.3 to -13.78 0.02 
 LS+In vs. LS+Combination -47.7 -119.4 to 24.13 0.27 
 
    
Ifit 
    
 Chow vs. LS 18.0 -2.943 to 38.88 0.11 
 Chow vs. LS+In 14.5 -6.460 to 35.36 0.24 
 Chow vs. LS+Combination -3.2 -24.08 to 17.75 0.97 
 LS vs. LS+In -3.5 -24.43 to 17.39 0.96 
 LS vs. LS+Combination -21.1 -42.04 to -0.2224 0.05 
 LS+In vs. LS+Combination -17.6 -38.53 to 3.294 0.12 
 
    
Ubd 
    
 Chow vs. LS 88.6 -51.11 to 228.3 0.30 
 Chow vs. LS+In 88.6 -51.11 to 228.3 0.30 
 Chow vs. LS+Combination -61.6 -201.3 to 78.10 0.60 
 LS vs. LS+In 0.0 -139.7 to 139.7 1.00 
 LS vs. LS+Combination -150.2 -290.0 to -10.51 0.03 
 LS+In vs. LS+Combination -150.2 -290.0 to -10.51 0.03 
 
    
Tap1 
    
 Chow vs. LS 27.2 -13.04 to 67.52 0.25 
 Chow vs. LS+In 22.2 -18.04 to 62.52 0.42 
 Chow vs. LS+Combination -14.9 -55.18 to 25.38 0.72 
 LS vs. LS+In -5.0 -45.29 to 35.28 0.98 
 LS vs. LS+Combination -42.1 -82.42 to -1.862 0.04 
 LS+In vs. LS+Combination -37.1 -77.42 to 3.143 0.08 
 
    
Gzmb 
    
 Chow vs. LS 20.5 0.9119 to 40.04 0.04 
 Chow vs. LS+In 17.4 -2.158 to 36.97 0.09 
 Chow vs. LS+Combination 6.2 -13.38 to 25.75 0.80 
 LS vs. LS+In -3.1 -22.64 to 16.50 0.97 
 LS vs. LS+Combination -14.3 -33.86 to 5.275 0.20 
 LS+In vs. LS+Combination -11.2 -30.79 to 8.345 0.39 
 
    
Zbp1 
    
 Chow vs. LS 28.1 -11.46 to 67.74 0.22 




 Chow vs. LS+Combination -13.9 -53.46 to 25.74 0.75 
 LS vs. LS+In -3.4 -42.96 to 36.25 0.99 
 LS vs. LS+Combination -42.0 -81.60 to -2.396 0.04 
 LS+In vs. LS+Combination -38.6 -78.25 to 0.9606 0.06 
 
    
Mgam 
    
 Chow vs. LS -520.4 -765.8 to -275.0 0.0001 
 Chow vs. LS+In -1188.0 -1433 to -942.6 0.0001 
 Chow vs. LS+Combination -1197.0 -1442 to -951.4 0.0001 
 LS vs. LS+In -667.5 -912.9 to -422.2 0.0001 
 LS vs. LS+Combination -676.3 -921.7 to -431.0 0.0001 
 LS+In vs. LS+Combination -8.8 -254.2 to 236.6 1.00 
 
    
Sis 
    
 Chow vs. LS -412.4 -836.6 to 11.83 0.05 
 Chow vs. LS+In -1089.0 -1513 to -664.3 0.0001 
 Chow vs. LS+Combination -1103.0 -1528 to -679.3 0.0001 
 LS vs. LS+In -676.2 -1100 to -252.0 0.002 
 LS vs. LS+Combination -691.1 -1115 to -266.9 0.001 
 LS+In vs. LS+Combination -14.9 -439.1 to 409.3 1.00 
 
    
Khk 
    
 Chow vs. LS -216.5 -365.0 to -67.97 0.004 
 Chow vs. LS+In -185.6 -334.1 to -37.10 0.01 
 Chow vs. LS+Combination -102.9 -251.4 to 45.57 0.24 
 LS vs. LS+In 30.9 -117.6 to 179.4 0.93 
 LS vs. LS+Combination 113.5 -34.95 to 262.0 0.17 
 LS+In vs. LS+Combination 82.7 -65.82 to 231.2 0.41 
 
    
Aldob 
    
 Chow vs. LS -232.5 -1020 to 555.6 0.83 
 Chow vs. LS+In -828.5 -1617 to -40.44 0.04 
 Chow vs. LS+Combination -1050.0 -1838 to -262.0 0.01 
 LS vs. LS+In -596.0 -1384 to 192.0 0.18 
 LS vs. LS+Combination -817.6 -1606 to -29.55 0.04 
 LS+In vs. LS+Combination -221.6 -1010 to 566.5 0.85 
 
    
Fbp1 
    
 Chow vs. LS -14.8 -41.93 to 12.43 0.43 
 Chow vs. LS+In -41.9 -69.09 to -14.74 0.002 
 Chow vs. LS+Combination -36.7 -63.86 to -9.501 0.007 
 LS vs. LS+In -27.2 -54.34 to 0.01358 0.05 
 LS vs. LS+Combination -21.9 -49.11 to 5.249 0.14 





    
Sglt1 
    
 Chow vs. LS -601.9 -876.8 to -327.0 0.0001 
 Chow vs. LS+In -542.8 -817.7 to -267.9 0.0002 
 Chow vs. LS+Combination -226.5 -501.4 to 48.38 0.13 
 LS vs. LS+In 59.14 -215.8 to 334.0 0.93 
 LS vs. LS+Combination 375.4 100.5 to 650.3 0.0062 
 LS+In vs. LS+Combination 316.3 41.35 to 591.2 0.02 
 
    
Glut2  
    
 Chow vs. LS -64.0 -114.0 to -13.96 0.010 
 Chow vs. LS+In -75.1 -125.1 to -25.08 0.003 
 Chow vs. LS+Combination -34.5 -84.49 to 15.55 0.24 
 LS vs. LS+In -11.1 -61.14 to 38.91 0.92 
 LS vs. LS+Combination 29.5 -20.51 to 79.53 0.36 
 LS+In vs. LS+Combination 40.6 -9.396 to 90.65 0.13 
 
    
Fgf15 
    
 Chow vs. LS -52.6 -74.77 to -30.39 0.0001 
 Chow vs. LS+In 9.2 -13.02 to 31.36 0.65 
 Chow vs. LS+Combination 10.6 -11.55 to 32.83 0.53 
 LS vs. LS+In 61.8 39.56 to 83.94 0.0001 
 LS vs. LS+Combination 63.2 41.04 to 85.42 0.0001 
 LS+In vs. LS+Combination 1.5 -20.71 to 23.67 1.00 
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The End 
